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Abstract 
Apicomplexan parasites of the genus Plasmodium are the causative agents of 
malaria, which along with tuberculosis and AIDS contributes to half of all human 
deaths from infectious disease. Five different Plasmodium species are known to 
cause malaria infections in humans with approximately 220 million new 
infections attributed each year. The major species in regards to disease severity 
and prevalence is P. falciparum. Great effort has been applied to eradication of 
malaria but this disease remains a major global health and economic burden. A 
major obstacle to eradication efforts is the widespread resistance to commonly 
used therapies. Improving our understanding of resistance mechanisms and 
identifying novel drug targets are essential weapons in the fight against malaria. 
A sound understanding of the basic biology of Plasmodium parasites is therefore 
vital. 
Autophagy is a cellular process believed to be conserved amongst all eukaryotes 
but has not yet been characterised in P. falciparum. Exploring this process in P. 
falciparum might lead to the elucidation of exploitable drug targets for future 
therapeutic intervention strategies. Autophagy is a homeostatic process 
facilitating the lysosomal turnover of long-lived proteins and cellular 
components. It can also be upregulated in response to triggers such as nutrient 
deprivation and during periods of cellular remodelling. It would seem likely that 
P. falciparum might rely on autophagy during the multiple differentiation events 
needed throughout its complex life cycle and when adapting to changes in 
cellular environments with varying nutrient availabilities. 
A number of proteins are known to be involved in autophagy in other organisms. 
This study aimed to explore the potential process of autophagy in P. falciparum 
via the characterisation of a major autophagy-related protein, ATG8. This 
protein is commonly used as a marker for autophagy in other organisms as its 
expression level, lipidation state and localisation are indicative of an active 
autophagic process. A bioinformatic screen of the P. falciparum genome 
revealed genes likely to encode ATG8 and other autophagy-related proteins. The 
putative ATG8 (PfATG8) was shown to be a functional homologue of the ATG8 of 
Saccharomyces cerevisiae, the reference organism for autophagy and was also 
iii 
found to be differentially expressed during the intraerythrocytic development of 
P. falciparum. In order to benefit further characterisation of PfATG8, transgenic 
P. falciparum lines were generated in which fluorescently tagged PfATG8 fusion 
proteins were expressed. These were used to demonstrate that PfATG8 is post-
translationally modified via lipid conjugation, similar to ATG8 in other 
organisms. Through the expression of a truncated version of a fluorescently 
tagged PfATG8, this lipid modification was shown to be entirely dependent on 
the C-terminal glycine residue of PfATG8, as has been demonstrated for other 
ATG8 homologues. However, in contrast to ATG8 homologues in other organisms, 
PfATG8 did not appear to be involved in a canonical autophagic process. 
Attempts to influence PfATG8 expression, lipidation or localisation through 
methods known to manipulate autophagy in other organisms failed to illicit a 
response. It was instead found that PfATG8 specifically localises to the 
apicoplast of P. falciparum, likely via association with the organelle’s outer 
membrane(s). When the apicoplast was disrupted, PfATG8 was seen to associate 
with apicoplast-targeted vesicles. The properties displayed by PfATG8 in the 
intraerythrocytic stages of P. falciparum, led to the hypothesis that it may play 
a role in apicoplast homeostasis, potentially via participation in the relatively 
enigmatic processes behind delivery of apicoplast-targeted proteins and lipids to 
the developing organelle. This is in starck contrast to the ATG8 homologue in the 
closely related parasite Toxoplasma gondii, which has been reported to function 
in mitochondrial homeostasis. Deletion of the Pfatg8 gene was not possible, even 
when the fluorescently tagged copy of the PfATG8 protein was co-expressed by 
the parasites. This suggested that the PfATG8 protein may have an essential role 
in the survival of P. falciparum erythrocytic stages. 
The apparent parasite-specific role for PfATG8 not observed for human ATG8 
homologues coupled with the potential essentiality of this role may prove to be 
exploitable for therapeutic design. 
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UV   Ultraviolet 
V   Volt 
v/v   Volume per volume 
w/v   Weight per volume 
WHO   World Health Organisation 
X-Gal  5-bromo-4-chloro-indolyl-β-D-galactopyranoside 
YNB  Yeast nitrogen base 
YPD medium Yeast extract peptone glucose medium 
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1   Introduction to malaria and autophagy 
1.1   Malaria and Plasmodium falciparum 
Malaria is one of the most important public health concerns globally with around 
half of the world’s population, 3.3 billion people, at risk. It is found in over 100 
countries mainly in sub-Saharan Africa, but also in other tropical regions (Figure 
1.1). In 2010, approximately 220 million new cases were reported, leading to an 
estimated 655,000 deaths, 90 % of which were in Africa (World Health 
Organisation (WHO)(a)). Most fatalities occur in vulnerable groups – children 
under 5 years old, pregnant women and immune-compromised individuals (Desai 
et al., 2007).  
Malaria is caused in humans by infection with one (or more) of five species of 
protozoan parasites of the genus Plasmodium; P. falciparum, P. vivax, P. ovale, 
P. malariae and P. knowlesi. Plasmodium parasites are transmitted to humans by 
female Anopheles mosquitoes. About 30 – 40 species of Anopheles mosquito can 
act as a vector for the human malaria Plasmodium spp. (Centers for Disease 
Control and Prevention (CDC)).  As the sexual development of the parasite 
occurs in the mosquito vector, malaria endemic areas only occur in regions 
where Anopheles mosquitoes are found. Disease burden is therefore intrinsically 
linked to mosquito populations and transmission rates. These can be greatly 
influenced by environmental factors such as rain fall, resulting in a malaria 
‘season’ coinciding with periods when rainfall is high and mosquito breeding 
rates are high. As well as seasonal variations in transmission and infection rates, 
expansion of mosquito environments, such as following flooding, or large scale 
movement of humans, can both have a large effect on transmission and infection 
rates. This can be particularly heightened when individuals from non-endemic 
areas, who will have poor immunity due to lack of exposure, move into a malaria 
endemic region. Crucially, environmental factors also affect the ability of 
Plasmodium parasites to execute sexual development, with environmental 
temperature known to be a controlling factor in developmental transition 
(Ogwan'g et al., 1993). This contributes to the fact that malaria is not endemic 
in many regions where Anopheles mosquitoes are present. Recently, vector 
control strategies appear to be having an impressive impact on disease control 
(Karunamoorthi, 2011).  
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Typical clinical symptoms of malaria include high fever, malaise, myalgia and 
vomiting (CDC). These symptoms will be absent for the first 10 – 15 days after 
the actual inoculation event and then often occur in bouts every 24 – 72 hours, 
depending on the species of parasite responsible for infection. More severe 
symptoms are associated with infection by P. falciparum. These can include 
severe anaemia, acute renal failure, pulmonary oedema and coma, resulting 
from infection of the central nervous system. These severe disease outcomes are 
largely the result of the ability of the P. falciparum parasite to cause the 
adhesion of infected and uninfected red blood cells in small capillaries, resulting 
in the disruption of blood flow to vital organs (Franke-Fayard et al., 2010).   
As well as being a major health concern, malaria represents a major economic 
burden in endemic regions.  Malaria has been calculated to be responsible for a 
1 % reduction of gross domestic product in some endemic countries (WHO(a)). 
Loss of working productivity, combined with the requirement for up to 40 % of 
total public health expenditure to be dedicated to tackling malaria, contribute 
to the fact that malaria disproportionately affects the poorest countries of the 
world.  
Malaria mortality rates have fallen by 25 % globally since 2010 (WHO(b)). 
Improving diagnostic, treatment and preventative methods, including insecticide 
spraying and use of bed nets have contributed to this decrease. Malaria is 
currently the focus of improved elimination and global eradication efforts 
(Alonso et al., 2011, Feachem and Sabot, 2008). However, resistance to 
commonly used treatment therapies is a growing problem (Volkman et al., 2012) 
and no vaccine for malaria is currently available for widespread employment 
(Schwartz et al., 2012). With a limited repertoire of available anti-malarial 
drugs and no decision on the implementation of a malaria vaccine until 2015 
(WHO(c)), it seems that eradication will not be achievable without further 
advances in these areas. 
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Web resources used for this section include:- 
 
WHO(a) (http://www.who.int/features/factfiles/malaria/index/en) [Last accessed 
14/09/2012]. 
WHO(b) (http://www.who.int/topics/malaria/en) [Last accessed 14/09/2012]. 
WHO(c) (http://www.who.int/mediacentre/factsheets/fs094/en/index.html) [Last accessed 
14/09/2012]. 
CDC (http://www.cdc.gov/malaria/about/index) [Last accessed 14/09/2012]. 
 
 
Figure 1.1: Global malaria prevalence in 2010. 
Malaria is endemic in over 100 countries, primarily in sub-Saharan Africa, South and South 
East Asia and South America. Malaria has been eliminated from 28 countries including the 
United States of America in 1951 (WHO, 2011). Countries shaded red have a high prevalence 
of malaria. Countries shaded green have no communicable transmission of malaria. 
Printed with permission from the World Health Organisation. (Original legend reads ‘The 
boundaries and names shown and the designations used on this map do not imply the 
expression of any opinion whatsoever on the part of the World Health Organisation 
concerning the legal status of any country, territory, city or area or of its authorities, or 
concerning the delimitation of its frontiers or boundaries’). 
 
1.1.1  Exoerythrocytic development 
The life cycle of Plasmodium spp. is complex, involving developmental 
transitions in both the Anopheles mosquito and the mammalian host. The life 
cycle can be roughly divided into the asexual cycle, which takes place in the 
mammalian host, and the sexual stages of development, which take place in the 
mosquito vector (Figure 1.2). Upon taking a blood meal from an infected 
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mammal, a female Anopheles mosquito will acquire female macrogametocytes 
and male microgametocytes that circulate in the mammalian host’s peripheral 
blood (Alano, 2007). The sudden change in environment triggers rapid cellular 
remodelling and exit from host erythrocytes. The male microgametocyte 
converts into up to 8 motile flagellated microgametes, which are capable of 
fertilizing a female macrogamete, which emerges from its erythrocyte in an 
enlarged spherical form. The zygote, which forms following fertilization, is 
capable of surviving in the hostile environment of the mosquito gut, where it 
develops further, firstly into a tetraploid motile ookinete, and then into an 
oocyst following meiosis (Sinden et al., 1985). The motility of the ookinete 
facilitates traversal of the peritrophic membrane and a layer of midgut cells, 
enabling the development of the oocyst on the basal lamina (Matuschewski, 
2006). Approximately 12 days later the oocyst has developed into a sporoblast, 
in which sporozoites form through multiple rounds of asexual proliferation. 
Sporozoites then actively egress from the sporoblast and enter the haemolymph 
system and eventually make their way into the salivary glands following 
penetration of the surrounding acinar cells (Matuschewski, 2006). 
Upon reaching the salivary glands, sporozoites mature into an invasion 
competent form capable of gliding motility. This is an actin-dependent motility 
mechanism that allows transit across a substrate (Morahan et al., 2009). This 
motility facilitates transit through the skin, away from the bite site, where 
sporozoites are introduced in varying numbers during salivation of a feeding 
mosquito (Hellmann et al., 2011, Singer and Frischknecht, 2012). Sporozoites 
must then reach the liver where they invade hepatocytes and reside within the 
replication-permissive intravacuolar niche of the parasitophorous vacuole (PV) 
(Matuschewski, 2006). The route they take is still not completely clear (Baldacci 
and Menard, 2004). They can either enter the bloodstream or lymphatic 
circulation in order to reach the liver. These processes may or may not involve 
the penetration of additional cell types, such as immunocompetent cells in the 
lymphatic system (Krettli and Dantas, 2000). Once at the liver, sporozoites are 
sequestered via interaction of their predominant surface protein, 
circumsporozoite protein, with subsets of heparan sulphate proteoglycans 
abundant on liver endothelial cells (Baldacci and Menard, 2004). Sporozoites 
sequestered in the liver can then invade hepatocytes, likely after penetration of 
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specialised macrophages called Kupffer cells, which line the liver sinusoid. Once 
residing within a PV inside a hepatocyte, sporozoites differentiate and undergo 
massive asexual multiplication over 5 – 15 days, depending on species, to form 
up to 30,000 erythrocyte-infective merozoites (Mikolajczak et al., 2011). The 
liver stages of P. vivax and P. ovale are capable of differentiating into dormant 
hypnozoite forms, which can cause relapses of disease many years after the 
initial infection (Markus, 2012). The mechanism of merozoite release may also 
differ according to species. In P. berghei and P. yoelii, breakdown of the PV 
precedes the release of merosomes, large membrane-bound vesicles containing 
multiple merozoites, which ensures that the released merozoites reach the 
bloodstream before being exposed to the host immune response (Sturm et al., 
2006). This process has not yet been elucidated in P. falciparum (Prudencio et 
al., 2006).  
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Figure 1.2: Life cycle of Plasmodium spp. (taken from (Wirth, 2002)). 
(a) Sporozoites injected into the skin by a feeding female Anopheles mosquito make their 
way to the liver where they invade hepatocytes. Asexual development leads to the release 
of tens of thousands of erythrocyte-infective merozoites into the bloodstream. Invasion of 
erythrocytes allows further asexual multiplication to form about 20 newly infective 
merozoites. A population of asexual erythrocytic stage parasites switch to develop into 
sexual gametocyte forms. 
(b) Gametocytes circulate in the bloodstream and are taken up into the midgut of a feeding 
mosquito. Following further differentiation into gametes, they fertilize each other to form a 
zygote. The zygote differentiates further into a motile ookinete and then an oocyst, in which 
asexual multiplication generates sporozoites. Sporozoites then travel to the mosquito 
salivary glands ready to be injected into another mammalian host. 
Printed with permission from the Nature Publishing Group. 
 
1.1.2  Intraerythrocytic development 
Merozoites begin the asexual, intraerythrocytic cycle by invasion and 
multiplication within circulating erythrocytes. P. falciparum parasites are able 
to cause rosetting; clustering of infected and uninfected erythrocytes and 
interaction with blood vessel endothelial cells (Chen et al., 1998). This is 
associated with more severe disease outcomes (Rowe et al., 1997). Erythrocytes 
are often considered to be cellular bags of haemoglobin specialised for the 
transport of O2 and CO2 around the mammalian body (Tilley et al., 2011). 
Haemoglobin is a metalloprotein which is modified to oxyhaemoglobin, which 
transports O2 from the lungs to the rest of the body and carbaminohaemoglobin, 
which transports CO2 back to the lungs (Klinken, 2002). Merozoites can invade an 
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erythrocyte within seconds (Boyle et al., 2010, Cowman and Crabb, 2006). 
Development within an erythrocyte again varies according to species. P. 
falciparum parasites progress through ring, trophozoite and schizont stages, 
before forming on average 20 new merozoites within 48 hours of the initial 
invasion event (Tilley et al., 2011). While residing in host erythrocytes, parasites 
avoid the display of their antigens via major histocompatibility complexes that 
would usually be the case in other cell types. However, in balance they must 
contend with the lack of host cell endocytic and secretory pathways which might 
be exploited to target host cell contents to the resident parasite. 
Intraerythrocytic parasites counter this potential obstacle by remodelling the 
host erythrocyte with parasite-derived tubular networks to both expand the 
effective surface area of interaction between parasite and host cell and to 
facilitate the export and import of extracellular factors (Hanssen et al., 2010, 
Silvie et al., 2008). The characteristic amoeboid appearance of trophozoite 
stage parasites is shown in Figure 1.3. While within the erythrocyte, Plasmodium 
parasites consume around 75 % of the erythrocyte’s haemoglobin, primarily as a 
source of nutrients but also as a way of regulating osmotic integrity and as a way 
of generating space for development (Abu Bakar et al., 2010). Continuation of 
the intraerythrocytic cycle can be almost perpetual (Cox, 2010) and is 
responsible for the majority of the disease pathology (Tilley et al., 2011). The 
completion of the parasite life cycle occurs with the differentiation of a subset 
of erythrocytic asexual parasites into the sexual gametocyte stages (Reininger et 
al., 2012). Male and female gametocytes are characterised by the presence of a 
sub-pellicular membrane complex analogous to the inner membrane complex 
seen in other Apicomplexan parasites (Dearnley et al., 2012). The gametocytes 
of P. falciparum transition through 5 distinct stages before reaching a point at 
which, following ingestion by a feeding Anopheles mosquito, microgametes and 
macrogametes can be formed (Baker, 2010). 
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Figure 1.3: Schematic representation of a trophozoite stage P. falciparum parasite. (taken 
from (Bannister et al., 2000)). 
The trophozoite stage parasite resides within a host erythrocyte and is surrounded by a 
parasitophorous vacuole (not shown). An amoeboid form with surface extensions and 
invaginations increases the area of interaction with the host erythrocyte. The parasite 
ingests host erythrocyte cytosol and digests haemoglobin, generating haemozoin pigment 
crystals as waste. The nucleus, mitochondrion, apicoplast and other organelles develop as 
the parasite undergoes multiplication via schizogony.  
Printed with permission from the Elsevier Publishing Group. 
 
1.1.3  Cellular differentiation and organelle biology 
The ring, trophozoite, schizont and merozoite stages that constitute the 
erythrocytic asexual cycle are characterised by their differing cellular 
architecture, organellar composition and metabolism, underpinned by 
differential gene expression (Bozdech et al., 2003, Otto et al., 2010). A great 
deal of cellular remodelling is needed concurrently and at each transitional 
stage of parasite development along with tightly controlled temporal protein 
expression (Florens et al., 2002). This is typified by the de novo biogenesis of 
stage-specific organelles and their subsequent loss upon transition to 
downstream stages of development. Merozoites and other parasite stages 
possess a core set of organelles common to most eukaryotes, such as a nucleus, 
endoplasmic reticulum, a simplified Golgi network and a single mitochondrion 
(Tilley et al., 2011). The parasite also possesses an apicoplast, a remnant plastid 
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derived from secondary endosymbiosis (McFadden et al., 1996). At various stages 
the parasite also develops a variety of parasite-specific organelles. In 
intraerythrocytic parasites a lysosome-like compartment called the digestive 
vacuole (DV) is formed (Abu Bakar et al., 2010), while in merozoite stage 
parasites a set of apical organelles can be found. These are composed of the 
rhoptries, micronemes, exonemes and  dense granules and are essential for the 
invasion of host cells (Bannister and Mitchell, 2009).  
1.1.3.1   Apical organelles and invasion 
The apical organelles give Apicomplexan parasites their name (Cowman and 
Crabb, 2006). Late in schizogony, proteins needed for invasion of new 
erythrocytes are expressed and packaged into the apical organelles ready for 
release when merozoites egress from an erythrocyte and invade another (Figure 
1.4) (Srivastava et al., 2010). It remains uncertain quite how the micronemes 
and rhoptries are generated de novo each asexual cycle; the precursors from 
which these organelles are generated have yet to be identified (Baumeister et 
al., 2010). Compartmentalisation of these different proteins allows the tightly 
controlled release of specific proteins exactly when they are needed during the 
complex and rapid, parasite controlled process of invasion (Cowman and Crabb, 
2006, Preiser et al., 2000).  
Merozoites must first recognise invasion-competent erythrocytes, a process that 
is low in affinity and reversible to avoid adherence to other types of cell, 
including already infected erythrocytes (Pei et al., 2007). Stronger interactions 
then precede merozoite reorientation so that their apical end is in contact with 
the selected erythrocyte (Crosnier et al., 2011), causing a deformation of the 
erythrocyte membrane as they do so (Mitchell et al., 2004). Invasion of the 
erythrocyte is then mediated by the formation of a tight junction complex, a 
component of which is an actin-myosin motor which actively drives the 
merozoite forward into the erythrocyte (Angrisano et al., 2012). Invasion into 
the erythrocyte in this manner, without rupture of the erythrocyte membrane, 
leaves the invaded merozoite enclosed within a membrane called the 
parasitophorous vacuole, apparently derived from both parasite and host lipids 
(Preiser et al., 2000). Following invasion, these organelles are lost as the 
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parasite converts to a ring stage. The process(es) involved in the turnover of 
apical organelles remains largely unknown (Jayabalasingham et al., 2010). 
 
 
Figure 1.4: Schematic representation of a merozoite stage P. falciparum parasite (taken 
from (Bannister and Mitchell, 2009)). 
The merozoite stage parasite is released from host hepatocytes or erythrocytes following 
multiplication via schizogony. Merozoites are polarised and possess a complement of apical 
organelles not maintained in the intraerythrocytic stages. The micronemes, rhoptries, 
exonemes and dense granules localise to the apical prominence and the whole cell is 
surrounded by a proteinaceous merozoite coat. 
Printed with permission from Cambridge University Press. 
 
1.1.3.2   Digestive vacuole and nutrient acquisition 
Similarly to other parasitic eukaryotes, Plasmodium parasites possess a full 
complement of biosynthetic pathway components for only 6 non-essential amino 
acids, and can not generate any of the 9 essential amino acids they need de 
novo (Payne and Loomis, 2006). The nutrient-rich environment of the parasite’s 
host appears to have allowed the loss of non-essential biosynthetic pathways 
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while concurrent expansion of the mechanisms of amino acid acquisition, either 
from host cells or the extracellular environment, appears to have fulfilled the 
amino acid requirements of Plasmodium parasites (Istvan et al., 2011). 
Haemoglobin degradation has been shown to be one such important mechanism 
and is sufficient to provide intraerythrocytic parasites with the nutrients needed 
to make all 20 amino acids except for isoleucine (Liu et al., 2006).  
Plasmodium parasites invade host red blood cells and feed on haemoglobin. The 
toxic by-product of haemoglobin breakdown, Fe(II)-protoporphyrin IX, is 
sequestered into a cyclic dimer. These dimers link and assemble via an ordered 
bio-crystallisation process (Hempelmann et al., 2003), forming insoluble 
haemozoin crystals which are predominantly found in a specialised organelle 
called the digestive vacuole (DV) (Kapishnikov et al., 2012). 
Compartmentalisation of this process into the DV allows for control of the 
production and detoxification of Fe(II)-protoporphyrin IX. The Plasmodium DV is 
distinct from lysosomes and the vacuole of yeast, as it does not contain other 
hydrolases commonly found in lysosomes and appears to be specialised solely for 
haemoglobin degradation (Goldberg et al., 1990). 
The origin(s) of the DV remain unresolved. It is thought to be formed by the 
fusion of haemoglobin-containing vesicles derived from the cytostome, a 
microtubule-supported focus of membrane invagination and vesicle formation 
unique to protozoa (Abu Bakar et al., 2010). It has also been suggested that the 
initial formation of the DV is mediated by a single event distinct from 
macropinocytosis or phagocytosis in that it does not require actin polymerisation 
(Elliott et al., 2008). This event, termed the ‘big gulp’ involves the folding over 
of the flattened early ring stage parasite to envelop a portion of host 
erythrocyte cytosol equivalent to up to 40 % of the parasite volume. This forms 
the DV which then expands following the fusion of haemoglobin-containing 
vesicles derived from either the cytostome or from smaller scale ‘gulps’. Either 
mechanism requires the breakdown of the nascent DV’s inner membrane, 
acidification of its lumen and the delivery of haemoglobin degrading enzymes 
before DV maturity is made evident by the presence of distinctive haemozoin 
crystals (Abu Bakar et al., 2010). However, a degree of haemoglobin degradation 
has also been observed in haemoglobin-containing vesicles prior to or in the 
absence of fusion with the DV (Abu Bakar et al., 2010, Hempelmann et al., 
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2003). Parasites appear to digest haemoglobin until late in intraerythrocytic 
development and when merozoites egress from an erythrocyte, remnants of the 
DV remain as part of the residual body (Dluzewski et al., 2008). The routes of DV 
formation and haemoglobin uptake from host erythrocyte cytosol are 
summarised in Figure 1.5.  
 
Figure 1.5: Schematic representation of haemoglobin uptake. 
1. Early ring stage parasites have been proposed to engulf a large proportion of host cell 
contents in an initial ‘big gulp’. 
2. The predominant uptake mechanism in late rings and trophozoite stage parasites is via the 
cytostome, a structure from which small haemoglobin-containing vesicles (sHVs) bud and 
traffic to the digestive vacuole (DV), which is formed following either the big gulp or from 
fusion of multiple sHVs. Degradation of haemoglobin has also been shown to occur in sHVs 
before fusion with the DV. 
3. Cytostomes also contribute, in part, to haemoglobin uptake via the formation of 
cytostomal tubes. These elongated tubular invaginations of both the parasitophorous vacuole 
membrane (PVm) and parasite plasma membranes (PPm) either fuse directly with the DV, 
forming a corridor between the DV and host cytosol, or pinch of at either end before 
trafficking to the DV. 
4. An additional uptake mechanism predominant in the later stages of development involves 
the formation of large haemoglobin-containing vesicles or phagotrophs following a process 
similar to that which instigates the big gulp. 
 
1.1.3.3   Mitochondrion and apicoplast 
Plasmodium parasites possess only a single mitochondrion with a 6 kb genome 
(Waller and McFadden, 2005). In other organisms, one of the major but certainly 
not the only role of mitochondria is the oxidation of substrates in the 
tricarboxylic acid (TCA) cycle, which feeds electrons into the electron transport 
chain and hence provides energy in the form of ATP via a process known as 
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oxidative phosphorylation (McBride et al., 2006). However, asexual Plasmodium 
parasites appear to feed the majority of glucose acquired from the host blood 
serum into glycolysis, bypassing the TCA cycle as the pyruvate generated is 
converted into lactate rather than acetyl-CoA (Sherman, 2005). Therefore the 
mitochondrion in Plasmodium spp. is thought to have been maintained due to its 
involvement in processes distinct from energy production (van Dooren et al., 
2006). It has been suggested that mitochondrion of erythrocytic stage parasites 
primarily functions in pyrimidine biosynthesis (Painter et al., 2007). 
The genome of the Plasmodium mitochondrion is one of the smallest yet 
sequenced and encodes only 3 protein-coding genes, along with 20 rRNAs 
(Sherman, 2005). As such, the majority of mitochondrial proteins are nuclear-
encoded and must be trafficked back to the mitochondrion by one of a number 
of mechanisms (van Dooren et al., 2006). All proteins passing beyond the outer 
membrane of the mitochondrion have to pass through the translocator of the 
outer membrane (TOM) complex. An N-terminal leader sequence can target a 
nuclear-encoded protein for translocation via TOM, after which additional signal 
motifs within the protein can then direct it to different locations within the 
mitochondrion (Macasev et al., 2004). To continue on to the matrix of the 
mitochondrion, translocation of the inner membrane via the translocator of the 
inner membrane (TIM) complex is required (Pfanner and Wiedemann, 2002). To 
be integrated into the inner membrane, proteins possessing additional signal 
motifs can either be inserted into the membrane directly via TIM22 and so called 
tiny-TIM proteins (Rehling et al., 2003), or from the matrix after translocation by 
TIM complexes via the activity of Oxa1 (Pfanner and Geissler, 2001). While a 
number of the proteins known to contribute to these processes appear to be 
conserved in Plasmodium spp. our understanding of mitochondrial targeting and 
import of nuclear-encoded proteins in P. falciparum is limited (van Dooren et 
al., 2006).  
Along with most Apicomplexan parasites, Plasmodium spp. possess a remnant 
plastid termed the apicoplast (Foth and McFadden, 2003). This organelle is 
bound by 4 membranes as a result of its origin by secondary endosymbiosis (Nair 
and Striepen, 2011). Apicomplexans, along with other chromalveolates arose 
from the uptake of a eukaryotic algal symbiont, possessing a photosynthetic 
chloroplast, by an ancestral eukaryotic protist (Botte et al., 2011). The 
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membranes of the apicoplast in Plasmodium spp. therefore represent, working 
from host cytosol to apicoplast lumen, the phagosomal membrane of the host, 
the plasma membrane of the engulfed alga, the outer chloroplast membrane and 
finally the inner chloroplast membrane (Lim and McFadden, 2010). 
The apicoplast of P. falciparum resembles its ancestral chloroplast in its semi-
autonomous nature facilitated by its own 35 kb genome and protein expression 
machinery but crucially has lost photosynthetic abilities (Wilson et al., 1996). It 
has been shown to contain components of isoprenoid biosynthesis, iron/sulphur 
cluster assembly, fatty acid, haem and lipoic acid biosynthetic pathways 
(DeRocher et al., 2012). Fatty acid synthesis and isoprenoid precursor synthesis 
appear to only occur within the apicoplast (Nair and Striepen, 2011), with the 
former being shown to be essential to development of liver stage parasites 
(Vaughan et al., 2009, Yu et al., 2008) and the later for blood stage parasites 
(Yeh and DeRisi, 2011). 
While the apicoplast appears to encode as few as 64 genes, many of which are 
rRNAs and tRNAs, up to 1,000 proteins might localise to the apicoplast (Foth et 
al., 2003, Waller and McFadden, 2005). Therefore transport of nuclear-encoded 
proteins into the organelle is an essential requirement for its function and 
presumably parasite survival (Waller et al., 1998). Recent identification of a 
nuclear-encoded endoplasmic reticulum associated protein degradation system 
(ERAD)-like complex, that is targeted to the second outermost apicoplast 
membrane has improved understanding of how nuclear-encoded proteins are 
targeted to the apicoplast lumen (Spork et al., 2009). Most nuclear-encoded, 
apicoplast-targeted proteins possess an N-terminal bipartite leader sequence so 
called because the first part encodes an ER signal peptide and the second part 
encodes an apicoplast transit peptide (Tonkin et al., 2008). The signal peptide 
directs the protein into the secretory pathway by translocation across the ER 
membrane via the Sec61 complex (Waller et al., 2000). Following cleavage of 
the signal peptide during co-translational import into the ER, apicoplast-
targeted vesicles are then believed to transfer these proteins to the space 
between the outermost and third membrane of the apicoplast (Lim et al., 2009). 
The transit peptide directs the protein across the 3 innermost membranes of the 
apicoplast (Spork et al., 2009). The ERAD-like complex facilitates translocation 
of the third outermost membrane, while a translocator of the inner chloroplast 
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membrane (TIC) complex facilitates entry into the apicoplast lumen (Kalanon et 
al., 2009). Translocation of the second innermost membrane might be achieved 
through an as yet unidentified translocator of the outer chloroplast membrane 
(TOC) complex, or via an additional ERAD-like complex (Tonkin et al., 2008). 
Upon entry to the apicoplast lumen the transit peptide is then cleaved by a 
protease similar to the stromal processing peptidase of plant chloroplasts (van 
Dooren et al., 2002). As well as the large number of luminal apicoplast-targeted 
proteins, a smaller number of nuclear-encoded proteins are targeted to the 
outer membrane(s) of the apicoplast, however identification of these proteins is 
made difficult by the frequent absence of a bipartite leader sequence (Lim et 
al., 2009). The exact route(s) by which these proteins reach their target 
membranes remains unresolved. 
Both the mitochondrion and apicoplast must be inherited by each daughter 
merozoite as it forms late in schizogony. This unusual and complicated 
multiplication strategy places the need for organelle division processes distinct 
from the binary fission observed in most other organisms (van Dooren et al., 
2006). The processes responsible for this exquisitely controlled action are poorly 
understood in Plasmodium spp. but a link with nuclear division and a dynamin-
related protein have been identified in T. gondii (Striepen et al., 2000, van 
Dooren et al., 2009). Through the use of fluorescence and immunoelectron 
microscopy, the expansion and segmentation of the mitochondrion and 
apicoplast has been observed during the intraerythrocytic development of P. 
falciparum (Hopkins et al., 1999, van Dooren et al., 2005). This appears to be an 
adaptation to division by schizogony that is not shared in similar organisms that 
divide by more simple fission (Ferguson et al., 2005). The characteristic 
elongation, branching and segmentation of the mitochondrion and apicoplast in 
P. falciparum are represented in Figure 1.6. Little is known about either the 
mitochondrion or the apicoplast in Plasmodium parasites outside of the 
intraerythrocytic stages (van Dooren et al., 2006). When asexual stages 
differentiate into the gametocyte stages, the mitochondrion has been observed 
to undergo extensive morphological changes, while the apicoplast remains small 
(Okamoto et al., 2009). Despite these differences, the close association between 
the two organelles, as that observed in asexual stages, appears to be maintained 
(van Dooren et al., 2006). 
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Figure 1.6: Development of the apicoplast and mitochondrion during intraerythrocytic 
development. (Figure is composed of data generated by Dr. P. McMillan). 
(A) An early trophozoite stage with a single nucleus. The apicoplast (green) and 
mitochondrion (red) are single copy organelles often seen in close proximity. 
(B) A late trophozoite stage with an expanded nucleus. The mitochondrion elongates early in 
intraerythrocytic development. The apicoplast begins to elongate in a similar but slightly 
delayed manner. 
(C) An early schizont stage with multiple nuclei. The mitochondrion and apicoplast are highly 
elongated and are beginning to form branches, often closely associated with individual 
nuclei. 
(D) A late schizont / segmenter stage with > 20 nuclei. The apicoplast and mitochondrion 
segment and distribute into forming merozoites. The residual body is devoid of apicoplast or 
mitochondrial material following egress.  
Blue shows DNA staining by Hoechst 33258, red shows the mitochondrion labelled with 
MitoTracker Cmx-Ros and green shows the apicoplast reported by PfLipDH1-GFP. 
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1.2   Autophagy 
1.2.1  The process of autophagy 
Organisms must rely on both the continuous biosynthesis and degradation of 
cellular components in order to maintain homeostasis (Vellai and Takacs-Vellai, 
2010). Not only does protein degradation provide the building blocks for new 
protein synthesis and energy generation in times of starvation but it is also vital 
for the removal of non-functional, damaged and potentially harmful proteins. 
Degradation of cellular components is performed by two different but 
potentially overlapping mechanisms (Korolchuk et al., 2010, Wong and Cuervo, 
2010).  
Short-lived and aberrantly folded proteins are primarily degraded via the 
ubiquitin-proteosome system (UPS) (Liu et al., 2010). This process involves the 
post-translational modification of a target protein via the conjugation of 
ubiquitin, a small but abundant protein, through a tightly controlled cascade of 
protein:protein interactions (Varshavsky, 2012). The ubiquitination cascade is 
facilitated by 3 types of protein – ubiquitin-activating (E1), ubiquitin-conjugating 
(E2) and ubiquitin ligase (E3) enzymes. The eventual conjugation of free 
ubiquitin to the target protein takes 2 forms - monoubiquitination or multi-
monoubiquitination, while the conjugation of free ubiqiutin to ubiquitin already 
conjugated to the target protein is referred to as polyubiquitination 
(Hochstrasser, 2009, Komander and Rape, 2012). Among roles in cell cycle 
progression, signal transduction, DNA repair and inflammation, ubiquitination 
demarcates the target protein for degradation via the 26S proteosome, a large 
protein complex which cleaves the unfolded target protein or peptide into 
shorter peptides which can then be broken down further (Liu et al., 2010, Wong 
and Cuervo, 2010). Other mediators of protein degradation including caspases, 
calpains and separases, may also act upstream of the UPS, predestining a protein 
for degradation (Varshavsky, 2012). 
Long-lived proteins, along with macromolecules and organelles are primarily 
degraded via a different mechanism, relying on the process of autophagy (Levine 
and Deretic, 2007). The term autophagy is used to refer to a range of catabolic 
processes which converge on the degradation of cellular components in the lytic 
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compartment i.e. the lysosome or food vacuole in yeast and plants (Inoue and 
Klionsky, 2010). This can be achieved by three routes (Figure 1.7) (Yang and 
Klionsky, 2009). The major pathway, macroautophagy, involves the engulfment 
of cellular components into a double-membraned vesicle termed the 
autophagosome. This sequesters cytosolic proteins, protein aggregates and in 
some cases whole or portions of organelles (Baba et al., 1994). Autophagosomes 
then traffic sequestered cargo to the lytic compartment, where after fusion of 
the outer membrane and collapse of the inner membrane, lytic enzymes initiate 
the breakdown of cargo (Dennis and Mercer, 2009). The second pathway, 
microautophagy, involves the invagination of the lytic compartment membrane 
to form an autophagic tube (Li et al., 2012b). Vesicles bud from this tube into 
the lumen of the lytic compartment and are then degraded by the same route as 
autophagosomes (Kunz et al., 2004). The third process, chaperone mediated 
autophagy (CMA), involves the translocation of single unfolded proteins across 
the lytic compartment membrane via specific chaperone and transporter 
proteins (Li et al., 2011b). The specificity of CMA target proteins relies on the 
recognition of a KFERQ-related consensus peptide sequence by a chaperone 
protein complex (Dice, 1990). Interaction between the chaperone:target 
complex and a lysosomal receptor then promotes the translocation of the target 
with the help of additional chaperones in the lumen of the lytic compartment 
(Agarraberes et al., 1997). 
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Figure 1.7: Schematic representation of the three variations of autophagy. 
(A) Macroautophagy – Cytosolic components are engulfed by a double-membraned 
autophagosome and delivered to the lytic compartment via fusion of the autophagosome 
outer membrane and breakdown of the inner membrane.  
(B) Microautophagy – Cytosolic components are engulfed by invagination of the lytic 
compartment limiting membrane. 
(C) Chaperone-mediated autophagy – Specific cytosolic components are recruited to the lytic 
compartment and, via interaction with chaperone proteins, are translocated across the lytic 
compartment limiting membrane. 
 
All of these degradation processes result in the conversion of cellular 
components into smaller macromolecules and amino acids, which can then be 
utilised in the generation of new proteins. These processes contribute to the 
maintenance of intrinsic cellular homeostasis by removing damaged, redundant 
or toxic proteins and replenishing the pool of available amino acids. This ongoing 
process is often referred to as basal autophagy (Hara et al., 2006, Pattison et 
al., 2011, Xia et al., 2010). However, autophagic activity can be upregulated to 
mediate response to cellular stresses, such as when countering invading 
pathogens (Birmingham et al., 2006, Singh et al., 2006),  in adaption to an 
environment of nutrient starvation (Mizushima et al., 2004) or at times of 
cellular differentiation (Alvarez et al., 2008, Besteiro et al., 2006). The 
regulation of an autophagic response is therefore important for initiating a rapid 
response to stress(es) but must also be tightly controlled to prevent unnecessary 
turnover of cellular components (Chang et al., 2009, He and Klionsky, 2009). 
Aberrant control of autophagy is linked to many human diseases and has 
therefore been the focus of intense study over recent years (Behrends et al., 
2010, Levine and Kroemer, 2008). 
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It was long regarded that autophagy (primarily macroautophagy) represented 
bulk, non-specific catabolic processes, while ubiquitination represented a 
process mediating the breakdown of specific targets at specific time points 
(Yoshimori, 2004). However, increasing evidence points towards the involvement 
of macroautophagy in the degradation of specific protein cargos (Johansen and 
Lamark, 2011, Noda et al., 2010, Pankiv et al., 2007). Forms of specific 
autophagy, where organelles are inclusively and exclusively incorporated into an 
autophagosome have also been described, for example mitophagy of 
mitochondria (Kim et al., 2007), pexophagy of peroxisomes (Bellu and Kiel, 
2003), xenophagy of intracellular pathogens (Levine, 2005) and ‘chlorophagy’ of 
chloroplasts in plant leaves (Izumi et al., 2010). While large gaps in our 
knowledge of autophagy still exist, a great deal is now known following 
extensive study in yeast and mammalian cells and increasingly in other 
organisms (Duszenko et al., 2011, Inoue and Klionsky, 2010, Kiel, 2010, 
Mizushima et al., 2010). 
1.2.2  Macroautophagy 
Of the three forms of autophagy, macroautophagy has attracted the most 
attention in the research community. This process is referred to as autophagy 
from hereafter. In yeast, over 30 proteins have been identified to play a role in 
autophagy and have subsequently been named autophagy-related (ATG) proteins 
(Klionsky et al., 2003, Yang and Klionsky, 2009). Many of these proteins have 
been found to have homologues in mammals and other higher eukaryotes (Levine 
and Klionsky, 2004). For clarity, the nomenclature used to describe ATGs in 
yeast is used throughout this study. Many other proteins in yeast and other 
organisms involved in or complementary to autophagy have been named 
according to their roles in other processes (Jager et al., 2004, Lin and Zhong, 
2011). ATG proteins can be grouped according to their function and role during 
autophagy. ATG1, 13, 17, 20, 24, 29 and 31 are involved in the signalling 
processes which control induction of autophagosome formation. ATG3, 4, 5, 7, 8, 
10, 12 and 16 are involved in the two conjugation pathways responsible for ATG8 
lipidation and drive autophagosome expansion and completion. ATG2, 6, 9, 14, 
18, 23 and 27 are involved in autophagosomal nucleation and the membrane 
dynamic events surrounding autophagosome formation. ATG11 plays roles in both 
the induction of autophagosome formation and in the recognition of autophagic 
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cargo. ATG15 plays a role in the lysosomal breakdown of autophagosomes and 
their contents. ATG22 plays a role in the recycling of autophagic cargo. ATG19 
and 21 play specific roles in cargo recognition and the membrane dynamic 
events of the cytoplasm to vacuole targeting (Cvt) pathway, a specific type of 
autophagy found in yeast. ATG25, 26, 28 and 30 play specific roles in cargo 
recognition during pexophagy. ATG32 and 33 play specific roles in cargo 
recognition during mitophagy (Inoue and Klionsky, 2010). 
Different models for autophagosome biogenesis have been put forward, with 
membrane fusion and fission events forming the basis of each (Krick et al., 
2011). It remains undetermined if there is a definitive membrane source that 
contributes to the formation of autophagosomes (Tooze and Yoshimori, 2010). It 
appears that under differing circumstances the ER (Axe et al., 2008), Golgi 
(Ohashi and Munro, 2010), plasma membrane (Ravikumar et al., 2010) and 
mitochondria (Hailey et al., 2010) can all contribute to autophagosome 
biogenesis. It has also been suggested that lipids reversibly-destined for 
autophagosome biogenesis might first enter a pool of tubular/vesicular 
structures referred to as the ATG9 reservoir (Mari et al., 2010). In yeast, 
autophagosomes are generated from a single focus called either the pre-
autophagosomal structure or the phagophore assembly site (PAS) (Suzuki et al., 
2001), while in mammalian cells autophagosomes form from multiple isolation 
membranes (IMs) also called phagophores (Tooze and Yoshimori, 2010). Once 
nucleation of the pre-autophagosomal membrane has been initiated a series of 
interactions between proteins and lipids drives the expansion and curvature of 
the membrane to form a nascent double-membraned autophagosome (Figure 
1.8) (Kraft and Martens, 2012).  
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Figure 1.8: Schematic representation of autophagosome formation. 
Clockwise from top left: A membrane source is acquired from a pre-existing membranous 
structure (e.g. the ER or mitochondria), the plasma membrane or a vesicular pool donated to 
autophagy; initiation of autophagosome formation requires, amongst others, the recruitment 
of the ATG5:ATG12:ATG16 complex; via its E3-like activity, this complex promotes ATG8 
lipidation to phosphatidylethanolamine (PE), recruiting additional membrane material 
possibly in an ATG9-dependent manner; as the autophagosome completes, ATG8 is the 
predominant ATG protein trapped inside, along with autophagic cargo, as it is still 
conjugated to PE; the ATG5:ATG12:ATG16 complex dissociates from the completed 
autophagosome and ATG4 cleaves ATG8 from PE on the outer face; fusion of the 
autophagosome outer membrane with the membrane of the lytic compartment precedes 
breakdown of the autophagosome inner membrane and contents. 
 
A complete autophagosome contains autophagic cargo destined for the cell’s 
lytic compartment. Cargo can be non-specifically engulfed or, through various 
protein:protein interactions, specific protein or organelle cargoes might be 
selectively engulfed via their interaction with ATG8, which remains conjugated 
to the autophagosome inner face throughout expansion and completion of the 
autophagosome (Noda et al., 2008). Autophagosomes are known to fuse with 
endocytic vesicles prior to fusion with the lytic compartment, forming an 
amphisome (Berg et al., 1998). Autophagosomes and amphisomes are thought to 
be directed to the lytic compartment via interaction with the microtubule 
network, again through interaction with ATG8, this time conjugated to the outer 
face of the autophagosome (Geeraert et al., 2010, Pankiv et al., 2010). Fusion 
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of the autophagosome with the lysosome (or vacuole in yeast and plants) is 
mediated by endosomal sorting complexes (Raiborg and Stenmark, 2009) and 
results in the formation of an autophagolysosomes, characterised by a reduced 
internal pH and the presence of lytic enzymes (Kimura et al., 2007). 
1.2.3  Autophagosome biogenesis 
The formation of autophagosomes requires upstream signalling and regulation of 
this signalling has been a recent focus of autophagy research (Inoue and 
Klionsky, 2010, Moretti et al., 2007). ATG8 has been shown to be upregulated by 
autophagy induction in yeast, with 8 - 20 times more protein detected following 
starvation of nitrogen (Huang et al., 2000, Kirisako et al., 1999). This 
upregulation determines the size of autophagosomes rather than their frequency 
(Inoue and Klionsky, 2010, Xie et al., 2008), showing that the initiation of 
autophagosome biogenesis occurs upstream of ATG8. Current knowledge 
suggests that initiation of autophagosome biogenesis is regulated through ATG1, 
a serine/threonine kinase which forms a complex with ATG13 and other proteins 
depending on its phosphorylation state (Kamada et al., 2000). 
The ATG1 complex receives signals relating to, among other triggers, cellular 
nutrient levels and via interaction with multiple other proteins, promotes the 
recruitment of ATG proteins to the site(s) of autophagosome biogenesis 
(Mizushima, 2010). Initiation of autophagosome formation is inhibited by the 
target of rapamycin (TOR), the so called master regulator of autophagy (Kohli 
and Roth, 2010), which acts upstream of ATG1.  
ATG1 activity promotes the localisation of the phosphoinositide 3-kinase class III 
(PI3K) complex to membranes destined to contribute to autophagosomes by a 
poorly understood mechanism (Juhasz et al., 2008). It also plays a role in the 
shuttling of ATG9 between autophagic and peripheral membranes (Reggiori et 
al., 2004a), which in turn is believed to facilitate the expansion of autophagic 
membranes by the acquisition of lipids  (Reggiori et al., 2005). PI3K forms a 
complex with other proteins including ATG6 and the vacuolar protein sorting 
protein Vps15 and through its lipid kinase activity it phosphorylates 
phosphatidylinositol to generate phosphatidylinositol (3)-phosphate (PI3P) in 
autophagic membranes (Simonsen and Tooze, 2009). Enrichment of PI3P in 
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autophagic membranes is described as the nucleation step of autophagosome 
biogenesis and promotes recruitment of the autophagosome marker protein 
ATG8 along with other components of the ATG8 and ATG12 conjugation 
pathways (Zhong et al., 2009), likely through interaction with additional PI3P-
binding proteins such as ATG18 (Nair et al., 2010).  
The ATG8 and ATG12 conjugation pathways control the expansion and 
completion of the autophagosome (Chen and Klionsky, 2011). These two proteins 
show limited sequence similarity with ubiquitin, but do show structural 
similarities and are the focus of a ubiquitination-like conjugation cascade 
involving E1, E2 and E3-like proteins (Figure 1.9) (Geng and Klionsky, 2008, 
Ichimura et al., 2000).  
 
Figure 1.9: Schematic representation of the ubiquitination-like conjugation pathways of 
ATG8 and ATG12. 
The proteins ATG8 and ATG12 both possess ubiquitin-like folds in their core. They undergo 
ubiquitination-like conjugation pathways sharing ATG7 as an E1-like protein. ATG10 acts as 
an E2-like protein in the conjugation of ATG12, which is finally conjugated to ATG5. The 
ATG12-ATG5 complex recruits ATG16 and forms a tetramer. This tetrameric complex acts in 
an E3-like manner in the conjugation of ATG8, transferring it from ATG3, its E2-like protein, 
not to another protein but to phosphatidylethanolamine (PE). 
 
ATG12 is activated by the E1-like enzyme ATG7 when a labile thioester bond 
forms between the C-terminal glycine residue of ATG12 and a catalytic cysteine 
of ATG7 (Tanida et al., 1999). ATG12 is then transferred to the E2-like enzyme 
ATG10, forming the same bond with the catalytic cysteine of ATG10 (Shintani et 
al., 1999). ATG12 is then transferred to ATG5 with which it forms a stable 
isopeptide bond between its C-terminal glycine and the ε-amino group of a lysine 
in ATG5 (Mizushima et al., 1998). The ATG12:ATG5 complex then acts as an E3-
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like enzyme in the conjugation pathway of ATG8 (Hanada et al., 2007), following 
interaction between it and its E1-like and E2-like enzymes ATG7 and ATG3, 
respectively (Taherbhoy et al., 2011). The ATG12:ATG5 complex promotes the 
transfer of ATG8 from ATG3, not to another protein but rather to 
phosphatidylethanolamine (PE), a phospholipid found in autophagic and other 
membranes (Ichimura et al., 2000). This is directed by another protein, which 
interacts with the ATG12:ATG5 complex, ATG16 (Fujita et al., 2008). While the 
final bond between ATG12 and ATG5 appears to be irreversible (Hanada et al., 
2007), the isopeptide bond between ATG8 and PE can be cleaved by the cysteine 
peptidase ATG4 (Tanida et al., 2004). ATG4 is first required to process the C-
terminus of ATG8 by cleaving the residue(s) beyond the reactive glycine, a post-
translational modification that renders ATG8 lipidation-competent (Kirisako et 
al., 2000). It can then also deconjugate ATG8 to release it from the membrane, 
which may also require other ATG proteins for the strict control of this function 
(Chen and Klionsky, 2011). As with earlier steps in initiation and nucleation of 
autophagosomes, quite how the proteins of the ATG8 and ATG12 conjugation 
pathways promote autophagosome biogenesis is poorly understood (Chen and 
Klionsky, 2011). ATG8 has been shown to promote tethering and hemifusion of 
membranes in vitro (Nakatogawa et al., 2007) and it has been suggested that 
through interaction with another protein, Shp1, and resultant recruitment of 
cdc48, an AAA-type ATPase, ATG8 might function to bring about the final steps 
of autophagosome expansion and closure (Krick et al., 2010). 
1.2.4  ATG8 and autophagy in diverse eukaryotes 
While subsets of ATG homologues have been identified in all eukaryotic genomes 
analysed, there is increasing evidence that the ability to perform autophagy is in 
fact, not maintained in all eukaryotes. For example, while a small number of 
potential genes encoding ATG homologues have been identified in Giardia 
lamblia and Cyanidioschyzon merolae, the protein products of these genes are 
likely to participate in other cellular processes, in the absence of a full 
complement of core autophagy components (Rigden et al., 2009). It is also 
known that in organisms with either a full complement of homologues to core 
autophagic machinery or with characterised autophagic processes, ATG 
homologues also contribute to distinct cellular processes. For example, in the 
yeast Pichia pastoris, ATG8 has been shown to play a role in vesicular membrane 
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dynamics during the adaptation to methanol consumption (Tamura et al., 2010). 
This role does not rely on the ATG8 conjugation pathway and the protein does 
not need to be lipidated. In Schizosaccharomyces pombe, ATG8 has been shown 
to participate in vacuolar function in relation to stress response, again 
independent to its role in autophagy (Mikawa et al., 2010). In mammalian cells, 
ATG12 has been shown to conjugate to ATG3, the E2-like enzyme of ATG8, with 
which it contributes to mitochondrial homeostasis (Radoshevich et al., 2010). It 
has recently been demonstrated that in mammalian cells performing xenophagy, 
a homologue of ATG8 can become lipidated to non-classical autophagic 
membranes without ATG1 complex signalling or ATG9-dependent recruitment of 
the PI3K complex (Kageyama et al., 2011). When ATG9 or ATG14 were 
genetically ablated, ATG8 was seen to localise to a single-membraned vesicle, 
enveloping an invading Salmonella typhimurium bacterium and the formation of 
a double-membraned xenophagosome seen in wild type cells was absent. ATG8 
has also been shown to become lipidated at non-autophagosomal membranes 
and is only released to a lipidation-competent form through the activity of ATG4 
(Nakatogawa et al., 2012a). Its function, if any at these non-autophagic 
membranes has not been determined. 
These instances show that ATG8 and likely other ATG proteins can have far 
reaching roles distinct from autophagy and that in some organisms, such roles 
might be in fact be the only reason for their conservation. Whether ATG proteins 
contribute to autophagic or distinct processes in Plasmodium spp. has not yet 
been explored. Recent studies into related organisms have shed light on an 
autophagic process in each. In Toxoplasma gondii, an ATG8 homologue has been 
shown to participate in both basal and starvation-induced autophagy (Besteiro et 
al., 2011). It was shown that when TgATG8 lipidation was blocked via depleting 
TgATG3, mitochondrial homeostasis was disrupted and growth was inhibited. 
This suggests that in T. gondii, TgATG8 and autophagy may have roles in both 
response to nutrient starvation and in maintaining mitochondrial integrity. More 
recently, mitophagy mediated by TgATG8 has also been suggested to contribute 
to an apoptosis-independant, autophagic programmed cel death mechanism in 
amino acid-starved T. gondii tachyzoites (Ghosh et al., 2012). The requirement 
and maintainance of programmed cell death mechanisms in unicellular 
eukaryotes remains controversial but the potential invovlvement of TgATG8 in 
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such a process indicates that ATG8 homologues can play unexpected roles in 
diverse eukaryotes. Whether a programmed cell death mechanism exists in P. 
falciparum remains to be determined.  
In Trypanosoma brucei, three ATG8 homologues have been identified and 
characterised (Proto, 2010), with one being found to display ATG12-like 
characteristics. The two de facto ATG8 homologues appear to be involved in 
processes relating to cell death under starvation conditions (Li et al., 2012a). In 
Trypanosoma cruzi, an ATG8 homologue was found to complement yeast ScATG8 
and was processed by two ATG4 homologues to expose its C-terminal glycine 
(Alvarez et al., 2008). This ATG8 homologue was found to localise to 
autophagosomes in response to starvation and during the differentiation of 
epimastigotes. In Leishmania major, homologues of ATG8, ATG3 and ATG4 have 
been shown to participate in canonical autophagy in response to starvation. 
Autophagy was also shown to be upregulated during the differentiation from 
promastigotes to infective metacyclic promastigotes (Besteiro et al., 2006). 
Genetic ablation of one of two ATG4 homologues was found to reduce the 
parasite’s ability to differentiate into metacyclic promastigotes, indicating that 
autophagy is needed for differentiation. Interestingly, the repertoire of ATG8 
homologues in L. major is vastly expanded in comparison to other organisms, 
with 25 atg8 genes identified (Williams et al., 2009). Examples of the 4 families 
of ATG8 homologues appear to play different roles, with members of 2 families 
apparently participating in a process other than autophagy (Williams et al., 
2009). It has recently been shown that L. major also possesses an active ATG12 
conjugation system, which is required for ATG8-dependent autophagosome 
biogenesis (Williams et al., 2012). Genetic ablation of ATG5 prevented 
autophagosome formation which resulted in morphological defects, 
mitochondrial dysfunction, reduced viability and decreased ability to 
differentiate. These findings show that in many parasitic eukaryotes, the 
involvement of ATG8 in an autophagic process appears to be conserved. However 
they also indicate that in many of these organisms, ATG8 is involved in processes 
such as organelle maintenance, differentiation and viability, either in relation to 
its role in autophagy, or due non-canonical roles. 
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1.3   Rationale for study 
At present it is proving difficult to interpret how the fight against malaria is 
progressing. While at first glance it would appear that worldwide incidence is 
actually on the decline, the rapid emergence of populations of parasites 
resistant to therapeutics used in the field is a great worry. In the absence of an 
effective malaria vaccine, and without promise for delivery of such a vaccine in 
the near future, there is a clear requirement on therapeutics for the treatment 
of malarial infections, particularly in the individuals who are most at risk of 
serious or fatal disease. Our knowledge of basic parasite biology remains fairly 
limited, despite decades of dedicated research. However, in this, the post 
genomic era for human malarial parasites, great leaps forward in our 
understanding of parasite biology are now being achieved. Our understanding of 
resistance mechanisms and the factors that might promote development of 
resistance is becoming more detailed (Summers et al., 2012). Our knowledge of 
how anti-malarial drugs actually work is also improving (Bouquet et al., 2012), 
facilitating the development of chemically designed therapeutics (Mullie et al., 
2012). However, without the identification of additional drug targets, new 
‘designer’ drugs based on compounds to which resistance in the field has already 
developed, will have a limited input into attempts to eradicate malaria. Gaining 
additional knowledge of parasite biology is therefore crucial, as identifying 
potential weaknesses in the parasite’s armour, provides a platform from which 
to identify potential drug targets.  
Autophagy is well established as a stress response as well as being involved in 
homeostatic processes in a number of organisms. It has also more recently been 
shown to be involved in cellular remodelling and differentiation. As Plasmodium 
parasites switch between invertebrate and mammalian hosts and the different 
tissues, cells and environments within each, they perform elaborate and vast 
changes to their cellular structure, contents and metabolism. It would seem 
likely that an autophagic process might contribute to these crucial steps in the 
parasite life cycle.  
At the onset of this study it was not known whether an autophagic process was 
conserved in the malaria parasite Plasmodium falciparum. It is becoming 
increasingly evident that the canonical autophagic process has been modified or 
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built upon in a species-specific manner in a number of organisms. It is also 
apparent that a number of fundamental biological processes are performed 
differently in P. falciparum intraerythrocytic stages than in its human host. 
Therefore, understanding the process of autophagy in P. falciparum will add to 
our overall understanding of parasite biology and could uncover a weakness or 
difference to human biology. Identifying such differences could aid the 
elucidation of novel therapeutic targets in P. falciparum.   
1.4   Aims of this study 
Autophagic membranes are mostly devoid of any transmembrane proteins and 
proteins peripheral to the outer membrane of autophagosomes have proven 
difficult to identify (Fengsrud et al., 2000). Due to the recruitment of ATG8 to 
autophagic membranes early in autophagosome biogenesis and the fact that this 
protein remains conjugated to PE on the inner face of an autophagosome until 
after lysosomal fusion, ATG8 is commonly used as a marker for autophagosomes 
(Kabeya et al., 2000, Kirisako et al., 1999, Weidberg et al., 2010). The lipidation 
state of ATG8 is also commonly used as a measure of autophagic flux, 
particularly when autophagosome turnover is blocked (Kabeya et al., 2004, 
Mizushima and Yoshimori, 2007). As such, ATG8 commonly constitutes the focus 
of research during the early examination of autophagy in various organisms 
(Koopmann et al., 2009, Perez-Perez et al., 2010, Williams et al., 2009). 
Preceding this study, an initial bioinformatic screen had identified a potential 
ATG8 homologue in P. falciparum. This study therefore intended to build upon 
this initial screen and characterise the potential ATG8 homologue in the 
intraerythrocytic stages of P. falciparum. Aims therefore included:- 
 Identify potential homologues to components of the autophagic machinery 
already characterised in yeast and other organisms. 
 Characterise the potential homologue of ATG8, a commonly used marker 
for autophagy. This would involve:- 
o Analysis of its function. 
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o Analysis of its expression in intraerythrocytic parasite stages. 
o Analysis of its post-translational modification. 
o Analysis of its localisation in intraerythrocytic parasite stages. 
o Analysis of how these three aspects are altered in response to 
manipulation of the processes responsible for regulation of 
autophagy in other organisms. 
o Analysis of its essentiality to parasite viability or development. 
 Place knowledge gained about the potential homologue of ATG8 into the 
context of parasite biology and how this relates to what is known about 
ATG8 and autophagy in other organisms. 
The results of this study are organised into 3 chapters. Chapter 3 details the 
identification of a homologue to ATG8 (PfATG8) and the analysis of its function 
and expression. Chapter 4 details the attempts made generate P. falciparum 
lines in which the endogenous copy of Pfatg8 has been genetically ablated or 
replaced with a tagged version. Chapter 5 details the analysis of PfATG8 
localisation and explores the possible role(s) of PfATG8 in P. falciparum 
intraerythrocytic stages. 
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2   Materials and methods 
2.1   Consumables, biological and chemical reagents 
Ambion RETROscript reverse transcription for real time PCR 
kit, Turbo DNA-free 
BDH     Saponin 
Bio-Rad    Bradford protein assay reagent, Gene Pulser 
electroporation cuvette (0.2 cm), Precision Plus 
dual-colour protein standard, Certified Megabase 
agarose, CHEF DNA marker (Hansenula wingei), 
InstaGene Matrix 
Blood transfusion service  Human full blood 
BOC     Malaria culture gas (3 % CO2, 1 % O2, 96 % N2) 
Clontech  Mouse monoclonal anti-His antibody, Mouse 
monoclonal anti-mCherry antibody 
Eurogentec    Oligonucleotides, antisera generation programmes 
Fisher Scientific  Gelcode Blue Safe protein stain, 10 x Phosphate 
buffered saline (PBS), Reddy mix PCR mastermix, 96 
well plates, imidazole (low absorbance), Protran 
Nitrocellulose, Restore western stripping buffer, 500 
ml 0.2 µm Stericup filter units, 0.2 µm syringe filters, 
Sodium hydrogen carbonate, Reagent reservoirs, 
disposable filtration columns 
Glasgow Royal Infirmary Ancotil (5-FC)    
Greiner Aspiration pipettes, 50 ml pipettes, 25, 75 and 175 
cm2 tissue culture flasks 
GE Healthcare   Gene images AlkPhos direct labelling and 
detection system, Gene images CDP-Star 
detection module, Hypercassettes (18 x 24 cm), 
Hyperfilm ECL, Hybond N+ membrane, PD-10 de-
salting columns 
Jacobus pharmaceuticals  WR99210 
Kodak Autoradiography film 
Life Technologies LysoSensor green DND-153, LysoSensor green DND-189, 
MitoTracker green-FM, Novex tricine gels and buffer 
kit, goat monoclonal anti-mouse Alexa 594-conjgated 
antibody, blasticidin-S-HCl, Accuprime Pfx SuperMix, 
Albumax II, gel cassettes, EBSS, Gateway multi-site 
cloning kit, glycogen, agarose, low melting point 
(LMP) agarose, chemically competent E. coli TOP10 
and ccdB Survival T1 cells, gentamycin, POROS MC 
nickel column, RPMI 1640 (with 
25mM HEPES, L- glutamine, without NaHCO3), 
SYBR Safe, TRIzol reagent 
Lonza (UK)   TaKaRa Ex-Taq polymerase   
Melford  Benzamidine, leupeptin, E64, kanamycin, ampicillin, 
carbenicillin, isopropyl-O-dithiogalacopyranoside 
(IPTG), dithiothreitol (DTT), proteinase K 
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Merck-Millipore Chloramphenicol, BugBuster extraction reagent, 
YeastBuster extraction reagent, Immobilon western 
blot detection kit 
Miltenyi LS+ Columns 
Nalgene    1.0 ml cryotubes 
New England Biolabs  T4 ligase and buffer, 1 kb DNA ladder, 100 b DNA 
ladder, 6 x DNA loading dye, all restriction 
endonucleases and associated buffers 
Novagen  Benzonase, chemically competent E. coli BLR (DE3), 
pET28a(+) vector 
PAA    Gentamycin, amino acid-limited RPMI (custom) 
Promega    Anti-mouse IgG (HRP conjugated), anti-rabbit 
IgG (HRP conjugated), pGEM-T Easy vector system II 
Qiagen  QIAprep Hispeed maxiprep extraction kit, QIAprep 
spin DNA miniprep Kit, QIAquick gel extraction kit, 
QIAamp DNA mini kit, QIAquick PCR purification kit, 
Ni-NTA resin 
Roche    Bovine Serum Albumin (BSA) 
Sigma  All chemicals unless otherwise stated 
StrataGene    Chemically competent E. coli XL10-Gold, 
chemically competent E. coli StrataClone Solo Pack, 
StrataClone Blunt PCR cloning kit 
Thermo Scientific Restore Plus western blot stripping buffer, AminoLink 
coupling resin, LabTek II chamber slides (Nunc) 
VWR     Giemsa stain, Vivaspin protein concentrators 
Wallac Betaplate Scintillant, Printed Filter Mat A filter 
membranes 
Zeiss     Imersol microscopy oil 
 
2.2   Equipment 
Applied Systems  Delta Vision Core microscope, SoftWoRx software 
Beckman Coulter  Avanti J-26 XP centrifuge with JA25.50 rotor (used for 
spins at 48,000 g) and F10BCL rotor (used for spins at 
4,400 g) 
Bio-Rad    Gel tanks, Gene Pulser Xcell electroporator, 
Power Pac 300, Power Pac Basic, PowerPac HC,  
Transblot semi-dry transfer cell, GelDoc 2000 
(Mitsubishi P91 printer) CHEF-DR-III system, Biologic 
DuoFlow purification system, BioFrac collector, 583 
Gel dryer (KNF vacuum pump) 
Constant Systems   One shot cell disrupter 
Eppendorf  Microcentrifuge 5415D with F45-24-11 rotor (used for 
spins at 16,000 g), BioPhotometer 6131 000.055 (DPU-
414 thermal printer) 
Fisher  Microcentrifuge Accuspin MicroR with 13-100-515 rotor 
(used for spins at 13,000 g and 16,000 g), water bath 
GE Healthcare   Vacu Gene Pump, Vacu Gene XL 
G Storm    GS4 4 block PCR machine 
Grant     Heat block QBT2, water bath 
GraphPad   GraphPad Prism software 
GRI    DR-88M transilluminator 
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Hamamatsu    C4742 CCD camera 
Hansal   Impulse sealer 
Hawksley   BS.748 Neubauer chamber 
Heidolph    Reax top whirly mixer, Rotamax 120 shaker 
HT    CH4103 Shaking incubator 
Hybaid    Mini 10 incubator 
Kühner    Shaking incubator ISF-1-W 
Life Technologies  250 EX power pack, Vector NTI software 
Millipore   Quantum ddH2O system 
Miltenyi   Vario MACS magnet system 
Molecular Devices  Versamax microplate reader 
Motic    BA400 microscope 
Perkin Elmer 1450 microbeta scintillation counter, Openlab 
software 
Photometrics  CoolSNAP HQ2 camera 
Prestige medical  2100 classic autoclave 
Sigma  Sigma 6K 15 centrifuge with 11150 rotor (used for 
spins at 1,000 g) 
Thermo Scientific  Sorvall ST-16R centrifuge with TX-400 rotor (used for 
spins at 400 g and 1,800 g), NanoDrop 1000, Holten 
Maxi Safe hood 
TomTec Mach III harvester (GAST and Charles Austin Dymax 30 
pumps) 
UVP     HB-1000 hybridization oven, UV cross linker 
Wallac   1295-012 heat sealer 
Zeiss     AxioSkop 2 mot plus microscope 
 
2.3   Buffers, solutions and media 
2.3.1  General buffers 
1 x PBS     140 mM NaCl, 3 mM KCl, 10 mM Na2HPO4, 1.8 
mM KH2PO4, pH 7.4  
Potassium phosphate (pH 7.2) 5 mM KH2PO4, 5 mM K2HPO4 (in 28:72 ratio from 
0.5 M stocks)    
 
2.3.2  DNA analysis 
6x DNA loading dye   0.25 % (w/v) bromophenol blue, 0.25 % (w/v) 
xylene cyanol FF, 0.25 % (w/v) orange-G, 40 % 
(w/v) sucrose 
20 x SSC     300 mM Trisodium citrate, 3 M NaCl, pH 7-8 
Southern depurination   0.25 N HCl 
Southern denaturing   1.5 M NaCl, 0.5 M NaOH 
Southern neutralisation  3 M NaCl and 0.5 M Tris (pH 7.0) 
Southern hybridisation   Gene images AlkPhos hybridization buffer, 0.5 
M NaCl, 4 % (w/v) blocking reagent 
Southern primary wash buffer  2 M Urea, 0.1 % (w/v) SDS, 50 mM sodium 
phosphate pH 7.0, 150 mM NaCl, 1 mM MgCl2, 
0.2 % (w/v) blocking reagent 
Southern secondary wash buffer  50 mM Tris base, 100 mM NaCl, 2 mM MgCl2 
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TE      10 mM Tris-HCl, 1 mM EDTA, pH 8.0 
1 x TAE     40 mM Tris-acetate, 1 mM EDTA, pH 8.0 
 
2.3.3  Protein analysis 
Coomassie stain    Gelcode Blue Safe reagent 
Destaining solution    20 % (v/v) Methanol, 10 % (v/v) acetic acid 
Protein loading buffer   62.5 mM Tris / HCl pH 6.8, 2 % (w/v) SDS, 10 % 
(v/v) glycerol, 0.001 % (w/v) bromophenol 
blue, 5 % (v/v) 2- mercaptoethanol 
Bulk lysis buffer  50 mM TRIS, 500 mM NaCl, 10 % glycerol in PBS 
supplemented with 5 µg/ml RNase A, 1 
mM PMSF, 1 mM benzamidine, 2 µg/ml 
leupeptin, 10 µM E-64, 2 mM 1,10- 
phenanthroline, 4 µM pepstatin A 
Running gel buffer 375 mM Tris-base pH 8.9, 0.1 % SDS (w/v), 5-15 
% (v/v) acrylamide 
1x SDS-PAGE running buffer  25 mM Tris, 192 mM glycine, 0.1 % (w/v) SDS 
Stacking gel buffer   122 mM Tris-HCl pH 6.7, 0.1 SDS (w/v), 5 % 
acrylamide 
Towbin buffer    25 mM Tris, 192 mM glycine, 20 % (v/v) 
Methanol 
 
2.3.4  Bacteria culture 
Ampicillin     100 mg/ml in ddH2O (1000 x stock) 
Chloramphenicol    34 mg/ml in ethanol (1000 x stock) 
Kanamycin     50 mg/ml in ddH2O (1000 x stock) 
Luria Bertani (LB) medium  10 g/l Tryptone, 5 g/l yeast extract, 5 g/l NaCl 
LB agar     1.5 % (w/v) agar in LB medium 
Terrific Broth medium   12 g/l Tryptone, 24 g/l yeast extract, 0.4 % 
(v/v) glycerol, 9.4 g/l K2HPO4, 2.2 g/l KH2PO4 
pH 7.2 
TfB I      100 mM RbCl, 50 mM MnCl2 x 4 H2O, 30 mM 
potassium acetate, 10 mM CaCl2 x 2 H2O, 15 % 
(v/v) glycerol 
TfB II  10 mM MOPS, 10 mM RbCl, 75 mM CaCl2 x 2 
H2O,15 % (v/v) glycerol 
 
2.3.5  Yeast culture 
YPD medium 20 g/l bacteriological peptone, 10g/l yeast 
extract, 20 g/l glucose, (20g/l bacteriological 
agar for YPD agar) in ddH2O 
SC medium 7g/l YNB without amino acids, 1.92 g/l Kaiser 
medium supplement, 20 g/l glucose, (20 g/l 
bacteriological agar for SC agar) in ddH2O 
Induction medium 1.9 g/l YNB without amino acids or ammonium 
sulphate, 20 g/l glucose, 20 % glycerol in ddH2O 
Transformation buffer 100 mM lithium acetate, 10 mM Tris / HCl, 1 
mM EDTA 
Materials and Methods  35 
PLATE buffer 40 % PEG 3350 in transformation buffer 
Kaiser medium supplement SC, -Ura (DSCK102, Formedium) 
 
2.4   P. falciparum culture 
5-FC (Ancotil)   4 mM in blood wash medium 
Blasticidin-S-HCl (BLA)  10 mg/ml in blood-wash medium 
Blood-wash medium  15.9 g/l RPMI 1640 (with 25 mM HEPES and L-
glutamine), 0.1 % (w/v) sodium bicarbonate, 10 
mM glucose, 200 µM hypoxanthine, 20 µg/ml 
gentamycin, pH 7.4 
Complete RPMI 1640 medium  Blood wash medium supplemented with 0.5 % 
(w/v) Albumax II 
Amino acid limited medium  Complete RPMI 1640 medium except RPMI 1640 
replaced with amino acid free RPMI and 
supplemented with 50 mg/l L-Isoleucine, 65.2 
mg/l L-Cystine 2 HCl, 15 mg/l L-Methionine, 
300 mg/l L-Glutamine and 20 mg/l L-Glutamic 
Acid 
Earle’s balanced salt solution  5.33 mM KCl, 26.19 mM NaHCO3, 117.24 mM 
(EBSS)     NaCl, 1.01 mM NaH2PO4.H2O 
EBSS+G     As above plus 11mM D-glucose 
IC50 Medium     RPMI 1640 medium without hypoxanthine 
Cytomix  120 mM KCl, 0.15 mM CaCl2, 2 mM EGTA, 5 mM 
MgCl2, 10 mM K2HPO4 / KH2PO4 pH 7.6, 25 mM 
HEPES pH 7.6 
Freezing solution    30 % (v/v) glycerol in PBS 
Parasite lysis buffer  1 % Triton X-100 in PBS supplemented with 5 
µg/ml RNase A, 1 mM PMSF, 1 mM benzamidine, 
2 µg/ml leupeptin, 10 µM E-64, 2 mM 1,10-
phenanthroline, 4 µM pepstatin A 
WR99210     Stock solution: 20 mM in dimethylsulphoxide 
Working solution: 20 µM in blood wash medium 
 
2.5   Bacteria strains 
BLR (DE3) (Novagen) Used for PfATG8 expression: 
F- ompT hsdSB(rB- mB-) gal dcm (DE3) 6(srl-recA)306::Tn10 (TetR) 
 
JM109 (Promega) Used for pGEM-T Easy cloning: 
recA1, endA1, gyrA96, thi, hsdR17 (rK-,mK+), relA1, supE44, ∆(lac-proAB), [F’, 
traD36, proAB, lacIqZ∆M15] 
 
SoloPack® (StrataGene) Used for pSCBamp/kan cloning: 
Tetr Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 
relA1 lac Hte [F´ proAB lacIqZΔM15 Tn10 (Tetr) Amy Camr] 
 
One Shot® Top10 (Life Technologies) Used for Gateway cloning: 
F- mcrA 6(mrr-hsdRMS-mcrBC) \80lacZ6M15 6lacX74 recA1 ara2139 6(ara- 
leu)7697 galU galK rpsL (StrR) endA1 nupG 
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‘Homemade Top10’ Used for all other cloning: 
See above 
 
2.6   P. falciparum strains 
3D7 The Netherlands 
D10 Papua New Guinea 
2.7   Molecular methods 
2.7.1  Determination of DNA concentrations 
Concentrations of DNA were determined by measuring absorbance with a 
NanoDrop spectrophotometer (Thermo Scientific, UK) reading at 260 nm 
(Gallagher, 2001). 260/280 and 260/230 ratios were used as an indicator of DNA 
purity according to manufacturer’s guidelines. 
2.7.2  Agarose gel electrophoresis 
For separation of DNA, agarose or low melting point (LMP) agarose were heated 
and dissolved to the required concentration (0.8 – 1 % (w/v)) in 1 x TAE buffer 
and SYBR Safe was added to 0.5 µg/ml before casting of gels. DNA samples were 
mixed with 6 x DNA loading dye and separation was performed bathed in 1 x TAE 
at 5 – 10 V/cm2 gel. To determine the size of separated bands 1 kb or 100 b 
ladders were run alongside samples where appropriate. Ladder and sample 
bands were visualised with a transilluminator.  
2.7.3  Ethanol precipitation of DNA 
DNA was concentrated for transfection into P. falciparum by ethanol 
precipitation with sodium acetate (Russell, 2001). For each transfection 75 µg 
plasmid DNA in ddH2O was mixed with 3 x volumes of ice cold ethanol, 0.1 x 
volumes of 3 M sodium acetate pH 5.2 and 20 µg of glycogen. DNA was allowed 
to precipitate at - 20 °C overnight (16 h) before centrifugation at 16,000 g at 4 
°C for 10 min. The supernatant was removed and the pellet was washed in 100 
µl ice cold 70 % ethanol before a second spin. Under sterile conditions, the 
supernatant was removed and the pellet allowed to air-dry (~ 1 h) prior to 
resuspension in 30 µl ddH2O. 
Materials and Methods  37 
2.7.4  Restriction endonuclease digests 
All restriction endonucleases were purchased from New England Biolabs, UK 
(N.E.B.). Digests were performed according to manufacturers’ guidelines with 
appropriate buffer (and BSA) at 37 °C in an incubator to avoid evaporation and 
condensation. Typically 200 – 300 ng of plasmid DNA was digested in order to 
determine ligation results. 
2.7.5  Polymerase chain reaction 
Polymerase chain reaction (PCR) was used to amplify DNA products from 
genomic DNA or plasmid sequences. One hundred ng of gDNA or cDNA and 1 ng 
plasmid DNA was used as a template with 132 nM of each appropriate primer and 
either Pfx SuperMix (Life Technologies, UK), Reddy mix (Fisher, UK) or Ex-Taq 
(Lonza, UK) according to manufacturer’s guidelines. A GS4 PCR machine (G 
Storm, UK) was used to run the following programme, which was modified if 
needed. 
Step 1: 95°C, 5 min 
Step 2: 95°C, 30 sec 
Step 3: annealing temperature between 40 – 60°C, 30 sec 
Step 4: 60°C, 1.5 min per 1,000 base pairs to be amplified 
Repeat steps 2-4 for 30 cycles 
Step 5: 60°C, 10 min 
Step 6: Store at 10°C 
 
2.7.6  Oligonucleotides 
Oligonucleotide primers were ordered from Eurogentec, UK and were 
resuspended to 3.2 µM in ddH2O before use in PCRs or sequencing reactions. 
Oligonucleotides generated for this study are listed below. For the majority of 
sequencing reactions, standard M13F and M13R primers were used. 
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2.7.6.1   Amplification of genes encoding potential ATG homologues in P. 
falciparum 
PfATG3 fwd ATGAGTGACCAAATAAATGTCAAAC 
PfATG3 rev TCATAATCCTGCATTGCTATCC 
PfATG4 fwd ATGTCTAAAGAAATGAAAAACTTTG 
PfATG4 rev TTATAACACAACTAATCCTGAATC 
PfATG5 fwd ATGGAGATAGGTTATATGGAAGTAC 
PfATG5 rev TTAATAGGGGGGTATACGTATG 
PfATG7 fwd ATGAAAAAAAAATTCGAAGAG 
PfATG7 rev TCATTCCAATATTATAACATCATTC 
PfATG8 fwd ATGCCATCGCTTAAAGACG 
PfATG8 rev TTATCCTAGACAACTCTCACAAC 
PfATG10 fwd ATGTTACCTTACATTATAAATTTTC 
PfATG10 rev TTATGTATTTTTTTTTTTTTTTTC 
PfATG12 fwd ATGACAGAGAATTATATACAGTATATAC 
PfATG12 rev TTAATATGCTGGCGTAAAAC 
 
2.7.6.2   Yeast complementation 
Yeast-PfATG8 fwd (BamHI) GCGCGGATCCATGCCATCGCTTAAAGACGAAG 
Yeast-PfATG8 rev (PstI) GCGCCTGCAGTTATCCTAGACAACTCTCACAACTATATTC 
 
2.7.6.3   Recombinant His-PfATG8 expression 
His-PfATG8 fwd (NheI) AGCTAGCCCATCGCTTAAAGACGAA 
His-PfATG8 rev (XhoI) GCTCGAGTTATCCTAGACAACTCTCACA 
 
2.7.6.4   Gateway cloning 
Gway-EP fwd (attB4) 
GGGGACAACTTTGTATAGAAAAGTTGCGGGAAAAATAAAAAGTTGAACAC 
Gway-EP rev (attB1r) 
GGGGACTGCTTTTTTGTACAAACTTGCTATAAATAAAAATGTAAGTAC 
Gway-PfATG8 fwd (attB2r) 
GGGGACAGCTTTCTTGTACAAAGTGGTTCCATCGCTTAAAGACGAAG 
Gway-PfATG8 rev (attB3) 
GGGGACAACTTTGTATAATAAAGTTGCTTATCCTAGACAACTCTCACAACTATATTC 
Gway-PfATG8∆G rev (attB3) 
GGGGACAACTTTGTATAATAAAGTTGCTTATAGACAACTCTCACAACTATATTC 
 
2.7.6.5   Knockout cloning 
Pfatg8 5’ flank fwd (SacII) GCGCCCGCGGGTTGCCTGTGTTATAATTTACAACC 
Pfatg8 5’ flank rev (SpeI) GCGCACTAGTCACTTAGAAAGAAGGTGTGAAATTC 
Pfatg8 3’ flank fwd (NcoI) GCGCCCATGGCGATTACGAATATAATAGTGTCAATGTG 
Pfatg8 3’ flank rev (AvrII) GCGCCCTAGGGAGAAATTATTTGTAGAGAAAAGTTTG 
EP fwd (SacII) GCGCCCGCGGGTTGTGTGGAATTGTGAGCG 
PbDT 3’UTR rev (SpeI) ACTAGTCGCTACGTACTGCAGGG 
 
2.7.6.6 PCR analysis of the Pfatg8 locus 
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(1)ORF fwd ATGCCATCGCTTAAAGACG 
(2)ORF rev CATCTTTTCAAAACAACAAAATG 
(3)Genomic fwd GGAGGTAATAAAAATGTGAAG 
(4)Genomic rev ATTCGTTGAATATTTAACAAATC 
(5)pCC-4 fwd CCAATAGATAAAATTTGTAGAG 
(6)pCC-4-rev TTATTAAATCTAGAATTCATATCG 
(7)CD fwd ATCCCTTCCTTACTACAGATTAGG 
(8)CD rev ATCAGATTGTTGGTTGAAGAAGG 
 
2.7.7  Gateway cloning 
To generate P. falciparum expression constructs Life Technologies’ Multisite 
Gateway technology was used. This is based on the site specific recombination 
system of bacteriophage lambda (Landy, 1989). The technology allows the 
simultaneous cloning of 3 DNA fragments in a defined order and orientation into 
a final destination vector in a 2 step process. The first step requires the cloning 
of PCR products into donor vectors. This resembles the integration of the lambda 
phage into its E. coli host genome during the lysogenic cycle. The second step, 
which resembles the excision of the lambda genome at the onset of the lytic 
cycle, involves the combination of DNA fragments from 3 donor vectors into a 
single destination vector (Hartley et al., 2000). Standard entry clones were used 
for intermediate cloning steps. Two destination vectors were used in the 
generation of P. falciparum expression constructs. pHBlR-3/4 and pCHDR-3/4 are 
derived from pHBcam (van Dooren et al., 2005, Waller et al., 2000) and have 
key modifications for use in P. falciparum, amongst which a Rep20 element 
promotes inheritance of episomal plasmid into daughter merozoites by 
promoting segregation via interaction with chromosome ends (O'Donnell et al., 
2002). These constructs have been successfully used in sequential transfections 
in P. falciparum due to their different selectable markers (van Dooren et al., 
2005). 
2.7.7.1   Gateway entry clones 
PCR fragments generated by Pfx SuperMix were purified by gel extraction using 
Qiagen’s QIAquick gel extraction kit and were recombined with the appropriate 
donor vector via the BP reaction according to the manufacturer’s guidelines (Life 
Technologies, UK). Briefly, 50 fmoles of purified PCR product was mixed with 1 
µl vector and 2 µl BP Clonase II for overnight incubation at 25 °C. The following 
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morning, 1 µl Proteinase K was added for 10 min incubation at 37 °C prior to 
transformation of SoloPack cells using 2 or 4 µl of the mixture. Clones selected 
with 50 µg/ml kanamycin were analysed by restriction digest to test for 
presence of insert and potentially successful clones were sequenced to confirm 
correct recombination of PCR fragments. Plasmid maps of the three Gateway 
intermediate vectors used are shown in Figure 2.1. 
 
Figure 2.1: Plasmid maps of empty Gateway intermediate vectors. 
(left) pDONR P4-P1R was used as an intermediate vector for 5’ UTR elements. The ccdB 
death gene and chloramphenicol resistance cassette (CmR) replaced by the insert sequence 
are shown. 
(middle) pDONR 221 was used as an intermediate vector for mCherry / eYFP elements. The 
ccdB death gene and CmR replaced by the insert sequence are shown. 
(right) pDONR P2R-P3 was used as an intermediate vector for ORF elements. The ccdB death 
gene and CmR replaced by the insert sequence are shown. 
 
2.7.7.2   Gateway expression clones 
Sequenced entry clones were recombined with an appropriate destination vector 
to generate P. falciparum expression constructs according to the manufacturer’s 
guidelines (Life Technologies, UK). Briefly, 10 fmoles of each entry clone was 
mixed with 20 fmoles of the appropriate destination vector and 2 µl LR Clonase II 
Plus for overnight incubation at 25 °C. The following morning, 1µl Proteinase K 
was added for 10 min incubation at 37 °C prior to transformation of SoloPack 
cells using all of the mixture. Clones selected with 100 µg/ml ampicillin were 
analysed by restriction digest to test for presence of insert and potentially 
successful clones were sequenced to confirm correct recombination of DNA 
fragments. Plasmid maps of the two Gateway destination vectors used are shown 
in Figure 2.2. 
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Figure 2.2: Plasmid maps of empty Gateway destination vectors. 
(left) pHBlR-3/4 (Hsp86 5’ UTR driving blasticidin S deaminase with Rep20 in a head to tail (-) 
orientation with the attR3/R4 cassette), showing key regulatory elements. Recombination 
between entry clones and attR3 and attR4 sites results in the replacement of the lethal ccdB 
gene. Parasites transfected with pHBlR-3/4-based constructs were selected with blasticidin. 
(right) pCHDR-3/4 (Calmodulin 5’ UTR driving human DHFR with Rep20 in a head to tail (-) 
orientation with the attR3/R4 cassette), showing key regulatory elements. Recombination 
between entry clones and attR3 and attR4 sites results in the replacement of the lethal ccdB 
gene. Parasites transfected with pCHDR-3/4-based constructs were selected with WR99210. 
 
2.7.8  Subcloning into intermediate vectors 
To ensure efficient digestion of PCR products and to facilitate sequencing of PCR 
reactions before cloning into expression or transfection vectors, PCR products 
were first cloned into appropriate intermediate vectors.  
Ex-Taq (Lonza, UK) was used as the DNA polymerase to amplify the Pfatg8 3’ 
flank used in the generation of knockout constructs. PCR products contained 
single deoxyadenosine overhangs at their 3’-ends and so were cloned into the 
pGEM-T Easy vector using the pGEM-T Easy Vector kit (Promega, UK) according 
to the manufacturer’s guidelines. Briefly, ~ 25 ng of purified PCR product was 
mixed with 5 µl buffer, 1 µl vector and 1 µl ligase and allowed to mix overnight. 
Half or all of the ligation mixture was then used to transform JM109 cells and 
clones were subjected to blue / white screening by adding 0.5 mM IPTG and 80 
µg/ml X-Gal to Luria Bertani medium (LB) agar, which also contained 100 µg/ml 
ampicilin. Inserts were sequenced from minipreps generated from white colonies 
(see 2.7.12) and excised by restriction digest. A plasmid map of pGEM-T Easy is 
shown in Figure 2.3. 
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In all other PCRs intended for subsequent cloning steps, Pfx SuperMix (Life 
Technologies, UK) was used as the DNA polymerase. PCR products were blunt 
ended and so were cloned into pSC-B amp/kan via the StrataClone Blunt PCR 
cloning kit (StrataGene, UK) according to manufacturer’s guidelines. Briefly, ~ 
50 ng of purified PCR product was mixed with 3 µl buffer and 1 µl vector and 
allowed to mix for 5 min before transforming SoloPack cells with half or all of 
the ligation mixture. Inserts from white colonies subjected to blue / white 
screening by adding 80 µg/ml X-Gal to Luria Bertani medium (LB) agar, which 
also contained 100 µg/ml ampicillin, could then be sequenced and excised by 
restriction digest. A plasmid map of pSC-B-amp/kan is shown in Figure 2.3. 
 
Figure 2.3: Plasmid maps of intermediate vectors. 
(left) pGEM-T Easy was used for subcloning of 3’ homologous flanks before ligation into pCC-
4. The site where PCR products with single deoxyadenosine overhangs insert is shown. 
Insertion disrupts the Lac operon component LacZ, which allows blue / white screening. 
(right) pSC-B-amp/kan was used for all other subcloning steps. The site where blunt ended 
PCR products insert is shown. Insertion disrupts the Lac operon component LacZ, which 
allows blue / white screening. 
 
2.7.9 Cloning into transformation / transfection vectors 
Inserts were excised from intermediate vectors with appropriate restriction 
enzymes and were purified by gel extraction using Qiagen’s QIAquick kit. 
Purified insert DNA was mixed with 50 ng digested vector in 1:1 and 3:1 insert to 
vector ratios. Ligations were performed with 1 µl T4 DNA ligase (N.E.B.) in 1 x 
ligation buffer overnight at room temperature in total volume of 15 µl. Half or 
all of the ligation mixture was used to transform BLR (DE3) for E. coli expression 
constructs or Top10 for all S. cerevisiae expression and P. falciparum knockout 
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constructs. Plasmid maps of bacterial (pET28a(+)) and yeast (pCM186) expression 
vectors are shown in Figure 2.4. A plasmid map of pCC-4, used for genetic 
knockout in P. falciparum is shown in Figure 5.1. 
 
Figure 2.4: Plasmid maps of E. coli and S. cerevisiae expression vectors. 
(left) pET28a(+) was used to express His-tagged PfATG8 in E. coli. NheI and XhoI restriction 
sites used for directional cloning are indicated. The inserted sequence is in frame with a 
sequence encoding an N-terminal poly-histidine tag and is under control of the T7 promoter. 
(right) pCM186 was used to express PfATG8 in S. cerevisiae. BamHI and PstI restriction sites 
used for directional cloning are indicated. The URA3 cassette encoding orotidine 5-
phosphate decarboxylase, used for selection in yeast is shown. The inserted sequence is 
under control of the hybrid tetracycline-responsive (tetO-CYC1) promoter (Gari et al., 
1997). 
 
Constructs for transfection or transformation, generated for this study, along 
with the oligonucleotides and intermediate vectors used in their generation are 
detailed in Table 2.1.  
Table 2.1: Constructs generated for this study (see following page). 
PfATG8-pCM186 was used for complementation studies in S. cerevisiae lacking ScATG8 (see 
3.2.4). 
His-PfATG8-pET28a(+) was used for the recombinant expression of His-PfATG8 in E. coli (see 
3.2.5). 
The expression constructs EP-mC-A8, EP-mC-A8∆G, 86-mC-A8, EP-eY-A8, EP-eY-A8∆G and 
86-eY-A8, 86-eY-A8∆G were used for expression of fluorescent fusion proteins of PfATG8 or 
the truncated form PfATG8∆G in P. falciparum (see 4.2.1). A second version of EP-mC-A8 
was generated using the destination vector pHB1R-3/4 (selected with BLA) so that 
colocalisation studies could be performed (see 4.2.7). 
Pfatg8-pCC-4 was used in attempts to knockout the endogenous Pfatg8 ORF (see 5.2.1-2). 
mCherry-Pfatg8-pCC-4 was used in attempts to replace the endogenous Pfatg8 ORF (see 
5.2.3). 
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2.7.10  Preparation of chemically competent E. coli 
A 5 ml pre-culture was grown overnight in LB medium and used to inoculate 500 
ml fresh medium the next morning. Cells were grown at 37 °C in a shaking 
incubator until the OD600 of the culture reached 0.5. The bacteria culture was 
subsequently cooled on ice for 15 min before being transferred into sterile 
centrifuge tubes. Cells were centrifuged at 4,400 g for 10 min at 4 °C. The 
supernatant was discarded and the cells were resuspended in 30 ml TfB I. The 
cells were incubated on ice for 15 min before centrifugation at 4,400 g for 5 
min. The supernatant was again discarded and the cells were resuspended in 6 
ml TfB II. The cells were aliquoted into 1.5 ml tubes and shock frozen on dry ice. 
Chemically competent cells were stored at – 80 °C. This was performed by A. 
McIntosh. 
2.7.11  Transformation of chemically competent E. coli 
Plasmid DNA, Gateway or ligation reactions were added to aliquots of chemically 
competent E. coli, which had been allowed to thaw on ice. Cells were incubated 
on ice for 20 min before heat shock at 42 °C for 35 – 50 sec according to 
manufacturer’s guidelines. Following recovery on ice for 2 min, 200 µL LB 
medium was added and cells were incubated at 37 °C with gentle shaking for 1 
h. Typically 50 and 200 µL of the transformation mixture was then spread onto 
LB agar plates containing the appropriate antibiotics (100 µg/ml ampicillin, 50 
µg/ml kanamycin or 34 µg/ml chloramphenicol) and IPTG or X-Gal when 
necessary. 
2.7.12  Isolation of plasmid DNA from transformed E. coli 
For isolation of plasmid DNA for transfection of P. falciparum, QIAprep Hispeed 
maxiprep extraction (Qiagen, UK) kits were used according to manufacturer’s 
guidelines. Briefly, sequenced clones were used to inoculate 5 ml starter 
cultures of Terrific Broth (TB) with the appropriate antibiotic for 8 h incubation 
at 37 °C with gentle shaking. These were then diluted 1:100 to 500 ml overnight 
cultures of TB with the appropriate antibiotic for overnight incubation. The 
following morning cultures were divided into 2 x 250 ml and E. coli cells were 
pelleted by centrifugation at 4,400 g for 15 min at 4 °C. Plasmid DNA was then 
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extracted according to the provided protocol and eluted into 2 x 200 µl ddH2O. 
Typical yield was ~ 500 µg of plasmid DNA. 
For isolation of plasmid for all other cloning steps, Qiagen’s QIAprep spin DNA 
miniprep Kit was used according to manufacturer’s guidelines. Briefly, single 
colonies picked from selective LB agar plates were used to inoculate a 5 ml LB 
overnight culture with the appropriate antibiotic for overnight incubation at 37 
°C with gentle shaking. The following morning 1 ml of culture was used to make 
a glycerol stock (mixed thoroughly with 0.5 ml 50 % glycerol and stored at - 80 
°C) while the remaining E. coli cells were pelleted by centrifugation at 4,400 g 
for 5 min at 4 °C. Plasmid DNA was then extracted according to the provided 
protocol and eluted into 40 µl ddH2O. Typical yield was ~ 10 µg of plasmid DNA. 
2.7.13  Reverse transcription 
Reverse transcription of RNA was performed using the RETROscript reverse 
transcription for real time PCR kit (Ambion, UK) according to the manufacturer’s 
guidelines. Prior to reverse transcription, parasite RNA was treated with Turbo 
DNA-free (Ambion, UK) according to manufacturer’s instructions to remove any 
traces of contaminating DNA. Ten µg of extracted RNA was used in a 50 µl 
reaction for this treatment. Of the DNase treated RNA, 10 µl corresponding to 1 - 
2 µg of RNA was used for the generation of cDNA. Reverse transcription was 
performed following the two step RT-PCR protocol with heat denaturation step 
according to manufacturer’s instructions. The cDNA was stored at – 20 °C. This 
was performed by Dr. E. Patzewitz. 
2.7.14  Southern blot analysis 
To analyse the genotype of P. falciparum lines transfected with pCC-4–based 
constructs, 1.5 µg of isolated DNA was analysed by Southern blotting (see 2.10.6 
for DNA isolation). DNA was digested overnight at 37 °C with SpeI (N.E.B., UK) 
according to the manufacturer’s guidelines. The following morning an additional 
1 µl of SpeI was added for further 6 h incubation. Digested DNA was separated by 
electrophoresis in 0.7 % agarose at 20 V for ~ 20 h. Separated DNA was then 
depurinated in 0.25 M HCl for 10 min, denaturated in 1.5 M NaCl and 0.5 M NaOH 
for 30 min and neutralised in 3 M NaCl and 0.5 M Tris (pH 7.0) for 30 min. DNA 
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was then transferred to Hybond N+ nitrocellulose membrane using VacuGene XL 
apparatus (GE Healthcare, UK) at 50 mbar for 1.5 h whilst being bathed in 20 x 
SSC. Lanes were marked with pencil and DNA crosslinked to the membrane in a 
UV crosslinker at 700 x 100 µJ/cm2. Membranes were prehybridised in 
hybridisation buffer for 20 min at 55 °C before addition of the appropriate 
probe. Probes were generated from DNA fragments either amplified from gDNA 
or pCC-4 plasmid DNA by PCR using Pfx SuperMix (Pfatg8-specific and CD, 
respectively) or from restriction digests of Pfatg8-pCC-4 plasmid DNA (3’ flank 
(NcoI-HF and AvrII) and BSD (BamHI and HindIII-HF)). Fragments were purified by 
gel extraction before probes were generated using the Gene Images AlkPhos 
direct labelling kit (GE Healthcare, UK) according to the manufacturer’s 
guidelines. Probes were added to prehybridised membranes in 10 ml 
hybridisation buffer for incubation overnight at 55 °C. The following morning 
membranes were washed for 3 x 10 min in primary wash buffer at 55 °C and 
then transferred to a clean container for 2 x 10 min washes with secondary wash 
buffer at room temperature. The membrane was covered in CDP Star detection 
solution (GE Healthcare, UK) for 5 min incubation at room temperature after 
which excess detection solution was removed and the membranes were sealed in 
plastic sheet and exposed to Hyperfilm autoradiography films (GE Healthcare, 
UK). To strip membranes of bound probe in order to re-probe, membranes were 
bathed in 0.5 % SDS at 60 °C for 2 h and were prehybridised and probed as 
detailed above. 
2.8   Biochemical methods  
2.8.1  Bradford assay 
The concentration of protein samples was determined by Bradford assay 
(Bradford, 1976). Ten µl of bovine serum albumin (BSA) (Roche, UK) solutions of 
known concentrations or sample protein solutions were mixed with 250 µl 
Bradford protein assay reagent (Bio-Rad, UK) diluted 1:5 in ddH2O and 
absorbance of each sample was read at 595 nm. BSA standards were used to 
generate a standard curve from which the concentrations of sample protein 
solutions were calculated. 
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2.8.2  Phospholipase D incubation 
Protein extracted from wild type or parasite lines expressing mCherry-PfATG8 
(see 2.10.8 for parasite protein extraction) was incubated with phospholipase D 
from Streptomyces chromofuscus (PLD) to evaluate the lipidation state of 
PfATG8 or mCherry-PfATG8. PLD was resuspended in ddH2O to 10 units per µl 
and was stored at - 20 °C. Twenty µg of protein extract was incubated with the 
indicated units of PLD at 30 °C for 1 h. Samples were then mixed with protein 
loading buffer and were separated by SDS-PAGE or 6 M urea SDS-PAGE. 
2.8.3  Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Separation of proteins was performed by SDS-PAGE according to Laemmli 
(Laemmli, 1970). Gels were prepared with 5 % polyacrylamide stacking gel and 
resolving gel of either 7.5 % polyacrylamide for separation of mCherry-PfATG8 
and aminopeptidase-1(AP1) or 15 % polyacrylamide for separation of PfATG8. 
Gels were poured into 1 mm plastic cassettes (Life Technologies, UK). For each 
gel, 6 ml of resolving gel was made by mixing resolving gel buffer with ddH2O 
and 30 % acrylamide/bis-acrylamide and was polymerised by addition of 35 µl 
ammonium persulphate (20 % (w/v)) and 10 µl N,N,N’,N’- 
tetramethylethylenediamine (TEMED). Butanol was layered above the resolving 
gel while it set to ensure a smooth transitional surface and was then removed 
and thoroughly washed with ddH2O. Two ml stacking gel was made by mixing 
stacking gel buffer with ddH2O and 30 % acrylamide/bis-acrylamide and was 
added to the set resolving gel after addition of 20 µl ammonium persulphate and 
8 µl TEMED and an appropriate comb was inserted. Parasite protein extract or 
recombinant protein extract were denatured by mixing with protein loading 
buffer and boiling for 10 min before 20 µg of parasite or varying amounts of 
recombinant protein was loaded per lane. Six µl of Precision Plus Protein Dual 
Colour ladder (Bio-Rad, UK) was loaded into 1 lane of each gel. Proteins were 
separated by electrophoresis in 1 x SDS-PAGE running buffer at 20 mA (after 
penetration of resolving gel this was increased to 40 mA) at a maximum of 200 
V. When urea gels were necessary, resolving and stacking gels were prepared 
with the addition of 6 M urea and run as described. Warming of solutions to 50 
°C was needed to dissolve urea. 
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2.8.4  Staining of SDS-PAGE gels with Coomassie blue 
Following separation by SDS-PAGE, proteins were visually detected by staining 
with Coomassie (Gelcode Blue Safe). Gels were carefully removed from cassettes 
and washed briefly in ddH2O. They were then covered in Coomassie for 1 h with 
gentle rocking and destained by 3 x 5 min washes in ddH2O and multiple 1 h 
washes in destain at room temperature until background staining had been 
removed. 
2.8.5  Western blot analysis 
Following SDS-PAGE, separated proteins were transferred to Protran 
nitrocellulose membranes (Fisher, UK) using a semi-dry method. A Transblot 
(Bio-Rad, UK) system was used to transfer at 23 V for 40 min (increased up to 1 h 
if multiple gels were transferred) with the gels, membrane and filter membrane 
stacks all moistened in Towbin buffer. After transfer, confirmed by visible ladder 
bands on the membrane, membranes were washed briefly in ddH2O and proteins 
stained for 5 min with Ponceau S solution. Membranes were then washed briefly 
3 times with ddH2O to remove excess Ponceau S and allow a digital image to be 
taken. Lanes were marked with pencil when appropriate. Bound Ponceau S was 
then removed by 2 x 5 min washes in 0.1 % Tween 20 (v/v) in PBS before being 
blocked overnight at 4 °C in 5 % (w/v) milk powder in PBS with gentle rocking. 
The following morning membranes were washed briefly in 0.1 % Tween 20 (v/v) 
in PBS before addition of primary antibodies, diluted in 2 % milk powder (w/v) in 
PBS. Membranes were incubated in primary antibodies for 1.5 h at room 
temperature with gentle rocking before being washed 3 x 10 min in 0.1 % Tween 
20 (v/v) in PBS. Membranes were then incubated with secondary antibodies 
diluted in 2 % milk powder (w/v) in PBS for 1 h at room temperature with gentle 
rocking before being washed as above. Horseradish peroxidase (HRP)-conjugated 
secondary antibodies were detected using the Immobilon western detection kit 
(Millipore, UK) and exposed to autoradiography film (Kodak, UK). Antibodies 
used are detailed in Table 2.1. 
For loading controls, antisera raised against P. falciparum branched chain alpha-
keto acid dehydrogenase acyltransferase subunit (BCDH) were used (Storm et 
al., 2011). Membranes were first stripped by incubation in Restore Plus western 
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blot stripping buffer (Thermo Scientific, UK) for 15 min at 37 °C before being 
washed 3 times with ddH2O and blocked again in 5 % (w/v) milk powder in PBS at 
room temperature for 2 h. Membranes were then re-probed with anti-BCDH 
antisera as detailed in Table 2.2. 
Table 2.2: List of antibodies and dilutions used in western blotting. 
 
 
2.8.6  Yeast complementation 
A yeast line YBL078c (EuroScarf, Germany) was transformed with the constructs 
PfATG8-pCM186 or LmATG12-pCM186 (as described in (Williams et al., 2009)) 
according to the lithium acetate method (Gietz and Woods, 2006). A protocol 
published online as part of a yeast transformation kit was followed 
(http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/Bulletin/yeast1bul.Pa
r.0001.File.tmp/yeast1bul.pdf [Last accessed 14/09/2012]). In brief, yeast 
cultures were grown in YPD medium at 30 °C until saturation (OD600 > 2). Half of 
one ml of saturated culture was used to inoculate a fresh 25 ml YPD culture, 
which was incubated under the same conditions until OD600 was between 1.0 and 
1.2. At this point the cells were pelleted by centrifugation at 1,000 g at room 
temperature for 5 min. The pelleted cells were washed with 25 ml ddH2O before 
being resuspended in 0.5 ml transformation buffer and kept on ice before 
transformation. 
To prepare plasmid DNA for transformation, 1 µg of plasmid was mixed with 10 
µl of 10 mg/ml salmon sperm DNA, which had previously been boiled for 10 min 
and returned to ice. To this DNA mixture, 100 µl of competent cells and 600 µl of 
PLATE buffer were added. The transformation mixture was incubated for 30 min 
at 30 °C with gentle shaking before heat shock treatment at 42 °C for 15 min. 
Transformed cells were pelleted  by centrifugation at 16,000 g at room 
temperature for 30 sec. The transformation supernatant was removed and the 
cells were washed with 500 µl ddH2O before being finally resuspended in 500 µl 
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ddH2O. Fifty and 200 µl of the resuspended cells were plated onto SC agar and 
were incubated at 30 °C for ~ 3 days until colonies were visible. Single colonies 
were picked and restreaked onto fresh SC agar plates to ensure isolation of 
successful transformants. 
Single colonies of transformed lines or a wild type line, Y00000 (EuroScarf, 
Germany), were used to inoculate an SC or YPD medium culture, respectively. 
These cultures were allowed to grow to saturation at 30 °C. Two ml of each 
saturated culture was used to inoculate a fresh 100 ml SC or YPD culture, which 
was incubated under the same conditions until the OD600 reached 1.0. At this 
point each culture was divided in half and yeast cells were pelleted by 
centrifugation at 1,000 g at room temperature for 5 min. One pellet was stored 
at - 20 °C as the non-induced sample. The other pellet was washed 3 times in 10 
ml of Induction medium before being resuspended in 100 ml Induction medium 
for an additional 16 h incubation at 30 °C. After this incubation, cells were 
pelleted by centrifugation as above and the pellet was stored at - 20 °C as the 
induced sample. 
For extraction of yeast protein, a One Shot cell disruptor (Constant Systems, UK) 
was used to mechanically lyse wild type and transformed cells. Pelleted yeast 
cells were resuspended in 10 ml bulk lysis buffer and were disrupted twice at 35 
kpsi. The soluble protein fraction was collected from the supernatant following 
centrifugation at 48,000 g at 4 °C for 45 min and was concentrated using a 
Vivaspin 20 centrifugation column with a 10 kDa molecular weight cut-off (VWR, 
UK), until approximately 1 ml remained. The concentration of protein in 
concentrated non-induced and induced samples was determined by Bradford 
assay. Twenty µg of protein collected from wild type or transformed lines was 
separated by 7.5 % SDS-PAGE and western blots were performed as detailed in 
Table 2.2. 
2.8.7  Recombinant His-PfATG8 expression 
In order to determine optimal conditions for His-PfATG8 expression in E. coli a 
trial of expression temperatures and durations was performed. A 10 ml starter 
culture of LB supplemented with 50 µg/ml kanamycin and 34 µg/ml 
chloramphenicol was inoculated with BLR (DE3) cells transformed with His-
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PfATG8-pET28a(+) for incubation overnight at 37 °C. An aliquot of 1.6 ml of the 
overnight culture was used to inoculate a fresh 80 ml LB culture while the 
remainder was used to generate glycerol stocks. The 80 ml culture was 
incubated at 37 °C until OD600 reached 0.6, at which point 1 ml was collected as 
the pre-induced sample by centrifugation at 16,000 g at 4 °C for 5 min before 
being frozen as a pellet. The remaining culture was induced by addition of 1 mM 
IPTG and was split into 4 x 20 ml cultures for incubation at 15, 20, 30 and 37 °C. 
One ml samples were collected from each culture at 2, 4, 6 and 16 h post 
induction as above. At 16 h post induction the remaining cultures were 
harvested by centrifugation at 4,400 g at 4 °C for 15 min before being frozen as 
a pellet. All pellets generated from 1 ml samples were treated with BugBuster 
protein extraction solution (Merck, UK) in order to generate soluble and 
insoluble protein fractions according to manufacturer’s guidelines. In brief, 
pellets were resuspended in 100 µl BugBuster supplemented with 1 mM 
benzamidine, 20 µM leupeptin, 4 µM pepstatin A and 1 mM PMSF. After thorough 
mixing on a rocker for 15 min at room temperature, samples were pelleted by 
centrifugation at 16,000 g at 4 °C for 15 min. Supernatants were collected as the 
soluble protein fraction and 12 µl of each was mixed with 3 µl protein loading 
buffer for separation by 15 % SDS-PAGE. Each pellet was resuspended in 30 µl 
protein loading buffer and 30 µl ddH2O and 5 µl was loaded per lane for 
separation as above as the insoluble protein fraction. 
Once the expression trial of recombinant His-PfATG8 had been analysed, all His-
PfATG8 expressions were performed at 20 °C for 16 h. Two individual 20 ml LB 
starter cultures were inoculated with BLR (DE3) cells transformed with His-
PfATG8-pET28a(+) and incubated overnight at 37 °C. Ten ml of these overnight 
cultures were used to inoculate 2 x 500 ml LB cultures which were incubated at 
37 °C and were induced with 1 mM IPTG when OD600 was between 0.6 and 1.0. At 
this point the cultures were cooled to 20 °C and pellets were generated 16 h 
later by centrifugation at 4,400 g at 4 °C for 15 min and stored at - 20 °C. 
Soluble protein fractions were extracted from pellets by mechanical disruption 
using a Cell Disruptor (Constant Systems, UK) on a One Shot setting. Pellets were 
resuspended in 20 ml bulk lysis buffer and disrupted twice at 15 kpsi. The 
soluble protein fraction was collected from the supernatant following 
centrifugation at 48,000 g at 4 °C for 45 min. 
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2.8.8  Purification of His-PfATG8 
Two methodologies were used for purification of recombinantly expressed 
proteins. Metal chelating affinity purification using nickel (Ni2+) charged resin 
columns was used to purify His-tagged proteins of interest (Crowe et al., 1994). 
This was achieved by either a simple ‘bench-top’ or a semi-automated 
immobilized metal affinity chromatography (IMAC) ‘IMAC’ method as detailed 
below. 
2.8.8.1 ‘Bench-top’ purification 
For bench-top purification of His-PfATG8 or His-PfLiplA1, supernatants 
containing soluble protein were transferred to a fresh 50 ml tube to which 1 ml 
Ni-NTA resin (Qiagen, UK), washed free of ethanol, was added for incubation 
overnight at 4 °C on a rocker. The mixture was then transferred to disposable 
filtration columns and the flow through collected and stored at - 20 °C. The 
packed resin was then washed with 10 ml volumes of 40 mM, 60 mM and 80 mM 
imidazole in bulk lysis buffer, with the flow through of each being collected and 
stored at - 20 °C. His-tagged protein was then eluted from the packed resin in 1 
ml 250 mM imidazole in bulk lysis buffer and then 1 ml 500 mM imidazole in bulk 
lysis buffer. Aliquots of each elution were made and then stored at - 20 °C. One 
final wash was performed with 1 M imidazole in bulk lysis buffer. Ten µl of each 
elution and wash and 1 µl of the initial flow through (mixed with 9 µl ddH2O) was 
then mixed with 3 µl of protein loading buffer and proteins were separated by 15 
% SDS-PAGE. 
2.8.8.2 ‘IMAC’ purification 
For purification using a semi-automated protocol, supernatants containing 
soluble protein were first filtered through a 0.2 µm syringe filter (Fisher 
Scientific, UK). A POROS MC nickel column of 1.7 ml volume (Life Technologies, 
UK) was initially washed in ddH2O, stripped using 50 mM EDTA and 1 M NaCl in 
ddH2O, recharged using 0.1 M nickel sulphate (pH 5) in ddH2O and equilibrated 
with bulk lysis buffer using a Biologic DuoFlow System (Bio-Rad, UK). Soluble 
protein was then loaded onto the column and flow through was collected and 
stored at - 20 °C. The column was washed with 10 mM and then 20 mM imidazole 
in bulk lysis buffer to remove weakly bound contaminants. His-PfATG8 was then 
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eluted in 20 x 1 ml fractions of a constant gradient of 20 - 500 mM imidazole in 
bulk lysis buffer. Ten µl of peak elution fractions (monitored by UV absorbance 
spectra) and each wash and 1 µl of the initial flow through (mixed with 9 µl 
ddH2O) was then mixed with 3 µl of protein loading buffer and proteins were 
separated by 15 % SDS-PAGE. If His-PfATG8 purified by either method was not 
immediately separated by SDS-PAGE, then PD10 de-slating columns (GE 
Healthcare, UK) were used to buffer exchange into either 5 M MES (pH 5.5) or 
bulk lysis buffer for storage. The concentration of proteins in purified fractions 
was determined by Bradford assay.  
2.8.9  Generation of anti-PfATG8 antisera 
Approximately 125 µg of purified His-PfATG8 was used per injection during an 87 
day inoculation programme in a rabbit host in order to acquire antisera 
containing antibodies specific for PfATG8. Two rabbits were used per programme 
and were each injected 4 times. To further purify His-PfATG8 for inoculation, 
200 µl of His-PfATG8 from a bench-top purification was separated in a single 
well by 15 % SDS-PAGE. Proteins were Coomassie-stained and gel slices 
equivalent to ~ 125 µg were collected. The antisera generation programme was 
performed by Eurogentec (Belgium). Antisera collected from small, large and 
final bleeds were tested by western blotting of recombinant and parasite protein 
extracts for reactivity against His-PfATG8 and PfATG8, respectively. 
2.8.10  Purification of anti-PfATG8 antisera 
Antisera collected from rabbits following inoculation with His-PfATG8 was 
affinity purified against recombinant His-PfATG8 or His-PfLiplA1 protein 
preparations. His-PfATG8 was expressed in BLR (DE3) cells and purified by the 
bench-top method as previously described. His-PfLiplA1 was expressed at 37 °C 
for 4 h and protein was extracted and purified by the same methods as His-
PfATG8. Two ml AminoLink coupling resin (Thermo Scientific, UK) was washed 
and approximately 2 mg of purified recombinant protein was bound during 
overnight incubation at 4 °C. Two ml of antisera was then purified according to 
the manufacturer’s guidelines and was eluted into 500 µl fractions. Eluted 
antisera fractions along with unpurified and flow through fractions were tested 
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by western blotting of purified recombinant His-PfATG8 protein and parasite 
extracts separated by 15 % SDS-PAGE. 
2.9   Bioinformatic methods 
2.9.1  Homologue identification 
Protein sequences from S. cerevisiae  strain S288c (unless stated otherwise) 
were used as queries in order to identify genes in P. falciparum 3D7 that encode 
potential homologues to ATGs and other proteins complementary to autophagy. 
Protein sequences retrieved from the UniProtKB/Swiss-Prot database were 
submitted to BLASTp searches of the P. falciparum 3D7 genome available online 
at PlasmoDB (http://plasmodb.org/plasmo/ [Last accessed 14/09/2012]) and 
predicted translations of hits were aligned back to query sequences using AlignX 
(Life Technologies, UK). Predicted translations of hits were then submitted to 
BLASTp (WU-BLAST2) searches of the S. cerevisiae  strain S288c proteome 
available online at  (http://yeastgenome.org/cgi-bin/blast-sgd.pl [Last accessed 
14/12/2012]). 
2.9.2  Sequence alignment of ATG8 homologues 
The protein sequence of ScATG8 was used as a query in order to identify genes in 
other Plasmodium spp. that encode potential ATG8 homologues. Predicted 
translations of hits were aligned with the predicted translation of Pfatg8 along 
with other known ATG8 homologues and ScATG8 using the pair-wise alignment 
program EMBOSS Needle (EMBL-EBI, UK). The predicted translation of Pfatg8 was 
then aligned with the protein sequences of ScATG8 and human ATG8 homologues 
using ClustalW2 (EMBL-EBI, UK). The conservation of known key residues was 
analysed in each alignment.  
2.9.3  Structural modelling  
Protein sequences of known ATG8 homologues and the predicted translation of 
Pfatg8 were submitted to the online I-TASSER server (Zhang, 2008) and models 
retrieved with the highest confidence score (indicating the significance of 
alignment) were selected as the best models. I-TASSER is regarded as one of the 
best public protein structure prediction servers following Critical Assessment of 
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protein Structure Prediction (CASP) experiments over the last decade 
(http://predictioncenter.org/index.cgi [last accessed 12/06/2012]). 
2.9.4  Model alignment  
Alignment of structural models generated by I-TASSER and solved structures 
retrieved from (http://www.rcsb.org/pdb/home/home.do [Last accessed 
14/09/2012]) was performed using TM-align (Zhang and Skolnick, 2005). The TM 
scores produced were used as a measure of relatedness between two different 
proteins or as a measure of accuracy between a model and its corresponding 
solved structure. 
2.9.5  Densitometry of western blots 
Densitometry of western blots was performed using ImageJ software available 
from the National Institutes of Health (U.S.A.) (NIH), according to L. P. Miller 
2010 (http://lukemiller.org/index.php/2010/11/analyzing-gels-and-western-
blots-with-image-j [last accessed 14/09/2012]). Briefly, the intensity of bands of 
BDCH loading controls was used to normalise the intensities of bands of either 
PfATG8 or mCherry-PfATG8 in each lane. These were then expressed as either a 
percentage of the first band in time course experiments (see Figure 3.9 and 
Figure 3.14) or as a ratio of the lower band to the upper band when analysing 
the lipidation state of mCherry-PfATG8 (see Figure 3.13 and others). 
2.9.6  Statistical analysis 
Statistical analysis was performed using GraphPad Prism software (Graphpad, 
U.S.A.). Data groups were first tested for normal distribution (when applicable). 
To determine if two groups of data were significantly different, an unpaired 
Student t-test was performed. Data presented graphically was generated in 
GraphPad Prism and Excel (Microsoft, U.S.A.). 
2.9.7  Analysis of correlation by generation of Pearson’s 
coefficient 
The degree of overlap between signals from either fluorescent fusion proteins or 
Alexa Fluor 488/594-conjugated antibodies was analysed using SoftWoRx 
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(Applied Precision, UK). The degree of correlation was represented by a 
coefficient score based on Pearson’s coefficient (r) (Adler and Parmryd, 2010, 
Manders et al., 1993). 
2.10   Culturing of P. falciparum 
Erythrocytic stages of P. falciparum strains D10 and 3D7 were cultured according 
to Trager and Jenson (Trager and Jensen, 1976). All work with live parasites was 
performed under a Holten Maxi Safe 2010 category 2 tissue culture hood 
(Thermo Scientific, UK) and all medium and buffers were filter sterilised (0.2 
µm) before use. Parasites were grown in sterile tissue culture flasks at 37 °C and 
individual flasks were gassed with 3 % CO2, 1 % O2 and 96 % N2 before sealing. 
Erythrocytes from whole blood were isolated by repeated washes in blood wash 
medium until no trace of white blood cells were seen in Giemsa-stained thin 
smears. Erythrocytes were stored at 4 °C for no longer than 4 weeks. 
Erythrocytes were added to cultures at 5 % haematocrit unless stated otherwise 
and were given fresh culture medium every 24 h after careful aspiration of old 
medium. Cultures were diluted with fresh erythrocytes to ensure the 
parasitaemia remained below 10 %. If cultures were not transferred to new 
flasks during dilutions, for example whilst waiting for recovery of parasites after 
transfection, transfer to new flasks was performed once every 2 weeks.  
2.10.1  Giemsa staining of thin smears 
In order to calculate parasitaemia of cultures, thin blood smears were stained 
with Giemsa to allow identification of parasites. A small amount of sedimented 
infected erythrocytes was pipetted onto glass slide and smeared to achieve a 
thin film of cells. Slides were allowed to air dry and then fixed in 100 % 
methanol for 1 min and then stained for 5 min in Giemsa (1:25 dilution in H2O). 
Excess stain was washed off with H2O and slides allowed to air dry. Slides were 
then examined using a 100 x oil immersion lens light microscope (Motic, 
Germany). Parasitaemia was calculated as the proportion of infected 
erythrocytes to uninfected erythrocytes with around 1,000 cells being counted in 
total. 
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2.10.2  Freezing parasites 
Parasites were frozen as stabilates in liquid nitrogen for long term storage. 
Cultures of at least 4 % ring stages were centrifuged at 400 g at room 
temperature for 5 min to allow aspiration of medium. Pelleted infected 
erythrocytes were resuspended in 1 x volume of cold RPMI complete and 2 x 
volumes of cold 30 % (v/v) glycerol in PBS and carefully mixed. Six hundred µl 
were transferred to 1.5 ml cryovials and were incubated on ice for 10 min before 
being transferred to liquid nitrogen. 
2.10.3  Thawing parasites 
Stabilated parasites were thawed using increasingly isotonic buffers. Frozen 
cryovials were thawed at 37 °C for 1 min and then kept on ice. Cells were 
transferred to sterile tubes and 0.2 x volumes of 12 % (w/v) NaCl in PBS were 
added. Cells were incubated at room temperature for 5 min before 10 x volumes 
of 1.8 % (w/v) NaCl in PBS was added step-wise. After further incubation at room 
temperature for 5 min, 10 x volumes of 0.9 % (w/v) NaCl and 0.2 % (w/v) glucose 
in PBS was added step-wise. After a final incubation at room temperature for 5 
min infected erythrocytes were pelleted by centrifugation at 400 g for 5 min at 
room temperature. The supernatant was aspirated and the pellet resuspended 
with 200 µl uninfected erythrocytes in 8 ml RPMI complete and transferred to 
fresh flasks. Cultures were fed daily and when parasitaemia reached 1 %, 300 µl 
uninfected erythrocytes and appropriate selective drug(s) were added. 
2.10.4  Synchronising parasites 
Parasites were synchronised to ring stages using sorbitol according to Lambros 
and Vanderberg (Lambros and Vanderberg, 1979). Cultures of at least 1 % ring 
stages were centrifuged at 400 g at room temperature for 5 min to allow 
aspiration of medium. Pelleted infected erythrocytes were resuspended in 5 x 
pellet volumes of 5 % sorbitol (w/v) in 10 mM potassium phosphate (pH 7.2) and 
incubated for 5 min at 37 °C. Infected erythrocytes were again pelleted to allow 
aspiration of supernatant. Pelleted infected erythrocytes were then resuspended 
in culture medium to 5 % haematocrit and transferred to a fresh culture flask. 
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2.10.5  Isolation of parasites 
Parasites were isolated from erythrocytes by using saponin (Christopher, 1939). 
Cultures were resuspended in culture medium and 0.1 x volumes of 2 % saponin 
(w/v) in PBS added for 5 min incubation at 4 °C. Freed parasites were pelleted 
by centrifugation at 1,800 g for 5 min at 4 °C. The supernatant was aspirated 
and parasites repeatedly washed in PBS until the supernatant was visually clear 
of any haemoglobin. Pelleted parasites, isolated from erythrocytes were then 
used for DNA, RNA or protein extraction. 
2.10.6  Large scale isolation of P. falciparum DNA 
Parasite DNA was extracted from pelleted parasites using Qiagen’s QIAamp DNA 
mini kit according to the manufacturer’s guidelines for extraction from blood or 
body tissue. Briefly, the parasite pellet was resuspended in PBS supplemented 
with Proteinase K. Buffer AL was added and samples were incubated at 56 °C for 
10 min. Ethanol was added to precipitate DNA and samples were transferred to 
the provided spin columns. Following washing steps DNA was eluted in 2 x 200 µl 
of ddH2O. Parasites pelleted from a 25 ml culture of 5 % parasitaemia gave a 
typical yield of ~ 15 µg DNA. 
2.10.7  Extraction of RNA 
RNA was extracted from parasites as previously described (Smith et al., 1998). 
Pelleted parasites were resuspended in 10 x volumes of TRIzol reagent (Life 
Technologies, UK) and stored at – 80 °C until RNA extraction. After defrosting, 
RNA was extracted by addition of 0.2 x volumes of chloroform. Samples were 
mixed by shaking for 15 sec followed by 2 min incubation at room temperature 
and subsequent centrifugation at 13,000 g at 4 °C for 15 min. The aqueous phase 
was transferred to a clean 1.5 ml tube and 0.7 x volumes of isopropanol were 
added. The RNA was precipitated at 4 °C overnight. The following morning 
samples were centrifuged at 13,000 g at 4 °C for 30 min. The supernatant was 
removed and the RNA pellet washed with 70 % ethanol. Samples were again 
centrifuged at 13,000 g at 4 °C for 15 min and the supernatant removed. The 
RNA pellet was air dried before being resuspended in an appropriate volume of 
DEPC-treated RNase free water (20 - 40 µl) by heating to 60 °C for 10 min. RNA 
was stored at - 80 °C. This was performed by Dr. E. Patzewitz. 
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2.10.8  Extraction of protein 
P. falciparum protein was extracted from pelleted parasites by a process of 
sequential freeze thaw cycles. Pellets were resuspended in ~ 100 µl cold, freshly 
prepared parasite lysis buffer and mixed thoroughly by pulse vortexing for 3 x 30 
sec. Samples were then frozen on dry ice and thawed at room temperature. 
Thawed samples were again mixed by pulse vortexing and repeated pipetting 
(with a p200 tip (Greiner, UK)). This process was repeated twice more and then 
the samples were left on ice for 20 min before centrifugation at 16,000 g for 5 
min at 4 °C. Soluble protein in the supernatant was transferred into a fresh tube 
and subjected to Bradford assay to determine protein concentration. Samples 
were aliquoted into ~ 25 µg aliquots and stored at – 20 °C. The remaining 
parasite pellets were also stored at – 20 °C. 
2.10.9  Transfection of parasites 
Parasites were transfected when between 2 and 4 % ring stages according to 
Crabb and Cowman (Crabb et al., 2004). Infected erythrocytes were pelleted by 
centrifugation at 400 g for 5 min at room temperature to allow culture medium 
to be aspirated. Infected erythrocytes were then resuspended in 10 x volumes 
cytomix and spun again. Seventy five µg of precipitated plasmid DNA which was 
previously resuspended in 30 µl ddH2O was diluted with 370 µl cytomix and was 
kept on ice. Two hundred µl of pelleted infected erythrocytes were carefully 
mixed with the 400 µl of DNA and transferred to a 2 mm electroporation cuvette 
(Bio-Rad, UK) and electroporated at 310 V and 950 µF using a Gene Pulser Xcell 
electroporator (Bio-Rad, UK). A typical time constant was ~ 12 msec. 
Electroporated cells were immediately transferred to a fresh flask containing 
300 µl of uninfected erythrocytes and 8 ml RPMI complete pre-warmed to 37 °C 
and the electroporation cuvette was washed with 1 ml RPMI complete to give a 
total final volume of ~ 10 ml. Six hours after transfection, cultures were fed as 
described above. The following day cultures were fed again with RPMI complete 
supplemented with the appropriate selective drug(s). Transfected cultures were 
fed daily for 1 week and then every second day until parasites were detected in 
Giemsa-stained thin smears. 
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2.10.10   Cloning by limiting dilution 
Clonal lines of P. falciparum transgenic strains were generated by limiting 
dilution (Kirkman et al., 1996). Parasitaemia was determined by analysing 
Giemsa-stained thin smears and haematocrit was calculated by using a Neubauer 
chamber (Hawksley, UK). Cultures were diluted to 1.25 parasites / ml at 1 % 
haematocrit and 200 µl was added per well of a 96 well plate in duplicate. 
Plates were placed in an incubation chamber, gassed and incubated at 37 °C. 
Culture medium was replaced every 5 days for 15 days, after which medium was 
replaced every 2 days for a maximum of 21 days in total. Parasite growth was 
monitored after the second feed by analysis of Giemsa-stained thick smears and 
cultures showing growth of parasites were transferred to 2 ml cultures at 1 % 
haematocrit. Growth was monitored and cultures were bulked up to 10 ml at 5 % 
haematocrit before stabilates were made and DNA was isolated by using 
InstaGene Matrix reagent (Babiker et al., 1998) according to manufacturer’s 
guidelines (Bio-Rad, UK). This is referred to as small scale P. falciparum DNA 
isolation. 
2.10.11   Determination of IC50  
The concentration of various drugs at which 50 % of parasites are killed was 
measured by [3H]-hypoxanthine incorporation according to Desjardins et al. 
(Desjardins et al., 1979). Cultures were diluted to 0.5 % parasitaemia and 2 % 
haematocrit in IC50 medium. Serial dilutions starting from 2 x the desired 
starting drug concentration were prepared in 100 µl IC50 medium for each well in 
a 96 well plate. To each well 100 µl of diluted cultures were added and plates 
were placed in an incubation chamber, gassed and incubated at 37 °C for 48 h. 
To each well 0.4 µCi of [3H]-hypoxanthine was then added in 30 µl IC50 medium. 
The plates were gassed and incubated at 37 °C for a further 24 h before being 
frozen at – 20 °C. In parallel, wells were set up which contained uninfected 
erythrocytes only as a measure of background incorporation and infected 
erythrocytes without drug were used as growth controls. Plates were allowed to 
thaw for at least 3 h after which material was harvested onto Printed Filter Mat 
A filter membranes (Wallac, UK) using a Mach III harvester system (TomTec, 
U.S.A.). Membranes were dried and then soaked in 4 ml Betaplate scintillant 
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before reading in a 1450 Microbeta scintillation counter (Perkin Elmer, UK) for 1 
min per well. IC50 values were determined using GraphPad Prism software. 
2.10.12   Magnetic enrichment of late stage parasites 
Cultures were enriched for late stage parasites by magnetic separation (Ahn et 
al., 2008, Trang et al., 2004) with a Vario MACS magnet and LS+ columns 
(Miltenyi, UK). Infected erythrocytes were pelleted by centrifugation at 400 g at 
room temperature for 5 min to allow aspiration of culture medium. Pelleted 
infected erythrocytes were resuspended in 4 x volumes of 0.5 % BSA, 2 mM EDTA 
in PBS and applied to a mounted LS+ column that had been rinsed with 5 ml 0.5 
% BSA, 2 mM EDTA in PBS. Cells were allowed to flow through the column under 
gravity under the resistance of a 0.6 mm needle. Bound infected erythrocytes 
were then washed with multiple 1 ml volumes until eluate was colourless. 
Columns were then unmounted from the magnet and infected erythrocytes 
enriched for late stage parasites were eluted in 1 ml 0.5 % BSA, 2mM EDTA in 
PBS, pelleted by centrifugation at 400 g for 1 min at room temperature and then 
prepared for fluorescence light microscopy. Typically, enrichment resulted in ~ 
90 % parasitaemia of early trophozoite to segmenter stage parasites. 
2.10.13   Preparation of slides for live microscopy 
Infected erythrocytes were imaged by fluorescence light microscopy in EBSS 
supplemented with 11 mM glucose (EBSS+G). When enrichment of late stage 
parasites was not performed, for each slide prepared, 0.5 ml culture was 
resuspended and incubated with 100 µg/ml Hoechst 33258 at 37 °C for 5 min. 
Infected erythrocytes were then pelleted by centrifugation at 400 g for 1 min at 
room temperature. The supernatant was removed and infected erythrocytes 
were resuspended in 1 ml EBSS+G and pelleted as above. The supernatant was 
removed and infected erythrocytes were resuspended in ~ 30 µl EBSS+G. Five µl 
was dropped onto a glass slide and covered with a number 1 thickness cover slip. 
Images were taken from slides for no longer than 30 min after application of the 
cover slip. Where cultures were enriched for late stage parasites, the 1 ml 
elution was centrifuged at 400 g for 1 min at room temperature to allow removal 
of the supernatant. The pelleted infected erythrocytes were then washed once 
with 1 ml EBSS+G before incubation in 0.5 ml EBSS+G with 100 µg/ml Hoechst 
Materials and Methods  63 
33258 at 37 °C for 5 min. Samples were then washed and slides prepared as 
detailed above.  
2.10.14   Preparation of slides for Immunofluorescence assay 
The subcellular localisation of proteins was detected by immunofluorescence 
(IFA) microscopy using the antibodies detailed in Table 2.3. LabTek II 8 well 
chamber microscope slides (Thermo Scientific, UK) were used in the preparation 
of infected erythrocytes for microscopy. Slides were coated in poly-L-lysine prior 
to addition of infected erythrocytes reduced to 2.5 % haematocrit. Once dry, 
slides were fixed with 2 % paraformaldehyde and 0.0075 % glutaraldehyde in PBS 
for 20 min, permeabilised with 0.1 % Triton X-100 in PBS for 10 min and reduced 
with 0.1 mg/ml sodium borohydride in PBS for 10 min. Slides were washed with 
PBS between each treatment. Slides were blocked overnight in 3 % BSA in PBS at 
4 °C in a moist container. The following morning, blocking solution was replaced 
with fresh 3 % BSA in PBS containing primary antibody and slides were incubated 
for 1.5 h at room temperature. Unbound antibodies were removed by 3 x washes 
in 0.05 % Tween 20 in PBS before application of secondary antibodies in 3 % BSA 
in PBS for 1 h incubation at room temperature. For the final 5 minutes of the  
incubation, Hoechst 33528 was added to a final concentration of 0.5 µg/ml. 
Unbound antibodies were removed by washing as above and slides were mounted 
in 2.5 % DABCO, 50 % glycerol in PBS under a number 1 thickness cover slip. 
Cover slips were fixed in place using black nail polish and allowed to settle 
before microscopy. 
Table 2.3: Antibodies used in IFA analysis . 
 
 
Materials and Methods  64 
2.10.15   Microscopic analysis of live and IFA slides 
In total, three microscopes were used in the analysis of live and fixed parasites. 
A Motic BA400 microscope was used for calculating the parasitaemia of Giemsa-
stained thin smears at 100 x magnifications and the haematocrit using a 
Neubauer chamber slide at 20 x magnifications. For the analysis of live and fixed 
parasites an AxioSkop 2 mot plus microscope, using Openlab software and a 
Hamamatsu C4742 CCD camera was used. To facilitate quantification of 
colocalisation a deconvolving Delta Vision Core microscope, using SoftWoRx 
software and a CoolSNAP HQ2 camera was used. Images were captured at 100 x 
magnification using differential interference contrast (DIC) microscopy. GFP 
fusion proteins, MitoTracker Green-FM, ER Tracker, LysoSensor probes and Alexa 
Fluor 488-conjugated secondary antibodies were detected using a FITC filter 
(excitation at 461 nm, emission at 489 nm). mCherry-PfATG8, LysoTracker and 
Alexa Fluor 594-conjugated secondary antibodies were detected using an 
mCherry filter (excitation at 563 nm, emission at 588 nm). Hoechst 33258 was 
detected using a DAPI filter (excitation at 381 nm, emission at 399 nm). Images 
collected were deconvolved (where possible) on a conservative setting and 
layered using Photoshop Elements 9 (Adobe, U.S.A.). ImageJ was used to stack 
individual images in order to generate 3D reconstructions. Analysis of 
colocalisation between signals from FITC and mCherry or mCherry and DAPI 
filters was performed using SoftWoRx software as were measurements of vesicle 
size. 
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3   Bioinformatic and biochemical characterisation 
of an ATG8 homologue in P. falciparum. 
3.1   Introduction 
At the onset of this study, autophagy in Plasmodium spp. had only briefly been 
eluded to in published literature (Bonilla et al., 2007). Bonilla and co-workers 
showed that antibodies raised against a peptide of rat ATG8 detected proteins 
that could have represented a Plasmodium homologue of ATG8 and that these 
proteins were more abundant in parasites in which vacuolar plasmepsins were 
genetically ablated. They suggested that P. falciparum possesses an active 
autophagy system, which targets autophagic cargo to the digestive vacuole. It 
was predicted, due to the high degree of conservation of ATG proteins in all 
eukaryotes examined, that the genome of P. falciparum would be found to 
encode ATG homologues. However, ATG-encoding genes had not been identified 
and whether any ATG proteins were expressed during the intraerythrocytic 
stages of parasite development was not known. This study therefore started 
from the ground up in regards to exploring the potential presence of an 
autophagic process in these parasite stages. Therefore, initial bioinformatic 
scrutinisation of the P. falciparum 3D7 genome was required to determine if atg 
genes might be present in the parasite genome. To achieve this, a series of basic 
local alignment search tool (BLAST) searches were performed to analyse the 
parasite genome for genes that might encode proteins sharing sequence identity 
to the repertoire of ATG proteins in the reference organism S. cerevisiae. 
Following identification of any potential homologues, further analysis and 
characterisation of these hits was expected to help to determine whether 
autophagy exists during the intraerythrocytic stages of P. falciparum. 
3.2   Results 
3.2.1  Bioinformatic screening of autophagy homologues 
The protein sequences of a number of ATGs and proteins complementary to 
autophagy and the Cvt pathway in S. cerevisiae were used to probe the 
predicted proteome of 3D7 P. falciparum for potential homologues. Protein 
sequences retrieved from (http://www.ncbi.nlm.nih.gov/protein [Last accessed 
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14/09/2012]) for S. cerevisiae strain S288c (unless otherwise stated) were 
submitted to the online BLASTp function available at PlasmoDB 
(http://www.plasmodb.org [Last accessed 14/09/2012])) and hits with the 
smallest sum of probability (P value) were recorded. In order to analyse the 
percentage identity and similarity between queries and hits at the amino acid 
level, primary amino acid sequences were aligned using AlignX (Life 
Technologies). In some cases the size of the potential homologue and its protein 
query were vastly different, with the potential P. falciparum homologue often 
being much longer. In such cases the percentage similarity and identity between 
the query and hit were negatively affected. If the percentage of identity was 
found to be less than 10 %, hits from the initial screen with higher P values were 
analysed until a hit considered to represent the most likely potential homologue 
based on percentage identity of amino acid sequence was identified. The best 
hit was then submitted as a query to probe the S. cerevisiae strain S288c 
proteome by BLASTp (WU-BLAST2) seach. If the original query was returned as a 
hit in this ‘reverse’ search then its P value was recorded. Based on these 
analyses the most likely homologues of each ATG and protein complementary to 
autophagy probed are shaded in red in Figure 3.1. Homologues shaded blue are 
considered to be unlikely to represent true homologues of their query proteins. 
From this initial analysis, it appeared that a number of ATG proteins appeared to 
be missing or highly divergent in P. falciparum. For example, the genes 
considered most likely to encode homologues of ATG1, ATG4 and ATG15, are 
predicted to encode proteins that show only 9.3, 5.9 and 4.9 % identity to the 
yeast proteins, respectively. This might indicate that the autophagic machinery 
encoded by P. falciparum represents a reduced core set of components 
(Duszenko et al., 2011). Conversely, a number of genes were identified that are 
predicted to encode potential homologues to ATG proteins and proteins 
complementary to autophagy with much greater confidence. Genes considered 
most likely to encode homologues of ATG3, ATG8 and ATG12, are predicted to 
encode proteins that show 28.0, 38.1 and 16.0 % identity to yeast proteins, 
respectively. These proteins in yeast are involved in the ATG8 conjugation 
pathway (Kabeya et al., 2004), potentially indicating that this pathway, highly 
conserved amongst eukaryotes, is also conserved in P. falciparum. 
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In order to explore members of the ATG8 conjugation pathway further, gene-
specific primers were designed to amplify the genes likely to encode potential  
ATG3, 4, 5, 7, 8, 10 and 12 homologues. PCR analyses using these primers 
amplified products of the expected sizes when using gDNA isolated from 3D7 P. 
falciparum as a template. However, when using either a cDNA library or cDNA 
generated from RNA collected from asynchronous 3D7 parasites as a template, 
only the ORFs of atg3, 8 and 12 were amplified. This suggested that either the 
gene annotations for the remaining genes were incorrect, or that they were not 
transcribed during the intraerythrocytic development of P. falciparum. The atg 
gene product with the highest degree of confidence was that of PF10_0193, 
predicted to represent a homologue of ATG8. Therefore the characterisation of 
this gene and its protein product became the focus of this study. 
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Figure 3.1: Identification of genes potentially encoding homologues of ATGs and proteins 
associated to autophagy in the P. falciparum 3D7 genome. 
The protein sequences of ATGs and proteins associated or complementary to autophagy in S. 
cerevisiae (unless stated otherwise) were used as queries in BLASTp searches of the 
predicted P. falciparum 3D7 proteome. An initial screen of core ATGs (performed by Dr. R. 
Williams) is presented first. Hits with the lowest P values were aligned against their queries 
using AlignX (Life Technologies). In instances where the % identity between the whole amino 
acid sequence of a hit was less than 10 % of its query, hits of higher P values were examined. 
Hits considered the strongest following alignment to their queries were then used as queries 
in BLASTp (Wu-BLAST2 (Saccharomyces Genome Database)) and the E values of positive 
identifications were recorded. Genes shaded in red are considered likely to encode true 
homologues.Queries are designated as core autophagy components, components of specific 
autophagy or proteins complementary to the process of autophagy but named following 
discovery of their involvement in other processes (Inoue and Klionsky, 2010). NF (Not 
Found), NA (Not Applicable). 
 
3.2.2  Alignment of a putative PfATG8 homologue with known 
ATG8 homologues 
The protein sequence of the potential PfATG8 homologue identified in 
bioinformatic screening of the 3D7 P. falciparum genome was analysed in 
comparison to the protein sequences of characterised ATG8 homologues in other 
organisms and other putative Plasmodium ATG8 homologues using pair wise 
alignment available online via 
(http://www.ebi.ac.uk/Tools/psa/emboss_needle/ [Last accessed 14/09/2012]) 
(Figure 3.2(A and B)). As expected, having used ScATG8 as a query, the similarity 
between PfATG8 and ScATG8 was high (64.3 %) as was the amino acid identity 
(38.9 %). The degree of similarity was also high with human ATG8 homologues, 
particularly with members of the GABARAP family such as GATE-16 (62.5 %). The 
degree of conservation of putative ATG8 protein sequences within Plasmodium 
spp. was also very high (97.6 %). The similarity between PfATG8 and ATG8 
homologues in other Apicomplexans and other parasitic protists varied but was 
generally high. This suggests that ATG8 is highly conserved amongst eukaryotes, 
with Plasmodium spp. being no exception. Interestingly the degree of similarity 
between PfATG8 and Cryptosporidium hominis was considerably lower than that 
with Cryptosporidium muris, possibly indicating a divergence of the function or 
role of ATG8 in Cryptosporidium hominis or that the homologue identified in this 
organism has been incorrectly annotated. The protein sequences of ScATG8 and 
the putative PfATG8 homologue were aligned using ClustalW2 (EMBL-EBI) 
available online at (http://www.ebi.ac.uk/Tools/msa/clustalw2/ [Last accessed 
14/09/2012]). Key residues in ScATG8 responsible for interaction with ATG4 
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appeared to be highly conserved in PfATG8 (Figure 3.2(C)) (Amar et al., 2006). 
Interestingly, the C-terminus of PfATG8 features a conserved glycine residue, 
responsible for lipidation to PE, which is not followed by any other residues. This 
exposed C-terminal glycine is also a feature of ATG8 homologues in Trypanosoma 
brucei (Tb927.7.5900) and Arabidopsis thaliana (Q8S925). In T. brucei, TbATG8a 
and its exposed C-terminal glycine residue have been linked with a high rate of 
basal autophagy, while a second, more canonical homologue TbATG8b is 
believed to play a role in starvation or stress-induced autophagy (Koopmann et 
al., 2009). Also of note was the observation of a 9 amino acid motif 
(YGSNMKLFR) that does not align with any ATG8 homologue tested. This motif is 
conserved within all putative Plasmodium ATG8 homologues and is therefore 
considered to be Plasmodium-specific. 
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Figure 3.2: Analysis of a putative PfATG8 by alignment to ATG8 homologues from other 
organisms. 
(A and B) The amino acid sequence of PfATG8 was compared to those of other organisms by 
pair-wise alignment using EMBOSS Needle (EMBL-EBI). Percentage identity and similarity are 
shown for yeast, mammalian and putative Plasmodium spp. homologues (A) and 
Apicomplexan and other parasitic protozoa (B). Accession numbers used are as follows: 
PfATG8 (PF10_0193) Plasmodium falciparum; ScATG8 (P38182) Saccharomyces cerevisiae; 
MAPLC3a (NP_115903.1) Homo sapiens; MAPLC3b (NP_852610.1) H. sapiens; GABARAPL1 
(NP_113600.1) H. sapiens; GATE-16 (NP_009216.1) H. sapiens; PbATG8 (PBANKA_050410) 
P. berghei; PvATG8 (PVX_001860) P. vivax; PkATG8 (PKH_060390) P. knowlesi; PyATG8 
(PY00606) P. yoelii; PcATG8 (PCHAS_050420) P. chabaudi chabaudi; ChATG8 (Chro.70444) 
Cryptosporidium hominis; CmATG8 (CMU_014110) C. muris; TgATG8 (TGME49_054120) 
Toxoplasma gondii; NcATG8 (NC_LIV_041240) Neospora caninum; TaATG8 (TA12615) 
Theileria annulata; TbATG8a (Tb927.7.5900) Trypanosoma brucei;TbATG8b 
(Tb927.7.5910) T. brucei; LmATG8 (LmjF.19.1630) Leishmania major; LmATG8a.1 
(LmjF.19.0840) L. major; LmATG8b.1 (LmjF.19.0820) L. major and LmATG8c.1 
(LmjF.09.0150) L. major. 
(C The alignment between the ScATG8 query and PfATG8 hit sequences generated in 
ClustalW2 (EMBL-EBI) is presented graphically. Residues that constitute the first hydrophobic 
pocket are shown in red; the second hydrophobic pocket in blue; residues crucial for ATG4 
binding in green; and the glycine residue essential for binding of ATG7, ATG3 and 
phosphatidylethanolamine in orange (* indicates conservation; : indicates high similarity and 
. indicates similarity).  
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3.2.3  Modelling of the tertiary structure of a putative PfATG8 
The crystal structure of ScATG8 and a number of ATG8 homologues from other 
organisms, including LC3 of humans, have been solved (Kumeta et al., 2010, 
Sugawara et al., 2004). As it was apparent that a high level of primary sequence 
homology exists between PfATG8 and other ATG8 homologues, modelling of the 
tertiary structure of PfATG8 was performed in order to add insight into the 
structural properties of PfATG8.  The amino acid sequence of PfATG8 was 
submitted along with those of yeast and human homologues to I-TASSER, an 
online server delivering qualitative tertiary structure modelling (Zhang, 2008). A 
total of 3 models were generated for PfATG8, with the single model with the 
greatest confidence (C) score of 1.01 being considered the most accurate. C-
scores fall in the range of -5 to 2, with a higher value indicating a greater 
significance of alignment. A score of 1 therefore indicates a model that is highly 
likely to represent an accurate tertiary structure (Figure 3.3(A)). Models with 
the highest C-score for each yeast and human ATG8 homologue were similarly 
selected. 
In order to test the accuracy of the models generated, the models generated for 
each  yeast and human ATG8 homologue were aligned to their relevant solved 
structure using TM-Align, an online server delivering quantification of similarity 
between protein structures (Zhang and Skolnick, 2005). This algorithm returns a 
TM-score. Similar to more conventional root-mean-square-deviation scores, this 
value indicates the degree of similarity between 2 structures. A value greater 
than 0.5 is considered to indicate a high degree of similarity. As expected, TM-
scores for alignments between the solved structures of ATG8 homologues and 
models generated from primary sequence were all high, typically ~ 0.95. A score 
of 1, indicating perfect alignment was not observed between any pair potentially 
due to the inherent mobility of the N-terminus (Schwarten et al., 2010) and the 
difficulties associated with accurately resolving the N- and C-termini of 
crystallised proteins due to the unreliable diffraction patterns resulting from 
these  freely flexible amino acids 
(http://www.rcsb.org/pdb/101/static101.do?p=education_discussion/Looking-
at-Structures/missing.html [Last accessed 23/08/2012]). 
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The degree of similarity between the PfATG8 model and those of other 
homologues of ATG8 was analysed. The models generated from primary amino 
acid sequence rather than the solved structures were chosen for alignment for 
consistency as in some cases multiple, varying solved structures of a single ATG8 
homologue (e.g. crystal and NMR structures) exist. TM-scores ranging from 0.86 
to 0.95, showed that the model of PfATG8 was very similar in structure to those 
of other ATG8 homologues (Figure 3.3(B and C)). Interestingly, the highest 
similarities were with ScATG8 and GABARAP family homologues, with slightly 
lower similarities observed with LC3 family homologues. As P. falciparum only 
appears to encode a single ATG8 homologue, it would be likely that it would 
share a high degree of similarity to ATG8 homologues of organisms which also 
possess single homologues, such as S. cerevisiae. A higher degree of similarity 
with the GABARP family of human homologues, in comparison to the LC3 family 
may indicate that PfATG8 has functional properties more akin to the GABARAP 
family proteins GABARAPL1 and GATE-16 and possibly that this family of ATG8 
homologues is more closely related to ScATG8 than the members of the LC3 
family, in fitting with previous findings (Alberti et al., 2010, Slavikova et al., 
2005). As expected, the 9 amino acid region, observed only in the potential 
ATG8 homologues in Plasmodium spp. did not align with any region of other 
ATG8 homologue models or solved structures. These residues appeared to form 
an extended loop between the 3rd alpha helix and 3rd beta sheet. Experimentally 
solving the structure of PfATG8 would be needed to determine if the position of 
these residues is accurately predicted, as they may have been presented in an 
unstructured loop due to the lack of similar sequences within the reference 
structures available. Whether these residues contribute a functional capacity of 
PfATG8 not possessed by other ATG8 homologues is unclear. Searching for known 
motifs in PfATG8 using an online protein motif identifier 
(http://motifsearch.com/ [Last accessed 14/09/2012]) did not reveal any likely 
attributes for this region of the protein. 
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Figure 3.3: Modelling of the predicted tertiary structure of a putative PfATG8. 
(A) The predicted amino acid sequence of PfATG8 was submitted to I-TASSER. A predicted 
tertiary structure with a high confidence score of 1.01 is shown. Residues predicted to 
constitute the PfATG4 and PfATG3 interacting motifs are shown in blue and red, 
respectively. Residues forming an extended loop specific to Plasmodium spp. are shown in 
green. The C-terminal glycine residue predicted to facilitate membrane association via 
phospholipid conjugation is shown in orange. 
(B) The model of PfATG8 tertiary structure (black) was aligned with the model for ScATG8 
(pink), using TM-Align. 
(C) The model of PfATG8 tertiary structure was aligned with the models for ScATG8, 
MAPLC3a, MAPLC3b, GABARAPL1 and GATE-16 using TM-align and the resulting TM-scores are 
shown. 
 
3.2.4  Yeast complementation with a putative PfATG8 
All evidence pointed towards the likelihood that an ATG8 homologue was 
encoded in the genome of P. falciparum. In order to determine whether this 
putative PfATG8 homologue was comparable functionally to ScATG8, a 
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complementation experiment was performed in a yeast line lacking ScATG8. In 
the yeast S. cerevisiae a modified autophagy pathway called the cytoplasm to 
vacuole targeting (Cvt) pathway has been described (Baba et al., 1997). Rather 
than engulfing cytosolic cargo in a non-specific manner, with the end result of 
cargo degradation, the Cvt pathway involves the specific recruitment of the 
precursor form of the hydrolase aminopeptidase 1 (pAP1) into forming 
autophagosomes. Delivery of the autophagosome contents to the vacuole results 
in the processing of the hydrolase into its mature form (mAP1). This process 
relies on not only a unique subset of selective autophagy proteins but crucially 
also relies on the core subset of autophagy proteins including ATG8 (Figure 3.4). 
ScATG8 knockout lines grow normally under nutrient rich conditions but have 
reduced survival under conditions of nutrient starvation. One key phenotype of 
ScATG8 knockout lines is that while pAP1 can be detected, mAP1 is not 
detectable (Scott et al., 1996). Transformation of ScATG8 and other ATG 
knockout lines with constructs designed to drive expression of ATG8 and other 
ATG homologues has been successfully used to determine their functionality by 
the restoration of a Cvt-positive phenotype witnessed by the presence of mAP1 
(Alvarez et al., 2008, Marino et al., 2003, Williams et al., 2009).  
 
Figure 3.4: Aminopeptidase 1 maturation in S. cerevisiae. 
The premature form of aminopeptidase 1 (pAP1) (purple) is sequestered into 
autophagosomes via specific recruitment by the cytosol-to-vacuole (Cvt) pathway protein 
ATG19 (green). Following fusion with the food vacuole, pAP1 is hydrolytically processed into 
is active mature form, mAP1. Maturation of aminopeptidase 1 is therefore relient on ATG8 
(blue) and autophagosome formation and trafficking. 
 
The yeast expression vector pCM186 is used as a centromeric plasmid from which 
tetracycline-repressible expression of a protein of interest is driven (Gari et al., 
1997). Unlike in vectors commonly used to transform bacterial cells, yeast cells 
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successfully transformed with pCM186-based constructs are selected by their 
ability to grow in nutrient-deprived media rather than under antibiotic selective 
pressure. The pCM186 vector backbone contains an expression cassette (URA3) 
which drives expression of orotidine 5-phosphate decarboxylase. This enzyme is 
involved in the de novo synthesis of pyrimidine ribonucleotides and negates the 
requirement for supplementation of growth medium with exogenous uracil 
(http://www.yeastgenome.org/cgi-bin/locus.fpl?locus=ura3#S000081430 [Last 
accessed 14/09/2012]). Therefore, successful transformants of yeast lines 
lacking endogenous URA3 can be selected for by growth in medium lacking uracil 
(SC medium). The ORF of Pfatg8 was cloned into pCM186 to generate the 
construct PfATG8-pCM186. This was transformed into the ScATG8 knockout line 
YBL078c (EuroScarf). In a separate transformation, the YBL078c line was 
transformed with LmATG12-pCM186, a construct sharing the same backbone but 
with the ORF of Lmatg12 inserted into the same position as Pfatg8. This has 
been previously shown not to restore a Cvt-positive phenotype in a ScATG8 
knockout (Williams et al., 2009) and was used as a negative control. Successful 
transformants were selected and then grown in selective medium or medium 
lacking all amino acids in order to induce AP1 maturation. As a positive control 
to identify pAP1 and mAP1 by western blot, a wild type line (Y00000) was 
similarly cultured. The presence of each form of AP1 was detected in  protein 
extracts by western blotting with antisera directed against AP1 (Klionsky et al., 
1992). Both precursor and mature forms of AP1 were observed in wild type cell 
extracts obtained from cells grown under normal conditions, showing that the 
Cvt pathway was active (Figure 3.5). Only mAP1 was observed in nutrient 
starved wild type cells. This indicates that the starvation procedure was 
sufficient to induce an upregulation of AP1 maturation. While only the precursor 
form of AP1 was observed in protein extracted from cells transformed with 
PfATG8-pCM186 grown in SC medium, the mature form was also detected 
following starvation. This indicates that the Cvt pathway is active, albeit to a 
lesser extent than in wild type cells. In protein extracted from the negative 
control, only the precursor form of AP1 was detected, even following starvation. 
The presence of mAP1 in starved cells transformed with PfATG8-pCM186 
represents a specific, although only partial restoration of a Cvt-positive 
phenotype. This shows that PfATG8 is a functional homologue of ScATG8 and 
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that it is likely to interact with other autophagy proteins in S. cerevisiae, such as 
ScATG3 and ScATG7, in the same manner as ScATG8. 
 
Figure 3.5: Complementation of ScATG8 with PfATG8 in S. cerevisiae. 
An autophagy deficient line of S. cerevisiae, YBL0778c (EuroScarf) was transformed with 
plasmids driving expression of PfATG8 or LmATG12 (negative control). Transformants were 
grown to OD600 = 1.0 before being divided into “non-starved” cultures without induction of 
autophagy and “starved” cultures with induction of autophagy. Wild type S. cerevisiae 
Y00000 (EuroScarf) was cultured in YPD medium to OD600 = 1.0 before being divided and 
harvested as above (positive reference). Proteins were separated by SDS-PAGE (7.5%) and 
the precursor and mature forms of aminopeptidase 1 (pAP1 and mAP1, respectively) were 
detected by western blotting using rabbit anti-AP1 antiserum (1:1,000) and anti-rabbit HRP-
conjugated polyclonal goat antibodies (1:10,000). 
 
3.2.5  Recombinant expression of His-PfATG8 
A functional homologue of ATG8 appeared to be encoded in the genome of P. 
falciparum. In order to study the PfATG8 homologue in the parasite itself, 
recombinant PfATG8 protein was expressed in order to generate antibodies 
specific to PfATG8. The ORF of Pfatg8, minus the start codon was amplified from 
cDNA and inserted into the pET28a(+) plasmid by directional cloning. This 
enables the expression of an N-terminally His-tagged version of PfATG8 in E. coli 
from a plasmid inducible by IPTG. The E. coli line BLR (DE3) was selected for 
expression experiments as it features a copy of T7 RNA polymerase and features 
an additional pLysS construct, which aid in the expression and extraction of 
recombinant proteins (Studier et al., 1990, Zhang and Studier, 1997). Initially a 
small scale expression trial was performed in order to determine optimal 
conditions for expression of His-PfATG8 retrievable from the soluble fraction of 
protein extracts. At temperatures of 15, 20 and 25 °C, from an overnight 
culture, a large amount of His-PfATG8 (~ 16 kDa) was detected in the soluble 
fraction by western blotting of protein extracts with anti-His antibodies (Figure 
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3.6(A)). At 37 °C, less His-PfATG8 was detected in the soluble fraction. Due to 
the small size of His-PfATG8 it was difficult to identify any potential degradation 
products resulting from breakdown of His-PfATG8 by proteolysis in E. coli. 
Several reactive bands larger than His-PfATG8 were observed, suggesting that 
either His-PfATG8 forms stable covalent complexes or proteins cross-reactive 
with anti-His antibodies were present. In a compromise between yield and 
purity, expression for 16 h at 20 °C was chosen for subsequent larger scale 
protein expression. Typically 1 - 2 l of bacterial culture were induced per 
experiment. Two purification methodologies were performed in order to reduce 
the presence of any contaminating proteins. Both relied on metal chelating 
affinity purification of His-tagged PfATG8 using nickel (Ni2+) charged resin 
columns (Crowe et al., 1994). An immobilized metal affinity chromatography 
(IMAC) column packed with iminodiacetic acid and charged with Ni2+ ions was 
used in a semi-automated protocol using a Biologic DuoFlow System (Bio-Rad). 
This enabled a constant concentration gradient of imidazole to be used to elute 
proteins bound to the resin. A second, simplified method was also used where 
Ni-NTA resin (Qiagen) was packed into disposable columns and bound proteins 
were eluted with a step wise imidazole concentration gradient. The ‘IMAC’ and 
‘bench-top’ purification methodologies were compared for the purity of His-
PfATG8 eluted (Figure 3.6(B)) and the total protein concentration of eluted 
fractions was analysed by Bradford assay. The purification of His-PfATG8 
appeared to be more complete when using IMAC methodology, however, eluted 
protein was more dilute then when using bench-top methodology. Typical 
protein yields between the two methodologies were similar and ranged between 
2 and 5 mg per litre of inoculated culture. Total protein concentrations in 
elutions from bench-top purification procedures were typically 2.5 mg/ml while 
elutions from IMAC purification procedures were typically 1 mg/ml, as a greater 
elution volume was used.  
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Figure 3.6: Optimisation of His-PfATG8 expression and purification. 
(A) Western blot analysis of His-PfATG8 expression in E. coli. BLR (DE3) cells were 
transformed with His-PfATG8-pET28a(+) and expression of His-PfATG8 was induced with 1 
mM IPTG. Soluble protein was extracted using BugBuster reagent (Merck) following overnight 
culture at 15, 20 , 30 and 37 °C and expression of His-PfATG8 was analysed by western 
blotting with mouse monoclonal anti-His (1:10,000) and anti-mouse HRP-conjugated 
polyclonal (1:10,000) antibodies. 
(B) Analysis of nickel affinity purification of His-PfATG8. Protein extracted from BLR (DE3) 
cells expressing His-PfATG8 for 16 h at 20 °C was applied to nickel affinity purification resin 
either using semi-automated IMAC or manual bench-top methods. His-PfATG8 was eluted 
from columns with up to 500 mM imidazole. Proteins were separated by 15 % SDS-PAGE and 
stained with Coomassie to allow visualisation of His-PfATG8 and any remaining contaminants. 
 
3.2.6  Generation of antisera against His-PfATG8 
In total, 500 µg of purified His-PfATG8 was required for inoculation into a rabbit 
for an 87 day antiserum generation programme. In total, 3 independent 
antiserum generation programmes were performed by Eurogentec (Belgium), 
each making use of 2 rabbits. To reduce the amount of contaminating proteins, 
affinity purified His-PfATG8 was separated by 15 % SDS-PAGE and gel slices were 
excised from the Coomassie (Gelcode Blue Safe) stained gel. Gel slices were 
taken which contained His-PfATG8, leaving the contaminating proteins behind. 
Figure 3.7 shows a digital image of the Coomassie-stained polyacrylamide gel 
containing His-PfATG8 as the major protein present used in each of the 3 
antisera programmes. Antiserum from each rabbit in each programme was tested 
against recombinant protein and protein extracted from wild type P. falciparum 
by western blotting. The analysis of 1 of each rabbit is shown and in each case 
antisera collected from each rabbit were found to be similar. 
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Antiserum generated from the first His-PfATG8 purification (A) were found to 
react with His-PfATG8 in recombinant protein extracts and a protein 
corresponding in size to PfATG8 in parasite protein extracts. However, 
additional proteins were also detected in both recombinant and parasite protein 
extracts. This antiserum was subjected to purification (see 3.2.7) in an attempt 
to isolate antibodies specific for PfATG8. Antiserum generated from purification 
B were found to specifically detect His-PfATG8 and PfATG8 and so was used for 
the analysis of endogenous PfATG8 by western blotting and IFA analysis. 
Antiserum generated from purification C was tested against recombinant and 
parasite protein by western blotting but was not used in further experiments 
because it was seen to only poorly detect PfATG8 in parasite protein extracts. 
 
Figure 3.7: Generation and testing of antisera raised against purified His-PfATG8. 
Gel slices containing His-PfATG8 were cut from Coomassie-stained 15% SDS-PAGE gels for 
inoculation of rabbits to generate anti-His-PfATG8 antisera on three separate occasions (A, B 
and C). Lane 1 shows the Coomassie (Gelcode Blue Safe) stained gel and indicates the purity 
of the His-PfATG8 sample used for inoculation. Lane 2 shows the detection by western 
blotting of proteins in a purified recombinant His-PfATG8 protein extract (similar to that 
shown in lane 1). The predicted size of His-PfATG8 is 16 kDa. Lane 3 shows the detection by 
western blotting of proteins in total protein extracts from asynchronous D10 P. falciparum. 
The predicted size of PfATG8 is 14.6 kDa. In each case antisera were diluted to 1:2,000 and 
were reported with secondary anti-rabbit HRP-conjugated goat polyclonal antibodies 
(1:10,000). 
 
3.2.7  Purification of antisera against His-PfATG8 
Antiserum generated from purification A was seen to detect His-PfATG8 and 
PfATG8 by western blotting of recombinant or parasite protein extracts, 
respectively. However, additional protein bands were also detected in each 
extract (Figure 3.8(A – UP1)).  
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Figure 3.8: Western blot analysis of the attempts to purify anti-His-PfATG8 antisera. 
(A) α-PfATG8 antisera was purified against recombinant His-PfATG8 bound to AminoLink 
resin. Unpurified (UP1) (1:2,000), flow through (FT1) (1:500) and eluted antisera (EL1) 
(1:200) were tested against protein extracted from BLR (DE3) cells expressing His-PfATG8 
separated by 15 % SDS-PAGE. Reactive proteins were detected in each case with anti-rabbit 
HRP-conjugated goat polyclonal antibodies (1:10,000). 
(B) Eluted antisera purified against recombinant His-PfATG8 was further purified against His-
PfLipLA1 bound to AminoLink resin. Unpurified (UP2) (1:100), flow through (FT2) (1:10) and 
eluted antisera (EL2) (1:10) were tested as detailed above. 
(C) Purification fractions specific for α-PfATG8 antibodies (EL1 and FT2) were tested against 
60 µg protein extracted from 3D7 parasites, separated by 15 % SDS-PAGE. Reactive proteins 
were detected in each case with anti-rabbit HRP-conjugated goat polyclonal antibodies 
(1:10,000). 
 
Proteins of ~ 30, 65 and 70 kDa in recombinant protein extracts were cross-
reactive with unpurified (UP1) antiserum, while proteins of ~ 65 and 70 kDa in 
parasite protein extracts were also cross-reactive (see Figure 3.7). It was 
possible that the cross-reactive proteins represented conjugation products of 
PfATG8, either with heterologous proteins or between other PfATG8 proteins. 
Attempts to purify the antiserum were performed in order to determine whether 
the cross-reactive bands represented unrelated contaminants or possible PfATG8 
conjugation products. AminoLink resin (Thermo Scientific) was used to sequester 
His-PfATG8 (Allan et al., 2000), recombinantly expressed and purified in the 
same manner as had been for the preparation of antisera generation. Antiserum 
raised against purification A was then passed over the immobilized protein and 
the flow through and eluted fractions were collected. It appeared that a 
proportion of antibodies reactive against proteins of ~ 30, 65 and 70 kDa had not 
bound to sequestered His-PfATG8 and were therefore present in the flow 
through fraction (Figure 3.8(A – FT1)). Only weak detection of His-PfATG8 was 
observed showing that saturation of the AminoLink resin had not been reached. 
Detection of His-PfATG8 was observed when using the eluted fraction, as was a 
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protein of ~ 70 kDa (Figure 3.8(A – EL1)). This suggested that the cross-reactive 
proteins of ~ 30 and 65 kDa indeed represented unrelated contaminants, as the 
species of antibodies which had detected them had not bound to the 
sequestered His-PfATG8 protein. The protein of ~ 70 kDa on the other hand, 
potentially represented a PfATG8 conjugation product, as the species of 
antibodies which detects this protein, along with those which detected His-
PfATG8 had bound to the sequestered His-PfATG8 protein. 
In order to test this further an additional round of purification was performed. 
Contaminating proteins of ~ 65 and 70 kDa have been observed in purifications of 
recombinantly expressed Plasmodium and Leishmania proteins by members of 
this lab (Bissett, 2009, Patzewitz, 2009). These are predicted to be E. coli 
chaperonins, which are difficult to remove from recombinant protein 
preparations such as that for His-tagged lipoate protein ligase A1 (His-PfLiplA1), 
a cofactor essential to the function of alpha-keto acid dehydrogenase complexes 
(Gunther et al., 2005). His-PfLiplA1 was therefore expressed and purified by the 
bench-top method as described earlier. The (semi-)purified protein preparation, 
containing contaminant proteins of ~ 70 kDa, was applied to fresh AminoLink 
resin. The eluted antiserum fraction from the previous round of purification was 
then passed over the sequestered protein with the aim to remove any species of 
antibodies reactive against contaminant proteins. Therefore, purified antibodies 
against His-PfATG8 were expected to be present in the flow through, while any 
antibodies cross-reactive to epitopes present in both His-PfATG8 and His-
PfLiplA1 protein preparations would bind to the sequestered protein and would 
only be released in the elution. As expected, a population of antibodies reactive 
to His-PfATG8 were present in the flow through fraction (Figure 3.8(B – FT2)). 
However, antibodies reactive to proteins both of ~ 65 and 70 kDa were also 
present. No reactive bands were seen when the elution of the second round of 
purification was tested, suggesting that cross-reactive antibodies had not been 
separated following binding to the sequestered His-PfLiplA1 protein preparation 
(Figure 3.8(B – EL2)).  
The purification fractions known to contain antibodies reactive with His-PfATG8 
were then tested on protein extracted from wild type 3D7 parasites (Figure 
3.8(C)). Endogenous PfATG8 was detected with the EL1 fraction but not with 
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FT2. Proteins of ~ 65 and 70 kDa were also detected by the EL1 fraction and a 
protein of ~ 65 kDa was detected by the FT2 fraction. 
While efforts to purify the antiserum raised against His-PfATG8 appeared to have 
removed antibodies cross-reactive to a 30 kDa protein in recombinant protein 
preparations, a population of antibodies reactive only to His-PfATG8 was not 
achieved. This may have suggested that the proteins of ~ 65 and 70 kDa 
represented PfATG8 conjugates. However,  it would not be expected to see 
PfATG8 intermediates (with PfATG3 or PfATG7) when separated by denaturing 
SDS-PAGE as the bonds between these proteins are labile thioester bonds 
(Nakatogawa and Ohsumi, 2012). The identity of these potential conjugates 
remained unclear. In order to test whether these proteins were detected using 
an independently generated batch of antisera, His-PfATG8 protein from 
purification B was used in a second antiserum generation programme (see Figure 
3.7). These antisera were not subjected to purification as they appeared to 
specifically detect His-PfATG8 or PfATG8 in recombinant or parasite protein 
extracts, respectively. Proteins of ~ 65 and 70 kDa were not detected by these 
antisera. These antisera were therefore used in subsequent experiments unless 
stated otherwise. 
3.2.8  Analysis of PfATG8 expression in P. falciparum blood stage 
parasites 
Data on Pfatg8 transcript levels available from PlasmoDB showed a peak in 
transcript level during the later stages of intraerythrocytic development. No 
data, however, had been published detailing PfATG8 protein expression. As it is 
known that there can often be a discrepancy between transcript level and 
protein expression level (Le Roch et al., 2004), antisera generated from His-
PfATG8 purification B was used to analyse PfATG8 expression across the 
intraerythrocytic development of 3D7 wild type parasites. Parasites were tightly 
synchronised using two treatments with 5 % sorbitol 6 h apart and were 
harvested when at ring, trophozoite, early schizont and late schizont stages, 
confirmed by analysis of Giemsa-stained thin smears at each time point. Protein 
extracted from each stage was separated and analysed by western blotting with 
anti-PfATG8 (Figure 3.9). Blots were stripped and reprobed with antisera raised 
against P. falciparum BCDH to act as a loading control (see 2.8.5). This enabled 
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the quantification of band intensities representing endogenous PfATG8 at each 
time point by analysing the blot densitometrically using ImageJ software. It was 
observed that expression of PfATG8 varied across intraerythrocytic development, 
with a clear increase during the later stages of development. PfATG8 abundnace 
was ~ 10 fold higher in late schizonts than in ring stage parasites. This data 
supported that of transcript levels, suggesting that in the case of PfATG8, the 
increase in transcript level coincides with an increase in protein abundance. 
 
Figure 3.9: Western blot analysis of PfATG8 expression in 3D7 parasites. 
Twenty µg of protein isolated from synchronised 3D7 P. falciparum  (ring (R), trophozoite 
(T), early schizont (ES) and late schizont (LS) stages) were separated by 15 % SDS-PAGE and 
PfATG8 was detected by western blotting using rabbit anti-PfATG8 antisera (1:5,000) and 
anti-rabbit HRP-conjugated goat polyclonal antibodies (1:10,000). The western blot was 
stripped and reprobed with rabbit anti-BCDH antisera (1:1,000) as a loading control. The 
bottom panel displays the intensity of PfATG8, calculated densitometrically using ImageJ, for 
each life cycle stage as a percentage of the amount of PfATG8 in the ring stage parasites, 
normalised to the loading control. 
 
3.2.9  Analysis of PfATG8 lipidation 
It has been shown in other organisms that ATG8 homologues become lipidated to 
phosphatidylethanolamine (PE) (Besteiro et al., 2011, Besteiro et al., 2006, 
Mizushima and Yoshimori, 2007). This lipidation is responsible for the association 
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of ATG8 to the membranes of autophagosomes via conjugation to PE embedded 
in such membranes (Kabeya et al., 2000). Fortunately, the lipidated and non-
lipidated forms of ATG8 homologues can often be distinguished by SDS-PAGE due 
to the increased hydrophobicity of the lipidated form of ATG8 causing it to 
become more mobile (Kabeya et al., 2000). As a result, the lipidated form 
(ATG8-II) can often be seen below the non-lipidated form (ATG8-I) in western 
blots, even though the lipidated form is actually of greater mass. It appeared 
from western blotting that PfATG8 was only present as a single form during the 
analysis of expression throughout intraerythrocytic development. However, it 
has been shown that unlike human ATG8 homologues, the two forms of ScATG8 
and other yeast ATG8 homologues can only be distinguished when 6 M urea SDS-
PAGE is performed (Kirisako et al., 2000).  
In order to determine if separation of two forms of PfATG8 could be achieved, 
protein extracts from wild type D10 parasites were separated by 6 M urea SDS-
PAGE either with or without prior incubation with phospholipase D. 
Phospholipase D belongs to a family of enzymes which generate phosphatidic 
acid following the cleavage of the soluble head group from various phospholipids 
(McDermott et al., 2004). While it is primarily indicated in catalysing the 
cleavage of phosphatidylcholine, it is also used to analyse the conjugation of 
ATG8 to phosphatidylethanolamine, as the protein component (ATG8) will also 
be separated along with the head group from the phosphatidic acid moiety 
(Tanida et al., 2004). Following separation by 6 M urea SDS-PAGE, PfATG8 was 
detected in D10 extracts by western blotting with antisera raised against His-
PfATG8 purification B. While separation by 6 M urea SDS-PAGE did appear to 
influence the mobility of PfATG8 through the gel, separation of a second form of 
PfATG8 in either phospholipase D-treated or untreated samples was not 
apparent (Figure 3.10). However, it was noted that the intensity of bands 
corresponding to PfATG8 appeared to diminish proportionally with the amount of 
phospholipase D added. 
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Figure 3.10: Analysis of PfATG8 lipidation. 
Twenty µg protein extracted from D10 parasites was incubated with 0, 10 or 20 units of 
phospholipase D (Streptomyces chromofuscus) (PLD) for 1 h at 30 °C prior to separation by 6 
M urea 15 % SDS-PAGE. (left) PfATG8 was detected by western blotting using rabbit anti-
PfATG8 antisera (1:5,000) and anti-rabbit HRP-conjugated goat polyclonal antibodies 
(1:10,000). (right) Ponceau S-stained membrane indicating loading of protein to each lane. 
 
3.2.10  Generation of transgenic parasite lines 
It appeared that PfATG8 was differentially expressed during intraerythrocytic 
development but it had proved difficult to determine whether the endogenous 
protein was post-translationally modified. In order to circumvent the reliance on 
antisera specific for the endogenous protein an additional method was required 
to further the characterisation of PfATG8. A commonly used method to facilitate 
characterisation of parasite proteins involves the generation of transgenic 
parasite lines which express an epitope-tagged fusion protein which can then be 
specifically and sensitively detected by using epitope-specific monoclonal 
antibodies.  
A variety of tags can be used in the generation of fusion proteins and careful 
choices need to be made in order to satisfy different requirements. Introducing 
a fluorescent tag would allow the visualisation of PfATG8 in live cells by 
fluorescence light microscopy. Fluorescent tags have also previously been 
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exploited as a target for immunofluorescence and immunoelectron microscopy 
with anti-tag antibodies when antibodies against ATG8 itself are absent or lack 
specificity (Reggiori et al., 2004b). However, the addition of a large fluorescent 
tag (GFP-based tags are ~ 29 kDa) can, in some instances, affect the localisation 
and stability of the protein of interest (Hanson and Kohler, 2001). Using much 
smaller epitope tags, such as myc, 3 x haemagglutinin (HA) or 6-His tags could 
provide a more reliable tool for localisation by immunomicroscopy (Lee et al., 
2008, Roehl et al., 1996) but would not facilitate direct visualisation of the 
fusion protein in live cells. Positioning of the tag is of key relevance to the goals 
of a particular experiment. N-terminal tags are used to label ATG8 from its 
translation to the point at which ATG8, sequestered within an autophagosome as 
cargo, is degraded following fusion with a lytic compartment. N-terminal tagging 
of ATG8 has been used extensively in the study of autophagy in organisms 
ranging from yeast to human (Cheong and Klionsky, 2008). On the other hand, C-
terminal tags are used to analyse the activity of the ATG4 cysteine peptidase on 
the C-terminus of ATG8 (Cao and Klionsky, 2008). In most organisms, the glycine 
residue responsible for lipid conjugation is followed by 1 or more amino acid 
residues in the newly translated form of ATG8 (pATG8). The glycine residue is 
quickly exposed by the peptidase action of ATG4 to produce the lipidation-
competent form ATG8-I (Tra et al., 2011). ATG4 also plays a role in cleavage of 
the lipidated form of ATG8 (ATG8-II) to release ATG8-I from the outer face of 
autophagosomes (Tanida et al., 2004), although the control of this process 
remains poorly understood (Nair et al., 2012). Hence if a tag is situated 3’ of the 
glycine residue it will be cleaved from ATG8 when the lipidation-competent form 
(ATG8-I) is generated. This can provide valuable evidence for the specificities of 
ATG4 peptidases against multiple ATG8 homologues (Li et al., 2011a, Williams et 
al., 2009). 
In order to provide a platform for later detection of fusion protein localisation in 
live parasites by fluorescent light microscopy (see Chapter 5), fluorescent 
protein tags were chosen to aid the characterisation of the PfATG8 protein. An 
N-terminally-tagged copy of the gene was generated and introduced into 3D7 
and D10 lines. The Multisite Gateway system was employed to generate 
constructs for transfection (Figure 3.11). Firstly a set of entry clones were 
generated by the BP reaction between pDONR intermediate vectors and PCR 
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fragments amplified to contain relevant att sites to facilitate homologous 
recombination. 
A full length Pfatg8 and a Pfatg8 mutant form were cloned into pDONR P2R-P3. 
The former, (A8) was the Pfatg8 ORF with its start codon removed. The later, 
(A8∆G) was the Pfatg8 ORF with both its start codon and 3’ GGA codon, encoding 
the C-terminal glycine residue removed. Therefore the translated protein 
product of the A8ΔG ORF would not possess a C-terminal glycine residue. This 
was intended to provide a tool with which to explore the potential lipidation of 
PfATG8. Two different tags were cloned into pDONR 221 to provide scope for 
future colocalisation experiments. mCherry (mC) is derived from a monomeric 
red fluorescent protein (mRFP) from Discosoma sp. and is commonly used in 
fusion proteins primarily due to its impressive photostability (Shaner et al., 
2004, Shaner et al., 2005). It absorbs at 587 nm and emits at 610 nm and has 
been used in P. falciparum before (Putrianti et al., 2010). Enhanced yellow 
fluorescent protein (eY) is a dimeric fluorescent protein based on green 
fluorescent protein (GFP), derived from Aequorea victoria (Shaner et al., 2005). 
It absorbs at 514 nm and emits at 527 nm and has also been used in P. 
falciparum before (Armstrong and Goldberg, 2007). Two different promoter 
regions were cloned into pDONR P4-P1R to differentially drive expression of the 
different fusion proteins. As demonstrated in Chapter 3.2.8, expression of 
PfATG8 from its endogenous genomic locus peaks during the schizont stages of 
intraerythrocytic parasite development. In order to generate transgenic parasite 
lines in which the expression of the fusion protein closely resembled that of 
endogenous PfATG8, the endogenous Pfatg8 promoter region was used as a 
promoter to drive expression of fusion proteins. Specific primers were used to 
amplify the 810 bp sequence upstream of the Pfatg8 ORF and this sequence was 
regarded as the endogenous promoter region (EP). A second promoter region was 
used that was intended to drive constitutive expression of tagged-PfATG8 in 
blood stage parasites. The promoter region of Pfhsp86 (PF07_0030) has 
previously been shown to drive constitutive expression of fusion proteins in P. 
falciparum (Miao et al., 2010). This promoter region (86) was predicted to drive 
expression of tagged-PfATG8 equally in all intraerythrocytic parasite stages, 
allowing visualisation of the fusion protein in stages where expression driven by 
the endogenous promoter might be low. This group of 6 intermediate clones was 
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then used to generate expression constructs for transfection following 
homologous recombination with two different pDEST vectors, pCHDR-3/4 and 
pHBlR-3/4 via the LR reaction. The use of two different destination vectors 
would facilitate later co-transfections. 
The expression constructs EP-mC-A8, EP-mC-A8∆G, 86-mC-A8, EP-eY-A8, EP-eY-
A8∆G and 86-eY-A8, 86-eY-A8∆G (see Table 2.1 and Figure 3.11) were 
transfected into both 3D7 and D10 P. falciparum on two separate occasions. 
Parasites resistant to the appropriate selective drug were typically visible in 
Giemsa-stained thin smears after 6 - 8 weeks. The expression of the 
fluorescently tagged proteins was examined by western blotting. 
 
Figure 3.11: Schematic representation of Gateway cloning. 
Three sequence elements are amplified by PCR with primers designed to introduce attB 
flanking regions to each end of the PCR product. These regions promote integration of PCR 
products into intermediate (pDONR) vectors via homologous recombination with attP regions 
(BP reaction). Intermediate clones containing different PCR products are mixed and via 
homologous recombination with attR regions, ordered integration into a final vector is 
performed via the LR reaction. 
In this study, promoter elements (86/EP) were introduced into pDONR P4-P1R, (mC/eY) tags 
into pDONR 221 and (A8/A8∆G) gene ORFs into pDONR P2R-P3. This cloning design was 
employed in order to N-terminally tag gene ORFs. Constructs generated for transfection were 
EP-mC-A8, EP-mC-A8∆G, 86-mC-A8, EP-eY-A8, EP-eY-A8∆G and 86-eY-A8, 86-eY-A8∆G. 
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3.2.11  Analysis of mCherry-PfATG8 and mCherry-PfATG8ΔG 
expression 
D10 parasites transfected with EP-mC-A8 or EP-mC-A8∆G and selected with 
WR99210 were isolated from erythrocytes by incubation in 0.2 % saponin and 
parasite protein was extracted. Protein extracts were analysed for expression of 
mCherry-PfATG8 or mCherry-PfATG8∆G by western blotting with anti-mCherry 
monoclonal antibodies (Figure 3.12). A single band of the estimated molecular 
mass of mCherry-PfATG8 (44 kDa) was observed in protein extracted from 
parasites transfected with EP-mC-A8∆G, while this and a second, smaller band 
(42 kDa) was observed in protein from parasites transfected with EP-mC-A8. No 
band of the estimated molecular mass of free mCherry protein (29 kDa) was 
observed in either extract suggesting that both mCherry-PfATG8 and mCherry-
PfATG8ΔG fusion proteins are stably expressed in each parasite line. No bands 
were detected by anti-mCherry antibodies in protein extracted from D10 wild 
type parasites showing that the bands detected in EP-mC-A8∆G and EP-mC-A8 
extracts were specific to the transgenic expression of the fusion proteins. 
  
Figure 3.12: Analysis of mCherry-PfATG8 and mCherry-PfATG8∆G expression. 
Twenty µg of protein isolated from parasites transfected with EP-mC-A8∆G or EP-mC-A8 was 
separated by 7.5 % SDS-PAGE and analysed by western blotting with mouse anti-mCherry 
monoclonal (1:1,000) and rat anti-mouse HRP-conjugated (1:10,000) polyclonal antibodies.  
 
3.2.12  Analysis of mCherry-PfATG8 modification 
The presence of a second, smaller band of mCherry-PfATG8 that was not 
detected in extracts from parasites expressing mCherry-PfATG8ΔG suggested 
protein processing or degradation specific to full length PfATG8. As it is well 
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known that ATG8 is processed into a phosphatidylethanolamine-conjugated form 
(ATG8-II) in other organisms (Mizushima and Yoshimori, 2007), protein extracted 
from parasites expressing mCherry-PfATG8 was analysed further by using 
phospholipase D. Protein extracted from parasites transfected with EP-mC-A8 
was incubated with phospholipase D from Streptomyces chromofuscus and 
mCherry-PfATG8 was detected by western blotting. When compared to an 
untreated control of the same extract, the relative proportions of the two anti-
mCherry reactive bands was altered by phospholipase D treatment (Figure 3.13). 
Analysis of band intensities by densitometry (ImageJ) revealed that the ratio of 
intensity of the lower band in relation to the upper band dropped from 1.5 in 
the untreated extract to 0.7 in the treated extract, indicating that the lower 
band was greatly reduced by phospholipase D treatment. This suggested that the 
band running at 42 kDa seen in extracts from parasites expressing mCherry-
PfATG8 represents a lipidated form of the fusion protein, which is cleaved by 
phospholipase D. This is most likely to be a phosphatidylethanolamine-
conjugated form as seen in other organisms but, due to the lack of specificity of 
phospholipase D, without further characterisation this can not certain. The 
observation that this lipid modified form is not present in extracts from parasites 
that express mCherry-PfATG8∆G suggests that the C-terminal glycine residue of 
PfATG8 is necessary for the modification. This further supports the notion that 
the modified form of mCherry-PfATG8 is lipid modified, as has been 
demonstrated in other organisms (Kabeya et al., 2004). For ease of explanation, 
the two forms of mCherry-PfATG8 will subsequently be referred to as lipidated 
(mCherry-PfATG8-II) and non-lipidated (mCherry-PfATG8-I). 
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Figure 3.13: Analysis of mCherry-PfATG8 modification. 
Twenty µg protein extracted from parasites transfected with EP-mC-A8 was incubated with 
20 units of phospholipase D (S. chromofuscus) or an equivalent volume of ddH2O at 30 °C for 
1 h before being separated by 7.5 % SDS-PAGE. mCherry-PfATG8 was analysed by western 
blotting with mouse anti-mCherry monoclonal (1:1,000) and rat anti-mouse HRP-conjugated 
(1:10,000) polyclonal antibodies. The relative intensities of upper and lower bands in a 
sample were calculated densitometrically using ImageJ and are presented graphically. 
Numbers indicate the ratio of non-lipidated mCherry-PfATG8 (upper band) to lipidated 
mCherry-PfATG8 (lower band). 
 
3.2.13  Analysis of mCherry-PfATG8 expression throughout 
intraerythrocytic development 
In order to determine whether the expression of mCherry-PfATG8 was under 
temporal control, similarly to the expression of endogenous PfATG8 in different 
intraerythrocytic life cycle stages, a time course expression profile was 
examined in parasites transfected with either EP-mC-A8 or 86-mC-A8. Parasites 
transfected with EP-mC-A8 or 86-mC-A8 were synchronised twice, 6 h apart to 
ensure close synchronicity. Protein was extracted from synchronised parasites at 
defined time points after isolation of parasites from erythrocytes. Visualisation 
of parasites in Giemsa-stained thin smears allowed the classification of distinct 
life cycle stages for each time point - ring (R), trophozoite (T), early schizont 
(ES) and late schizont (LS). mCherry-PfATG8 was analysed in protein extracts by 
western blotting and the relative intensities of anti-mCherry reactive bands 
were compared by densitometry. The left half of Figure 3.14 shows the analysis 
of mCherry-PfATG8 expression in parasites transfected with EP-mC-A8. For 
comparison, the right half of Figure 3.14 shows mCherry-PfATG8 expression in 
parasites transfected with 86-mC-A8. As this analysis included a comparison of 
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mCherry-PfATG8 expression between lanes, as well as an analysis of the relative 
proportions of lipidated and non-lipidated mCherry-PfATG8, antibodies against 
BCDH were used as a loading control. 
Expression of endogenous PfATG8 was shown to peak during schizont stages in 
3D7 parasites. Expression of mCherry-PfATG8 appeared to peak during 
trophozoite stages when driven by either the endogenous Pfatg8 or Pfhsp86 
promoter regions. While total expression levels were lower when driven by the 
endogenous Pfatg8 promoter region, when compared to the constitutive Pfhsp86 
promoter (middle panel), an increase in the proportion of lipidated mCherry-
PfATG8 was observed in the schizont stages (lower panel). This suggested that 
despite a slight difference in the expression profile of the fusion protein, in 
relation to endogenous PfATG8, parasites expressing mCherry-PfATG8 under 
control of the endogenous promoter region exhibited a temporal control over 
protein processing, with a profile similar to that of the expression of endogenous 
PfATG8. The total expression level of mCherry-PfATG8 was higher at each time 
point when driven by the constitutive Pfhsp86 promoter. However, the lipidation 
state of mCherry-PfATG8 in these parasites did not appear to vary in the 
different life cycle stages (lower panel). This suggested that the loss of temporal 
control of mCherry-PfATG8 expression, as a result of the use of a constitutive 
promoter, had an effect on the control of the lipidation of the fusion protein. 
In light of the apparent differences in expression and protein processing when 
driven by each promoter region, further analysis was concentrated on parasites 
transfected with EP-mC-A8 or EP-mC-A8ΔG, unless stated otherwise, as this was 
believed to best resemble the expression of endogenous PfATG8.  
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Figure 3.14: Analysis of mCherry-PfATG8 expression throughout intraerythrocytic 
development. 
Parasites transfected with EP-mC-A8 (left) or 86-mC-A8 (right) were synchronised and 
protein extracted at defined life cycle stages: ring (R); trophozoite (T); early schizont (ES) 
and late schizont (LS). Twenty µg protein extract was separated by 7.5 % SDS-PAGE and 
analysed by western blotting with mouse anti-mCherry monoclonal (1:1,000) and rat anti-
mouse HRP-conjugated (1:10,000) polyclonal antibodies. The western blot was stripped and 
reprobed with rabbit anti-BCDH antisera (1:1,000) as a loading control. The total intensity 
(upper graph) and relative intensities of upper and lower anti-mCherry reactive bands (lower 
graph) in each lane were calculated densitometrically using ImageJ and normalised to 
loading controls. Numbers indicate the ratio of non-lipidated mCherry-PfATG8 (upper band) 
to lipidated mCherry-PfATG8 (lower band). 
 
3.3    Discussion 
3.3.1 Discovery of an ATG8 homologue in P. falciparum 
This chapter has detailed the identification of a putative ATG8 homologue in P. 
falciparum and the subsequent characterisation of this protein. Initial 
bioinformatic screening of the predicted P. falciparum 3D7 proteome revealed 
the presence of a number of potential homologues to ATG proteins along with 
proteins complementary to autophagy. While some of the strongest putative 
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homologues were members of the ATG8 and ATG12 conjugation pathways, many 
other putative homologues showed only low levels of similarity in amino acid 
sequence to their queries. It was often observed that the hits found in P. 
falciparum were substantially larger proteins than their queries, with only small 
regions within the amino acid sequence that aligned with the query sequence. 
This is characteristic of many Plasmodium proteins in previous screens (Pizzi and 
Frontali, 2001). This raises the question as to whether or not these proteins are 
likely to represent homologues to the autophagy proteins of the yeast S. 
cerevisiae. The level of identity between certain human ATG homologues and 
their yeast counterparts is equally as low as some of the potential homologues 
identified here. For example, the mammalian homologue of ATG14 shows only 
13 % sequence identity to yeast ATG14 and could only be identified following 
position-specific iterative BLAST searches (Itakura et al., 2008). Therefore, some 
apparently weak putative homologues identified in this screen should not be 
immediately discounted on the basis of low similarity in amino acid sequence to 
their yeast counterparts. More detailed analysis of conserved motifs and residues 
known to confer functional attributes will be needed to help determine if these 
hits represent potential homologues in P. falciparum. While this level of analysis 
for each potential homologue identified was beyond the scope of this study, it 
was noted for example, that the potential ATG3 homologue appeared to possess 
a conserved catalytic cysteine residue known to participate in protein function 
(Yamada et al., 2007). 
In support of this initial screen was the fact that a number of hits designated as 
potential ATG homologues during this study have since been re-annotated as 
such on PlasmoDB. Also, additional assignation of gene ontology terms and 
similarities to proteins in the Protein Data Bank (http://www.rcsb.org/pdb) 
support the identification of potential ATG homologues reported here. A 
thorough screen looking for ATG homologues in a number of protists has also 
since been published (Rigden et al., 2009). The genes identified and presented 
here are the same as those identified and reported in their screen of the P. 
falciparum genome. Together, these factors suggest that the bioinformatic 
screen performed in this study was robust and helped in the identification of a 
number of putative homologues to autophagy proteins, especially those involved 
in the conjugation pathways of ATG8 and ATG12. 
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The presence of likely homologues to proteins involved in the ATG8 and ATG12 
conjugation pathways supported the notion that a core, minimal set of 
autophagy genes are maintained in all eukaryotes (Mizushima et al., 2002). In 
some species, such as Giardia lamblia and Encephalitozoon cuniculi, loss of 
subsets of autophagy genes appears to have occurred (Rigden et al., 2009). This 
is likely due to the occupation of specific niches, which reduces the reliance on 
certain aspects of autophagy. Whether P. falciparum could also be an example 
of such a diverged organism is an interesting question. As previously discussed, 
this parasite has a number of adaptations and specialisations enabling the 
fulfilment of its life cycle in different tissues and environments within two 
different hosts. How this has impacted on the requirement of an autophagic 
process was a key focus of this study. Of the putative homologues of members of 
the ATG8 and ATG12 conjugation pathways, the DNA sequences of Pfatg3, Pfatg8 
and Pfatg12 could be amplified from both gDNA and cDNA using gene specific 
primers. The fact that these genes appear to be transcribed in the 
intraerythrocytic stages of parasites suggested that, at least in part, the 
components needed for an autophagic process might be present in P. 
falciparum. The genes predicted to encode putative ATG4, ATG5, ATG7 and 
ATG10 homologues could only be amplified form gDNA, suggesting that these 
homologues may only be present as low abundance transcripts or that the gene 
annotations of transcript start and finish sites are incorrect. Further work will be 
needed to determine whether homologous proteins to these members of the 
ATG8 and ATG12 conjugation pathways are expressed in P. falciparum 
intraerythrocytic stages.  
The genomic and transcript sequences of the potential ATG3 homologue 
amplified from gDNA and cDNA were also sequenced in full with 1 or 2 times 
coverage, respectively. It was found that there were a number of small 
differences from the sequence published on PlasmoDB. Most of these were 
within intronic regions but the boundary between exon 5 and intron 5 was found 
to have been miss-annotated. This alternative sequence would result in a 
predicted protein product containing an additional VQNVQN repeat. This gene 
was later re-annotated as a result of being found to be subjected to differential 
splicing to yield different protein isoforms (Sorber et al., 2011). One of the re-
annotated coding sequences PF3D7_0905700.1 was identical to the sequence 
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amplified from cDNA in this study. This highlights the complexity inherent in the 
steps between genomic sequence, transcript and protein expression in P. 
falciparum (Le Roch et al., 2004). It is possible that other putative homologues 
identified in this bioinformatic screen are also subjected to alternative splicing 
events or that their gene annotations are simply incorrect. This could result in 
what appear to be poor putative homologues with low levels of overall similarity 
to queries, actually much more closely resembling their queries. 
In this study a putative homologue for ATG8 was identified in the predicted 
proteome of P. falciparum. ATG8 is fundamental to autophagy in other 
organisms and it often used as a marker for autophagosomes (Kabeya et al., 
2004, Koopmann et al., 2009, Nakatogawa et al., 2007). It remained to be 
determined whether this putative ATG8 homologue was functionally similar to 
ScATG8 and whether the protein itself was expressed in P. falciparum 
intraerythrocytic stages. Presented here is evidence that not only is the PfATG8 
protein expressed in P. falciparum intraerythrocytic stages but that it can 
functionally compensate for ScATG8. Yeast complementation showed that unlike 
LmATG12, PfATG8 can complement for the loss of ScATG8, partially restoring 
the autophagy-positive phenotype of aminopeptidase 1 maturation. Less mAP1 
was detected in the complemented line than in wild type cells. This is possibly 
due to lower expression of PfATG8 in the complemented line in comparison to 
ScATG8 expression in wild type cells, as PfATG8 expression could not be 
detected with antisera raised against His-PfATG8 purification B in protein 
extracted from the complemented line. Another contributing factor could be a 
limited interaction capacity between PfATG8 and the members of the 
conjugation pathway of the yeast ScATG8 (Williams et al., 2009). For example, if 
PfATG8 was transferred from ScATG7 to ScATG3 with a lower efficiency than 
ScATG8, then it might be anticipated that the autophagic capacity of the 
complemented line would be lower than wild type yeast cells. A different 
mechanism of interaction between the ATG8 and ATG3 homologues of P. berghei 
has been alluded to (Duszenko et al., 2011), so much so that PbATG8 can not 
complement ScATG8. It is certainly possible that PfATG8 exhibits a reduced 
interaction with ScATG3 in comparison to that of ScATG8. Despite this, data 
presented here does show that PfATG8 is able to complement ScATG8. 
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PfATG8 was then seen to be differentially expressed during intraerythrocytic 
development, with a 10 fold increase in protein abundance evident in schizont 
stage parasites when compared to ring stages. The fact that this coincides with 
an increase in transcript level suggests that this is due to an upregulation in gene 
expression but may also be partly dependent on decreased turnover and 
increased stability of the protein during these stages (Foth et al., 2011). 
Interstingly, the reported transcript levels for the putative PfATG4 homologue 
identified during bioinformatic screening exhibited a similar transcriptional 
pattern, albeit slightly less pronounced. This might provide further indication 
that this protein may represent a true homologue of ATG4 in P. falciparum. It 
was noted that the available transcript profiles of other putative ATG 
homologues, including those of ATG3 and ATG12, indicated that transcript levels 
for these genes were generally constitutive during intraerythrocytic 
development. This potentially suggests that the regulation of PfATG8 may be, in 
part, controlled by the level of transcription and translation of its interacting 
partners.  
An attempt was made to determine whether endogenous PfATG8 was present as 
both lipidated and non-lipidated forms, as has been seen with ATG8 homologues 
in other organisms (Tanida et al., 2004). Incubation of protein extracted from 
wild type parasites with phospholipase D before separation by 6 M urea SDS-
PAGE did not result in the separation of two distinct protein species representing 
non-lipidated PfATG8-I and lipidated PfATG8-II. However, it did appear to result 
in a decrease in the amount of the single reactive protein. Unfortunately a valid 
loading control was not obtained for this blot, so it can not be determined 
whether this decrease represented a specific effect of phospholipase D 
incubation or was a result of less total protein being loaded or a non-specific 
peptidase contaminant of the phospholipase D added. Based on the Ponceau S-
stained membrane of this gel, it appeared that if anything, slightly more total 
protein was actually loaded into the lanes of protein treated with phospholipase 
D.  
Potentially, this finding suggested that incubation with phospholipase D 
decreased the amount of the lipidated species of PfATG8 (PfATG8-II), however 
the resultant non-lipidated PfATG8 (PfATG8-I) was not detected. This may have 
been due to the differing reactivity of the antiserum raised against His-PfATG8 
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to the lipidated and non-lipidated forms of PfATG8. It has been shown that 
antibodies raised against ATG8 homologues in other organisms preferentially 
recognise the lipidated form of ATG8 (Ichimura et al., 2004, Woods, 2009), 
potentially due to a conformational change in the N-terminus of the protein, 
which exposes an immunogenic epitope (Mizushima and Klionsky, 2007). If this 
was also true for the antisera raised against His-PfATG8, then the presence of 
non-lipidated PfATG8-I may have been missed in these experiments. If these 
antisera can only detect lipidated PfATG8-II, then that would suggest that the 
single band detected following separation by either by ‘normal’ or 6 M urea SDS-
PAGE actually represents lipidated PfATG8-II. Considering the fact that PfATG8 
appears to be expressed in a lipidation-competent form i.e. with an exposed C-
terminal glycine residue, it might be that PfATG8-I is converted to PfATG8-II 
quickly after expression and therefore PfATG8-I levels are low. The presence of 
a PE-conjugated form of the ATG8 homolgue in T. gondii has recently been 
confirmed by fluorographic analysis of 3H-ethanolamine uptake (Besteiro et al., 
2011). A similar experiment could be used to determine whether the single form 
of endogenous PfATG8 is lipidated or not. 
3.3.2  Establishment of tools to study PfATG8 
As it was unclear whether endogenous PfATG8 was subjected to post-
translational modification using PfATG8-specific antisera, additional tools were 
needed to further the characterisation of the PfATG8 protein. It was therefore 
decided to generate transgenic P. falciparum lines in which fluorescently tagged 
PfATG8 or PfATG8ΔG were expressed, with an intention of later performing live 
cell fluorescence microscopy.  
Separation of proteins extracted from parasites expressing mChery-PfATG8 by 
‘normal’ SDS-PAGE was sufficient to resolve two different forms of the protein, 
as detected using monoclonal antibodies specific for the mCherry tag, similarly 
to what has been reported for other ATG8 homologues (Ichimura et al., 2004, 
Kabeya et al., 2004, Williams et al., 2009). It is possible that the increased size 
of the fusion protein in comparison to the endogenous PfATG8 protein facilitated 
more pronounced separation of the two protein forms by SDS-PAGE. This factor, 
in combination with the issues surrounding use of ATG8-specific antisera 
discussed above, meant that the analysis of fusion proteins using mCherry-
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specific antibodies was greatly informative and added to what was discovered 
about the endogenous PfATG8 protein. Of note was that probing protein 
extracted from parasites expressing mCherry-PfATG8 with PfATG8-specific 
antisera only very weakly detected a protein band representing mCherry-
PfATG8. It could not be determined whether the weak band detected 
represented the upper or lower separating forms of the fusion protein. 
Treatment of protein extracts isolated from parasites expressing mCherry-
PfATG8 with phospholipase D resulted in a decrease in the ratio of the more 
mobile band in relation to the less mobile band. The fact that the truncated 
mCherry-PfATG8∆G fusion protein was only observed to separate as the less 
mobile form, suggested that without the C-terminal glycine, modification can 
not occur. These data strongly suggested that the two forms of mCherry-PfATG8 
represented lipidated and non-lipidated protein. 
It was earlier shown that endogenous PfATG8 is differentially expressed during 
intraerythrocytic development, displaying a ~ 10 fold increase in schizonts in 
comparison to rings. Analysis of the expression profile of mCherry-PfATG8 
revealed that while this fusion protein reached a peak in expression earlier, in 
trophozoite stages, it appeared to be differentially processed, in a similar 
profile to the expression of endogenous PfATG8. The increase in the relative 
amount of the lipidated fusion protein when expressed under control of the 
endogenous Pfatg8 promoter was seen to coincide with peak expression of the 
endogenous PfATG8 protein. It would therefore appear that as well as the 
temporal control over the expression of PfATG8, other factors influence its 
lipidation; otherwise more mCherry-PfATG8 would be converted to the lipidated 
form in trophozoites. It is known that components of the ATG12 and ATG8 
conjugation pathway are needed for lipidation of ATG8, even when upstream 
signals of autophagy are absent (Kageyama et al., 2011). It is therefore likely 
that the abundance of these conjugation partners may limit the lipidation of 
mCherry-PfATG8. Even if the expression of mCherry-PfATG8 is ‘inappropriately’ 
high in trophozoite stages, without the presence of ATG3 or other conjugation 
partners, it can be understood why the conversion to the lipidated form is 
limited. While the scope of this study was limited to the characterisation of the 
homologue of ATG8, bioinformatic screening of the 3D7 parasite genome 
revealed the presence of a number of genes encoding other likely ATG 
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homologues. To fully understand PfATG8 it will be necessary to also characterise 
other components of the ATG12 and ATG8 conjugation pathways. 
From the bioinformatic analysis of the P. falciparum genome a great deal was 
learnt about the potential for the parasite to encode components of the 
autophagic machinery as demonstrated in other organisms. The in silico, 
functional and biochemical characterisation of a homologue of the fundamental 
autophagy protein ATG8 demonstrated that in P. falciparum intraerythrocytic 
stages a functional PfATG8 homologue is expressed and appears to be post-
translationally modified. While analysis of this modification could be improved 
upon further, data collected is consistent with the hypothesis that PfATG8 
becomes lipidated, similarly to the ATG8 homologues of other organisms. Hence, 
evidence collected so far indicated the conservation of a functional PfATG8 
homologue in P. falciparum intraerythrocytic stages, suggesting that it can 
contribute to an autophagic process in these parasites. As ATG8 homologues are 
necessary for autophagy in other organisms, the characterisation of PfATG8 was 
continued by attempts to generate parasite lines lacking Pfatg8.  
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4   Genetic ablation of Pfatg8 
4.1   Introduction 
ATG8 in Saccharomyces cerevisiae is not essential for growth under normal 
culture conditions but is essential for the process of autophagy (Ichimura et al., 
2000). Indeed, it is the ability to genetically knockout atg8 from this organism 
that allows for yeast complementation experiments to be performed (Williams et 
al., 2009). However, S. cerevisiae lines lacking ATG8 do show a severe growth 
defect when placed under conditions of limited nutrient availability (Kirisako et 
al., 1999). In higher eukaryotes with single ATG8 homologues, similar effects are 
observed following genetic ablation or knockdown of ATG8 levels. For example, 
RNAi inactivation of the C. elegans homologue of atg8, lgg-1 has been shown to 
result in a loss of complete conversion to the dauer stage of the worm (Melendez 
et al., 2003). In higher eukaryotes with multiple copies or families of atg8, such 
as mammals, determining the essentiality of individual atg8 genes has proven 
difficult, largely due to the high degree of sequence similarity between genes 
and the functional redundancy between gene products (Kabeya et al., 2004). It 
is now becoming clear that expansion of atg8 families has allowed for 
specialisation and differential involvement of ATG8 homologues during 
autophagy (Weidberg et al., 2010, Williams et al., 2009). In order to assess 
whether PfATG8 is essential to parasite survival under normal culture conditions, 
genetic knockout of the endogenous Pfatg8 was attempted. 
Several methodologies exist for genetic deletion or disruption of target genes in 
Plasmodium (reviewed in (Goldberg et al., 2011)). One such method used in this 
lab (Gunther et al., 2009, Patzewitz et al., 2012) involves the removal of a 
target gene from its chromosomal locus by replacement with a selectable 
marker. This process relies on homologous recombination between genomic and 
plasmid elements. Two plasmid elements, homologous to the gene locus under 
investigation, flank a region of non-homologous sequence, typically a selectable 
marker cassette, which replaces the genomic sequence between the homologous 
elements during a double cross over event (de Koning-Ward et al., 2000). Due to 
the haploid genome of P. falciparum blood stages, genetic knockout or 
modification of a gene locus can be achieved by a single crossover event, and 
can be selected for with a single selectable marker (Su et al., 2007). 
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The pCC-4 construct used in this study possesses two multiple cloning sites into 
which regions homologous to regions within or flanking the locus of a gene of 
interest can be cloned (Figure 4.1) (Maier et al., 2006). Between these two sites 
is a blasticidin resistance cassette (BSD). During a double cross over event the 
gene locus under investigation will be replaced by BSD resulting in parasites that 
are resistant to blasticidin-S-HCl (BLA). Maintenance of episomal plasmid or 
integration into the genome via single cross over can be selected against, due to 
the presence of an additional selectable marker, referred to as a negative 
selectable marker (Duraisingh et al., 2002). The backbone of the pCC-4 
construct contains a modified cytosine deaminase (CD) cassette, from which a 
bi-functional chimera of cytosine deaminase and uracil phosphoribosyl 
transferase is expressed (Maier et al., 2006). Through the activities of these 
enzymes, 5-fluorocytosine (5-FC) is converted into 5-Fluorouracil (5-FU), which 
is toxic to parasites via inhibition of RNA synthesis and thymidylate synthase. 
Therefore, when culture medium is supplemented with 1 µM 5-FC, parasites 
expressing the chimeric enzyme will be killed (Maier et al., 2006). When a 
double cross over event occurs, the backbone of the plasmid is lost meaning that 
parasites in which the gene locus under investigation has been replaced will be 
unaffected by the addition of 5-FC. 
The frequency of double crossover events in P. falciparum is low (Duraisingh et 
al., 2002). To increase the likelihood of generating parasites in which a double 
cross over event has occurred, prior to supplementation of culture medium with 
5-FC, repeated cycles of positive selective drug pressure are performed (Maier 
et al., 2006). When parasites are detected following transfection, which are 
resistant to the selective drug used, cultures are divided into two, the first being 
supplemented with 5-FC and the second being taken off selective pressure. 
During this period of unhindered growth, loss of episomal plasmid is common due 
to the lack of selective pressure (O'Donnell et al., 2002). This means that the 
population of parasites maintaining episomal plasmid decreases. Parasites in 
which an integration event has already occurred will be largely unaffected by 
the lack of selective pressure. Once the selective drug is reapplied, parasites 
that had lost episomal plasmid will be killed, whereas those in which an 
integration event had already occurred will have maintained resistance and will 
potentially outgrow any remaining parasites with episomal plasmid, provided the 
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integration event is not of any fitness cost to the parasite. This cycling process is 
performed in order to accelerate selection of integrated parasites and has been 
successfully used to knockout non-essential genes such as those encoding 
erythrocyte binding-like proteins in intraerythrocytic P. falciparum parasites 
(Lopaticki et al., 2011). 
 
 
Figure 4.1: Plasmid map of pCC-4 
Key features are highlighted in grey. SacII and SpeI sites indicate the insertion site for the 5’ 
homologous flank. NcoI and AvrII sites indicate the insertion site for the 3’ homologous flank. 
Flanks ~ 500 bp in length are typically used to facilitate homologous recombination 
(Patzewitz et al., 2012). The BSD cassette, with PfCAM 5’ and PfhrpII 3’ regulatory elements 
is shown between the two flank insertion sites. The CD cassette with Pfhsp86 5’ and PbDT 3’ 
regulatory elements forms part of the plasmid backbone along with the ampicillin resistance 
marker (AmpR) for selection in E. coli. 
 
4.2   Results 
4.2.1 Pfatg8 knockout in wild type parasites 
To determine whether Pfatg8 is an essential gene in the intraerythrocytic stages 
of P. falciparum, the pCC-4 construct was employed in knockout attempts by 
gene replacement. Due to the small size of the Pfatg8 ORF (375 bp), homologous 
flanks that would facilitate homologous recombination between plasmid and the 
gene locus had to come from non-coding regions upstream and downstream of 
the Pfatg8 ORF. The genome of P. falciparum is highly enriched for adenosine 
and thymidine, especially in non-coding regions (Gardner et al., 2002). Regions 
were therefore carefully selected so that the complexity of sequence was 
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deemed sufficient to promote specific annealing of primers used in their 
amplification. As represented in Figure 4.2, 610 bp and 637 bp regions were 
selected from the non-coding regions upstream and downstream of the Pfatg8 
ORF, respectively. These regions do not encroach into the coding regions of 
neighbouring genes and so were predicted not to affect any other gene loci 
following integration of the BSD cassette into the Pfatg8 locus by double 
homologous recombination. These sequences, referred to as 5’ and 3’ flanks, 
were amplified from P. falciparum D10 gDNA and were cloned into the pCC-4 
plasmid as described in Chapter 2.7.7 and 2.7.11 to generate the construct 
Pfatg8-pCC-4.  
 
Figure 4.2: Schematic representation of the Pfatg8 (PF10_0193) genomic locus. 
The Pfatg8 ORF (PF10_0193) is encoded by a single exon on the anti-sense strand of 
chromosome 10. The 5’ UTR, as was cloned into Gateway expression constructs, runs for 810 
bp upstream of the start codon of Pfatg8. A 610 bp region ending 1,369 bp upstream of the 
start codon was amplified as the 5’ flank. A 637 bp region starting 171 bp downstream of the 
stop codon of Pfatg8 was amplified as the 3’ flank. 
 
The construct Pfatg8-pCC-4 was used to transfect 3D7 and D10 wild type P. 
falciparum on two independent occasions. Parasites resistant to BLA were 
detected in Giemsa-stained thin smears, after 6 – 8 weeks in 3 of the 4 
transfections. Cultures were then cycled according to Figure 4.3. Stabilates were 
made and DNA isolated when parasites resistant to either BLA or BLA and 5-FC 
were detected.   
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Figure 4.3: Schematic representation of knockout strategy 
(upper) Following transfection and initial selection with blasticidin (BLA), parasites were 
stabilated and DNA was isolated. Cultures were then divided into two independent lines. One 
culture was supplemented with 1 µM 5-FC. If parasites resistant to both BLA and 5-FC were 
detected up to 3 weeks later, they were stabilated and DNA was isolated. The other culture 
was taken off BLA selective pressure for 3 weeks. BLA resistant parasites were then 
reselected and the next cycle initiated. Up to three cycles (c0, c1, and c2) were performed. 
(lower) The constructs Pfatg8-pCC-4 or mCherry-Pfatg8-pCC-4 (see 4.2.3) were transfected 
into the indicated parasite lines. Green boxes indicate when parasites resistant to either BLA 
or BLA and 5-FC were generated. Red boxes indicate when drug resistant parasites were not 
detected. Boxes with heavy outlines indicate parasite lines analysed by Southern blotting 
and presented here with their appropriate nomenclature. 
 
To determine the genotype of transfected parasites, DNA from each cycle was 
subjected to analyses by PCR and Southern blotting and was compared to gDNA 
collected from their relevant D10 or 3D7 parental lines. Primer pairs were 
selected that would generate PCR products of distinct lengths, characteristic of 
the various integration events predicted to occur (see 2.7.6.6). The predicted 
sizes of PCR products formed when primer pairs align as a result of each 
integration event are detailed in blue in Figure 4.4. For analysis by Southern 
blotting, DNA was first digested with SpeI, which was predicted to cut either 
side of the Pfatg8 locus and once within the Pfatg8-pCC-4 construct. A set of 4 
DNA probes were generated for use in Southern blotting:- 
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 Pfatg8-specific – this probe is specific to the genomic Pfatg8 ORF and is 
predicted to detect only a fragment representing the endogenous Pfatg8 
locus. 
 3’ flank – this probe is predicted to detect fragments derived from both 
the endogenous Pfatg8 locus and the plasmid. 
 CD – this probe is specific to the CD cassette in the backbone of the 
plasmid. 
 BSD – this probe is also specific to the BSD cassette between the 2 flanks 
in the plasmid. 
The size of the fragments detected by each of these probes in each predicted 
scenario of integration events are shown in red in Figure 4.4. For the sake of 
brevity, the analysis of parasite cultures D10a c2 and D10a c2:5-FC is shown 
here. Analysis of parasites from earlier cycles showed similar results.  
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Figure 4.4: Graphical representation of predicted integration events. 
(No integration) The ORF of Pfatg8 (PF10_0193) lies on the complementary strand of 
chromosome 10. Digestion of DNA with SpeI is predicted to yield a fragment 7,921 bp in 
length which contains the Pfatg8 ORF, 5’UTR and 5’ and 3’ homologous flanks. The construct 
Pfatg8-pCC-4 features a BSD cassette between 5’ and 3’ homologous flanks and contains a 
single SpeI site. PCR primers (1) and (2) would produce a 477 bp product representing the 
endogenous Pfatg8 locus. PCR primers (7) and (8) would produce a 397 bp product 
representing the Pfatg8-pCC-4 plasmid backbone. 
(5’ + 3’ integration) A double cross event over between the corresponding 5’ and 3’ 
homologous flanks of Pfatg8-pCC-4 and the genomic Pfatg8 locus is predicted to result in the 
replacement of the Pfatg8 ORF and 5’UTR with the BSD cassette. PCR primers (3) and (5) 
would produce an 821 bp product representing 5’ integration. PCR primers (4) and (6) would 
yield a 1,000 bp product representing 3’ integration.  
(5’ integration) Single cross over at the 5’ homologous flank is predicted to result in the 
integration of the Pfatg8-pCC-4 construct upstream of the Pfatg8 ORF. PCR primers (1) and 
(2), (3) and (5) and (7) and (8) would be expected to produce their products. 
(3’ integration) Single cross over at the 3’ homologous flank is predicted to result in the 
integration of the Pfatg8-pCC-4 construct downstream of the Pfatg8 ORF. PCR primers (1) 
and (2), (4) and (6) and (7) and (8) would be expected to produce their products. 
Predicted fragment sizes detected by each probe used in analysis by Southern blotting are 
shown in red and predicted PCR product sizes are shown in blue. 
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DNA isolated from D10a c2 was first analysed by PCR (Figure 4.5). Primer pairs 
amplified products of the expected sizes representing the endogenous Pfatg8 
locus, the CD cassette and 5’ integration. A product was seen with the primer 
pair intended to show 3’ integration but this was of a smaller size than 
expected. Control reactions showed, where possible, that primers correctly 
annealed.  
 
Figure 4.5: PCR analysis of DNA isolated from D10a c2. 
DNA isolated from D10a c2 was used as a template for PCR reactions using primers designed 
to form pairs indicative of the predicted genomic events during knockout of the Pfatg8 ORF. 
PCR products were generated with primer pairs indicating that the intact endogenous Pfatg8 
locus, the CD cassette and the resultant locus of 5’ integration were present. Ladders used 
are 100 bp (left) and 1 kb (right) both (N.E.B.). 
 
The presence of a PCR product amplified using primers only predicted to form a 
pair once integration had occurred, suggested that, in at least a proportion of 
parasites in D10a c2, an integration event might have occurred. In order to test 
this further, the same DNA was analysed by Southern blotting, along with gDNA 
from the D10 parental line and DNA from D10a c2:5-FC i.e. parasites from the 
same cycle but those that were additionally resistant to 5-FC. Figure 4.6(A) 
shows the Southern blot analysis of the D10 parental line of D10a c2 and D10a 
c2:5-FC. A single fragment representing the endogenous Pfatg8 locus (7,921 bp) 
was detected by the 3’ flank and Pfatg8-specific probes, while no other 
fragments were visible with either these or the BSD or CD probes. This showed 
that the probes used were specific and that digestion by SpeI had produced the 
expected fragment size for the endogenous locus. 
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Figure 4.6: Southern blot analysis of wild type D10 parasites, parasites transfected with 
Pfatg8-pCC-4 and the Pfatg8-pCC-4 construct itself. 
(A) 1.5 µg gDNA from D10 wild type parasites was digested overnight with SpeI, separated by 
electrophoresis in 0.7 % agarose and analysed by Southern blotting with 3’ flank, Pfatg8-
specific, BSD and CD probes. Size standards are indicated in bp to the left of each blot. 
Likely fragment identities are indicated to the right and the probe used is detailed above 
each lane. 
(B) 1.5 µg DNA from D10 parasites transfected with Pfatg8-pCC-4 and selected with 
blasticidin was digested and analysed as above. A fragment representing the genomic Pfatg8 
locus is detected by 3’ flank and Pfatg8-specific probes. Additional fragments detected by 3’ 
flank, BSD and CD probes (*), or 3’ flank and BSD probes (**) are indicated. 
(C) 1.5 µg DNA from D10 parasites transfected with Pfatg8-pCC-4 and selected with 
blasticidin and 5-FC was digested and analysed as above. An identical banding pattern is 
observed as in (B). 
(D) 5 ng of Pfatg8-pCC-4 was digested overnight with SpeI and analysed as above. Bands with 
likely identities to those shown above are indicated. 
 
Figure 4.6(B) shows the analysis of D10a c2. The Pfatg8-specific probe detected 
a fragment representing the endogenous locus (7,921 bp). The 3’ flank probe 
detected fragments representing the endogenous locus and linearised plasmid 
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(8,635 bp). A fragment representing linearised plasmid was also detected by the 
BSD and CD probes. Interestingly, in addition to fragments representing the 
endogenous locus and linearised plasmid, a fragment was detected close in size 
to a predicted product of integration (6,518 bp) by the 3’ flank and BSD probes. 
An additional fragment of ~ 7,000 bp was also detected by the 3’ flank, BSD and 
CD probes. This appeared to be congruous with the analysis by PCR in suggesting 
that while the endogenous Pfatg8 was detected, an integration event may have 
occurred in a sub-population of parasites in D10a c2. 
Figure 4.6(C) shows the Southern blot analysis of D10a c2:5-FC. An identical 
banding pattern to that of D10a c2 with all 4 probes was observed. The presence 
of fragments representing linearised plasmid suggested that addition of 5-FC to 
the culture medium had not provoked death of parasites maintaining episomal 
plasmid as expected. This has previously been reported by members of this lab 
(Patzewitz, 2009).  
These analyses pointed towards the possibility of an integration event between 
Pfatg8-pCC-4 and the D10 genome. However, in the absence of selection against 
parasites maintaining episomal plasmid it was difficult to determine whether a 
double crossover event had occurred i.e. one that would cause a replacement of 
the Pfatg8 locus with the BSD cassette. Fragments of ~ 7,000 and 6,500 bp were 
not detected by any of the 4 probes in gDNA from the D10 parental line, showing 
that the fragments detected were specific to transfected lines. To show that 
these fragments were the result of integration between the Pfatg8-pCC-4 
construct and the D10 genome and were not merely representative of episomal 
plasmid, 5 ng plasmid DNA from the maxiprep used for transfection was also 
digested with SpeI and analysed by Southern blotting (Figure 4.6(D)). As 
expected the Pfatg8 specific probe did not react with any fragment following 
linearization of Pfatg8-pCC-4. While the 3’ flank, BSD and CD probes detected a 
fragment representing linearised plasmid (8,635 bp) they also detected 
fragments of ~ 7,000 and 6,500 bp in an identical pattern to those seen in D10a 
c2 and c2:5-FC. These fragments were therefore determined to represent 
unexpected digestion products of the Pfatg8-pCC-4 construct following 
incubation with SpeI. This suggested that the fragments thought to represent 
potential integration events in the analysis of D10a c2 and D10a c2:5-FC were in 
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fact likely to represent unexpected digestion products of episomally maintained 
plasmid, potentially the result of SpeI star activity (Wei et al., 2008).  
Attempts to knockout the Pfatg8 ORF by gene replacement in wild type P. 
falciparum had appeared to be unsuccessful. This suggested that either the 
Pfatg8 gene is essential to parasite viability during the erythrocytic stages, or 
that the locus can not be targeted for genetic manipulation. In order to test 
these two possibilities, further transfection strategies were explored. 
4.2.2 Pfatg8 knockout in mCherry-PfATG8 expressing parasites 
The possibility that the Pfatg8 locus could not be replaced in wild type parasites 
due to the essentiality of this gene was tested by attempts to perform the same 
knockout in parasites expressing an additional copy of PfATG8. A parasite line 
previously transfected with EP-mC-A8 and known to be expressing mCherry-
PfATG8 was therefore transfected with Pfatg8-pCC-4. This was predicted to 
alleviate any reliance on the endogenous Pfatg8 ORF that may have prevented 
gene knockout in wild type parasites, by providing a platform for PfATG8 
expression from an episomal plasmid. D10 parasites originally transfected with 
EP-mC-A8 and selected with WR99210, were transfected with Pfatg8-pCC-4 on 
two independent occasions and parasites resistant to both WR99210 and BLA 
were detected in Giemsa-stained thin smears up to 8 weeks later in 1 of the 2 
transfections (D10c) (Figure 4.3). DNA was isolated from these parasites and as 
before, cycling on and off BLA and additional selection with 5-FC was 
performed. At all times parasites were maintained under WR99210 selection. 
Parasites viable in the presence of 5-FC were attained from the first cycle (D10c 
c0:5-FC) but were not attained following cycling off BLA.  
DNA from D10c c0 and D10c c0:5-FC was analysed by Southern blotting. Figure 
4.7(A) shows the analysis of D10c c0 using the 4 previously described probes. A 
fragment representing the endogenous locus (7,291 bp) was detected by both 
the 3’ flank and Pfatg8-specific probes and not by the plasmid-specific BSD and 
CD probes. Surprisingly, a fragment representing linearised plasmid (8,635 bp) 
was not detected by the 3’ flank, BSD or CD probes. Instead, a much larger 
fragment was detected by all 4 probes. Although this fragment separates above 
the maximum reference band in the ladder used, its size can be approximated to 
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~ 15,000 bp. As 5’ integration is predicted to produce a fragment of 15,052 bp 
and this fragment would be detected by all 4 probes, it was thought that this 
fragment might represent a subpopulation of parasites in which a 5’ integration 
event had occurred. As either a 5’ or 3’ integration has been observed to 
precede a double cross over event (Duraisingh et al., 2002), it was predicted 
that additional selection with 5-FC might promote a second cross over at the 3’ 
flank, producing parasites in which the Pfatg8 locus had been replaced. 
 
Figure 4.7: Southern blot analysis of the genomic Pfatg8 locus in D10c c0 and D10c c0:5-FC. 
(A) 1.5 µg DNA from D10 parasites transfected with EP-mC-A8 and Pfatg8-pCC-4 and selected 
with WR99210 and BLA was digested overnight with SpeI, separated by electrophoresis in 0.7 
% agarose and analysed by Southern blotting with 3’ flank, Pfatg8-specific, BSD and CD 
probes. Size standards are indicated in bp to the left of each blot. Likely fragment identities 
are indicated to the right and the probe used is detailed above each lane. Additional 
fragments detected by 3’ flank, Pfatg8-specific, BSD and CD probes (*) are indicated. 
(B) 1.5 µg DNA from D10 parasites transfected with EP-mC-A8 and Pfatg8-pCC-4 and selected 
with WR99210, BLA and 5-FC was digested and analysed as above. Additional fragments 
detected by 3’ flank, Pfatg8-specific and BSD probes (**) are indicated. 
 
Figure 4.7(B) shows the analysis of D10c c0:5-FC. It was apparent that opposed 
to the lack of negative selection observed with transfection D10a, selection of 
D10c c0 in the presence of 5-FC had resulted in a different banding pattern to 
that observed without 5-FC selection. Similarly to D10c c0, the 3’ flank and 
Pfatg8-specific probes detected a fragment representing the endogenous locus 
(7,291 bp). However, no fragments were detected by the CD probe. This 
suggested that the presence of 5-FC had resulted in the loss of the CD cassette, 
showing that an integration event by double cross over had occurred leading to 
loss of the plasmid backbone. A fragment of ~ 15,000 bp corresponding to that 
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observed in D10c c0 was faintly detected by the 3’ flank, Pfatg8-specific and 
BSD probes. In addition, the same 3 probes also detected two similarly sized 
fragments of even larger size. A fragment of 6,518 bp representing replacement 
of the Pfatg8 ORF with the BSD cassette was not detected by the 3’ flank or BSD 
probes. This, along with the detection of a fragment representing the unaltered 
Pfatg8 locus suggested that the integration observed might have been into an off 
target locus or loci. However, due to the possibility of a population of parasites 
in which the Pfatg8 ORF had been replaced, the D10c c0:5-FC line was selected 
for cloning via limiting dilution (Kirkman et al., 1996). This was performed in 
order to isolate a clonal parasite line in which the Pfatg8 ORF may have been 
replaced with the BSD cassette. A total of 17 clones were obtained and analysis 
of the Pfatg8 locus in 12 clones was initially performed by PCR using DNA 
produced from small scale isolation (Figure 4.8). 
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Figure 4.8: PCR analysis of clones of D10c c0:5-FC generated by limiting dilution. 
Clonal lines were isolated from D10c c0:5-FC by limiting dilution. DNA isolated from 12 
clones was used as a template for PCR reactions using primers designed to form pairs 
indicative of the predicted genomic events during knockout of the Pfatg8 ORF. PCR products 
representing the endogenous Pfatg8 locus were amplified from isolates 2-12 with primers (1) 
and (2). PCR products representing the CD cassette (7+8), 5’ integration (3+5) or 3’ 
integration (4+6) were not detected in any isolate. A 100 bp ladder was used to determine 
PCR product sizes (N.E.B.). 
 
Eleven of the clones appeared to possess an unaltered endogenous Pfatg8 locus, 
as demonstrated by the presence of a 477 bp product amplified with the primer 
pair covering the Pfatg8 ORF in its genomic locus. In one clone (1), D10c c0:5-FC 
CLONE, this band was not present, suggesting that the endogenous Pfatg8 locus 
might have been altered. PCR products were not amplified using primer pairs 
covering the CD cassette in any clone, supporting the observation by Southern 
blotting that the CD cassette had been lost as a result of 5-FC selection. Also, in 
no clone were products amplified that were predicted to represent 5’ or 3’ 
integration events. This may have been expected in the 11 clones in which the 
Pfatg8 locus appeared to be unaltered but would have been predicted to be 
detected in D10c c0:5-FC CLONE. Therefore, to determine whether the Pfatg8 
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ORF had been replaced by the BSD cassette in D10c c0:5-FC CLONE, a larger 
scale DNA isolation was subjected to analysis by Southern blotting using the 3’ 
flank and Pfatg8-specific probes (Figure 4.9(A)). 
 
Figure 4.9: Southern blot analysis of the genomic Pfatg8 locus in D10c c0:5-FC CLONE and its 
parental mCherry-PfATG8 expressing line, EP-mC-A8. 
(A) 1.5 µg DNA from a clonal population of D10 parasites transfected with EP-mC-A8 and 
Pfatg8-pCC-4 and selected with WR99210 and BLA and 5-FC was digested overnight with SpeI 
and was analysed by Southern blotting with 3’ flank and Pfatg8-specific probes. Size 
standards are indicated in bp to the left of each blot. Likely fragment identities are indicated 
to the right and the probe used is detailed above each lane. Additional fragments detected 
by 3’ flank and Pfatg8-specific probes (*) and (**) are indicated. 
A fragment representing the genomic Pfatg8 locus is detected by both probes, as are two 
fragments corresponding to those seen in the non clonal line D10c c0:5-FC (*) and (**). 
(B) 1.5 µg DNA from D10 parasites transfected with EP-mC-A8 and selected with WR99210 
was digested and analysed as above. Additional fragments detected by the Pfatg8-specific 
probe (*), (**) and (***) are indicated. 
 
The 7,291 bp fragment representing the endogenous Pfatg8 locus was detected 
by both probes, along with much larger fragments, likely to be those also 
detected in the progenitor line, D10c c0:5-FC. In contrast to the PCR analysis of 
this clone, it appeared that the Pfatg8 ORF was still present and that while 
integration of the Pfatg8-pCC-4 construct had occurred, it had not affected the 
target locus. 
It appeared that the fragments of ~ 15,000 bp and larger represented integration 
events into an off target locus or loci. As had been seen in the analysis of D10a, 
the presence of the episomal plasmid can sometimes lead to unexpected 
banding patterns when analysed by Southern blotting. In order to add evidence 
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that these fragments were the result of integration events between Pfatg8-pCC-
4 and the D10 genome, DNA isolated from the parental line of D10c, EP-mC-A8, 
was also analysed by Southern blotting Figure 4.9(B). These parasites were 
known to be expressing mCherry-PfATG8 and were predicted to maintain EP-mC-
A8 as an episomal plasmid due to the presence of the Rep20 element (O'Donnell 
et al., 2002). The EP-mC-A8 construct does not contain any SpeI sites and 
therefore was expected to run as undigested plasmid following SpeI digest of 
isolated DNA. 
As expected, a fragment representing the endogenous Pfatg8 locus was detected 
with the 3’ flank and Pfatg8-specific probes, as this construct is not predicted to 
recombine with the Pfatg8 locus. This shows that similarly to wild type D10, the 
Pfatg8 ORF was unaltered. Interestingly, the Pfatg8-specific probe also detected 
multiple larger fragments. These fragments corresponded with those seen in 
Southern blotting analysis of D10c c0, D10c c0:5-FC and D10c c0:5-FC CLONE. 
The presence of these fragments suggests that the EP-mC-A8 construct may in 
fact integrate into the D10 genome at a locus or loci distinct from the Pfatg8 
locus, independently of the presence of the Pfatg8-pCC-4 construct. 
4.2.3 Pfatg8 tagging and targeting control 
Attempts to replace the Pfatg8 ORF with the BSD cassette of Pfatg8-pCC-4 either 
in wild type parasites or those expressing mCherry-PfATG8 (along with 
endogenous PfATG8) had proven unsuccessful. This raised the question as to 
whether the Pfatg8 locus was amenable to genetic manipulation (Patzewitz et 
al., 2012). A commonly used strategy to determine whether a gene locus of 
interest can be targeted in P. falciparum is to employ a construct designed to 
integrate into the gene locus via a single cross over event (Patzewitz et al., 
2012, Russo et al., 2009). Introduction of the full plasmid sequence into the 
locus of interest can disrupt the gene ORF if a truncated homologous region is 
used, or if a full length homologous region is used then the gene ORF will remain 
intact (de Koning-Ward et al., 2000). However, in this study a different method 
using the pCC-4 construct and therefore relying on double homologous 
recombination was utilised instead. This was chosen as it provided a method to 
both confirm that the Pfatg8 locus was able to be targeted by pCC-4-based 
constructs and also to replace the endogenous Pfatg8 ORF with an N-terminally 
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tagged Pfatg8 gene. It was anticipated that by effectively N-terminally tagging 
the endogenous Pfatg8 gene, an additional tool to study PfATG8 in live parasites 
would result. 
To do this, the Pfatg8-pCC-4 construct was modified so that both the BSD 
cassette and a cassette driving expression of mCherry-PfATG8 would replace the 
endogenous Pfatg8 ORF. The construct mCherry-Pfatg8-pCC-4 was generated by 
replacing the 5’ homologous flank of Pfatg8-pCC-4 with the mCherry-PfATG8 
expression cassette from the construct EP-mC-A8. This contains the Pfatg8 ORF 
in frame with the upstream mCherry sequence and endogenous Pfatg8 5’ UTR 
and is followed by the PbDT 3’ UTR. This created a construct containing an 
effective 5’ flank of 810 bp, corresponding to the endogenous Pfatg8 promoter 
region and a 3’ flank identical to that of Pfatg8-pCC-4. The predicted integration 
events between mCherry-Pfatg8-pCC-4 and the Pfatg8 locus are shown in Figure 
4.10 and the predicted fragment sizes following digestion with SpeI are again 
indicated in red.  
The mCherry-Pfatg8-pCC-4 construct was transfected into D10 and 3D7 parasites 
twice on two independent occasions. Unfortunately no BLA resistant parasites 
were detected in Giemsa-stained thin smears up to 10 weeks after transfection 
(see Figure 4.3). 
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Figure 4.10: Schematic representation of potential integration events between mCherry-
Pfatg8-pCC-4 and the endogenous Pfatg8 locus. 
(No integration) The mCherry-Pfatg8-pCC-4 construct has the same 3’ flank as Pfatg8-pCC-4 
but the 5’ flank has been replaced by an mCherry-PfATG8 expression cassette. The promoter 
region within the 5’ UTR is predicted to act as the 5’ flank to facilitate homologous 
recombination. 
(5’ and 3’ integration) A double crossover event is predicted to result in the replacement of 
the endogenous Pfatg8 ORF with the plasmid derived mCherry-Pfatg8 and BSD cassettes.  
(5’ integration) A single cross over event between the shared 5’ UTR elements would result 
in the integration of the mCherry-Pfatg8-pCC-4 plasmid upstream of the endogenous Pfatg8 
ORF.  
(3’ integration) A single crossover event between the shared 3’ flanks would result in the 
integration of the mCherry-Pfatg8-pCC-4 plasmid downstream of the Pfatg8 ORF. 
 
4.3   Discussion 
4.3.1 Interpretation of results 
This chapter has detailed the efforts made to deduce whether the Pfatg8 gene is 
essential for the blood stages of P. falciparum. Attempts to generate Pfatg8 
knockouts either in a wild type parental line or in a line expressing mCherry-
PfATG8 were unsuccessful. This indicates that either Pfatg8 is essential to the 
viability of erythrocytic parasites, or that the Pfatg8 locus is not amenable to 
manipulation using pCC-4-based constructs. 
The presence of a DNA fragment representing linearised Pfatg8-pCC-4 plasmid in 
D10 parasites transfected with Pfatg8-pCC-4 and selected with both BLA and 5-
FC indicates that negative selection had been unsuccessful in these parasite 
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lines. In the absence of negative selection, it is unlikely that a double cross over 
integration event will occur (Maier et al., 2006). A lack of negative selection 
suggests that either these parasites were not converting 5-FC to 5-FU or that the 
5-FU produced did not cause cell death. This could occur through multiple 
mechanisms. The fact that the same batch of 5-FC was successfully used to 
select against parasites maintaining the CD cassette in D10c c0:5-FC shows that 
the 5-FC used was efficacious. Resistance to 5-FC has been shown to be rapidly 
achieved by fungal agents - the usual indication of 5-FC is in antifungal therapy 
(Quinto-Alemany et al., 2012). This could occur through changes to transporters 
responsible for the uptake of 5-FC, transcriptional repression of the CD cassette 
or changes to the translation, post-translational modification or turnover of CD 
(Chapeland-Leclerc et al., 2005, Papon et al., 2007). Mechanisms to combat the 
effects of 5-FU could also provide a level of resistance to negative selection. 5-
FU acts as a thymidylate synthase inhibitor in the pyrimidine biosynthetic 
pathway. Modification of this pathway may out-compete 5-FU by the 
upregulation of pyrimidine biosynthesis (Sanglard, 2002, Vermes et al., 2000). 
The mechanism of 5-FC resistance in P. falciparum has not been identified.  
Knockout of the endogenous Pfatg8 locus using the Pfatg8-pCC-4 construct was 
also attempted in a parental line previously transfected with EP-mC-A8. In the 
analysis of these lines no DNA fragment representing linearised Pfatg8-pCC-4 was 
detected, as had been the case in wild type parasites transfected with the same 
construct. However, there was a larger fragment not seen in the analysis of the 
aforementioned parasite lines. This suggested that either the Pfatg8-pCC-4 
plasmid had readily integrated, or that a recombination event had occurred 
between the Pfatg8-pCC-4 and EP-mC-A8 plasmids, resulting in a larger product 
following linearization by SpeI. It has been shown that plasmids with homologous 
regions rapidly recombine following transfection into P. falciparum 
intraerythrocytic stages (Kadekoppala et al., 2001, Krnajski et al., 2002). Care 
was taken in the selection of plasmid pairings but the limited repertoire of 
transcriptional regulatory elements available meant that some elements were 
common to both plasmids in co-transfected lines. The cassettes conferring drug 
resistance to blasticidin or WR99210 in the constructs Pfatg8-pCC-4 and EP-mC-
A8, respectively, share the same PfCAM 5’ and PfhrpII 3’ regulatory elements. 
The length of homologous sequence between the two constructs may have been 
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sufficiently long to facilitate recombination between the plasmids transfected 
into P. falciparum parasites (Kadekoppala et al., 2001). The 3’ regulatory 
element of the mCherry-Pfatg8 cassette in EP-mC-A8, PbDT 3’, is also used in 
Pfatg8-pCC-4 as the 3’ regulatory element of the CD cassette (Maier et al., 
2006, van Dooren et al., 2005). Parasites transfected with EP-mC-A8 rather than 
86-mC-A8 were chosen for co-transfection with Pfatg8-pCC-4 as the Pfhsp86 5’ 
UTR is also common to both 86-mC-A8 and Pfatg8-pCC-4. This was intended to 
limit the possibility of recombination between the two plasmids that might 
interfere with integration of Pfatg8-pCC-4 into the Pfatg8 locus. Recombination 
between the two plasmids could create a larger product following linearization 
with SpeI, having ‘inherited’ only one SpeI site from the Pfatg8-pCC-4 construct. 
The predicted resultant construct size of 16 kb could explain the absence of a 
fragment representing linearised Pfatg8-pCC-4 in D10c c0 with a larger fragment 
detected in its place. The complexity of outcomes of recombination between 
the two plasmids and any subsequent integration into the Pfatg8 locus or any 
off-target locus or loci would make analysis by Southern blotting alone very 
difficult and would therefore require additional analysis by pulsed field gel 
electrophoresis and other methods to determine if intergration had occured 
(Krnajski et al., 2002).  
Considering the analysis of the genome of parasites transfected with only EP-mC-
A8, recombination between the two constructs may also have been further 
complicated by prior integration of the EP-mC-A8 construct into an unknown 
locus. EP-mC-A8 does not contain any SpeI sites and should therefore be 
detected as non-linearised plasmid by Southern blotting with the Pfatg8-specific 
probe. However, it was evident that multiple DNA fragments were detected 
using the Pfatg8-specific probe. This suggested that integration of the EP-mC-A8 
construct into the parasite genome had already occurred prior to transfection 
with the Pfatg8-pCC-4 construct. This integration would likely be by a single 
cross over recombination event, as recombination by double cross over would 
result in loss of WR99210 resistance and would be unlikely in the absence of 
negative selection. Therefore it is likely that the banding pattern observed in 
Southern blot analysis of the EP-mC-A8 parasite line represents either random 
integration of the construct into the parasite genome or possibly integration into 
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the Pfatg8 locus itself. Again, considering that the EP-mC-A8 line is not clonal, a 
mixture of populations with different integration events may have been present. 
Integration of the EP-mC-A8 construct into the Pfatg8 genomic locus before 
introduction of the Pfatg8-pCC-4 construct could have resulted in unexpected 
integration events between the Pfatg8-pCC-4 plasmid and the modified genomic 
locus. Integration of the EP-mC-A8 construct into an unrelated locus could also 
create an ‘artificial locus’ containing sequences homologous to those within 
Pfatg8-pCC-4. Again, the complexity and number of outcomes resulting from 
these possible integration events would lead to the determination of the status 
of the genomic locus by Southern blotting and PCR analysis being extremely 
difficult.  
Whatever recombination or integration events had occurred in the D10c line, 
transfected with both EP-mC-A8 and Pfatg8-pCC-4, the addition of 5-FC to 
culture medium did have an effect on the banding pattern observed during 
analysis by Southern blotting. The CD cassette had been lost, shown by the 
absence of any DNA fragment detected by the CD probe. Additional fragments 
were detected with the 3’ flank, Pfatg8-specific and BSD probes that were not 
detected before 5-FC selection. This suggested that addition of 5-FC had indeed 
caused the loss of the CD cassette and integration of the Pfatg8-pCC-4 construct 
by a double cross over event had occurred. Pulsed field gel electrophoresis could 
be used to determine the likely location(s) of integration events (Gunther et al., 
2009, Krnajski et al., 2002).  
Cloning of the D10c c0:5-FC parasite line by limiting dilution showed that while 
an integration event had occurred, the endogenous Pfatg8 locus remained 
unaltered.  The absence of a PCR product amplified by primer pairs covering the 
endogenous Pfatg8 locus was surprising, given the presence of a fragment 
representing the endogenous Pfatg8 locus in Southern blot analysis. Further PCR 
analysis was performed and results supported the initial findings. The 
endogenous Pfatg8 locus was detected using the relevant primer pair in DNA 
collected from wild type parasites, along with the other 11 clones, showing that 
the primers (1) and (2) were able to anneal as expected. However, the DNA 
isolates used for PCR and Southern blot analysis were collected independently 
and PCRs were not repeated on DNA isolated from parasites for analysis by 
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Southern blotting. It is possible that the yield of DNA isolated from D10c c0:5-FC 
CLONE for PCR analysis was overestimated in relation to isolates from the other 
clones, leading to undetectable amplification of the product representing the 
intact endogenous Pfatg8 locus. During further analysis by PCR, a product 
covering the 3’ flank, generic to both the unaltered locus and the locus resultant 
from integration was detected, while no product covering the 5’ flank was 
detected. This potentially indicated that a poor yield or quality of this DNA 
isolate was responsible for poor amplification of PCR products. During Southern 
blotting, the amount of DNA loaded is verified visually, meaning that even 
amounts of DNA between isolates can be judged. Given this assurance and the 
fact that Southern blotting is widely regarded as a more qualitative analysis 
method than PCR (Schiffman et al., 1991), evidence gathered from Southern 
blotting was deemed more reliable than that from PCR analysis.  
Verification of the methodology used to attempt knockout of Pfatg8 proved 
unsuccessful. Targeting the Pfatg8 locus with a pCC-4-based construct designed 
not to remove the Pfatg8 ORF but rather to introduce a mCherry-Pfatg8 ORF in 
its place was intended to have shown that the Pfatg8 locus is amenable to 
manipulation. Without this evidence it is impossible to say that the inability to 
knockout Pfatg8 is due to the essentiality of the PfATG8 protein (Patzewitz et 
al., 2012). Parasites resistant to BLA were not detected following transfection 
with the mCherry-Pfatg8-pCC-4 construct. The mCherry-Pfatg8-pCC-4 construct 
is large (> 10 kb) and contains both Plasmodium-specific A/T rich and non-
Plasmodium sequences. These factors have been suggested to result in problems 
with plasmid stability in E. coli (Tonkin et al., 2004). While the areas covering 
the inserted sequences of all plasmids used for transfection into P. falciparum 
were sequenced, this would not detect issues surrounding plasmid stability such 
as structural and isoforms variances (Silva et al., 2012), which may have limited 
transfection efficiency in P. falciparum. 
The mCherry-Pfatg8-pCC-4 construct was designed in an attempt to kill two 
birds with one stone. A simpler method for genomic locus targeting relies on 
single cross over integration (Patzewitz et al., 2012). Introducing an upstream 
sequence encoding an mCherry-tag to the endogenous Pfatg8 ORF seemed 
impossible using a construct designed to integrate by single cross over. This was 
desired as a mechanism for monitoring endogenously expressed PfATG8 in live 
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parasites. Therefore the decision was made to attempt to combine the analysis 
of Pfatg8 locus susceptibility to genetic manipulation with an attempt to 
effectually introduce a tag to the endogenous Pfatg8 ORF. 
The mCherry-Pfatg8-pCC-4 construct was made by replacing the 5’ homologous 
flank of Pfatg8-pCC-4 with the expression cassette from the EP-mC-A8 construct. 
The length of regions homologous to genomic sequence was therefore increased 
from 610 bp in the 5’ flank of Pfatg8-pCC-4, to 810 bp in the endogenous 
promoter region of mCherry-Pfatg8-pCC-4. Whether the increased length of 
homology could improve the efficiency of recombination has yet to be 
determined. Also, the possibility of recombination between the endogenous 
Pfatg8 ORF and the Pfatg8 coding sequence within the plasmid has not been 
explored. Homologous flanks of typically 500 bp are commonly used in this lab to 
facilitate integration into gene loci (Patzewitz et al., 2012). Whether the 372 bp 
sequence encoding the Pfatg8 ORF shared between the genome and plasmid 
would be sufficient to facilitate homologous recombination could be assessed by 
Southern blotting. Unfortunately, if this was to occur, then recombination 
between the plasmid and the Pfatg8 locus would not be guaranteed to replace 
the endogenous Pfatg8 ORF with the full mCherry-PfATG8 expression cassette. 
This could possibly be avoided by generating the Pfatg8 coding portion of the 
mCherry-PfATG8 expression cassette synthetically i.e. adjusting the nucleic acid 
sequence without affecting the translated sequence (Yeoh et al., 2007).  
Replacement of the endogenous Pfatg8 ORF with an mCherry-tagged Pfatg8 ORF 
would have facilitated visualisation of the tagged fusion protein by live cell 
fluorescent microscopy. However, using a small epitope tag (e.g. myc) might 
result in a smaller plasmid more stable in E. coli and with a smaller region 
intended to integrate into the genome, potentially improving integration 
efficiency. The localisation of the epitope-tagged PfATG8 fusion protein could 
then be detected by IFA with antibodies specific for the tag (Sun et al., 2008).  
4.3.2 Future considerations 
Due to the apparent inability to achieve genetic ablation of Pfatg8 using the 
pCC-4 construct, additional methods may be needed to determine whether 
PfATG8 is essential to parasite viability. While many methods have been 
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employed they are often hampered by the same issues surrounding low 
transfection efficiencies and low integration efficiencies (Crabb et al., 2004). 
Similarly to the negative selection strategy based around the bi-functional 
cytosine deaminase chimeric enzyme, a method based around thymidine kinase 
has also been employed to kill parasites maintaining episomal plasmid 
(Duraisingh et al., 2002). This enzyme (from Herpes simplex virus) is encoded in 
the backbone of pHTK-based vectors and converts the pro-drug ganciclovir into 
toxic metabolites, which inhibit DNA synthesis by competing for deoxyguanosine 
triphosphate (Matthews and Boehme, 1988). This method has been employed in 
the analysis of a number of genes in P. falciparum (Duraisingh et al., 2003, 
Haase et al., 2008). Considering the apparent inconsistency in selection 
observed when wild type parasites transfected with Pfatg8-pCC-4 were treated 
with 5-FC, use of this similar system with a different selectable marker might 
prove more reliable in regards to application of negative selection. 
Attempts to show that the endogenous Pfatg8 locus can be targeted by pCC-4-
based constructs by using mCherry-Pfatg8-pCC-4 were unsuccessful. Additional 
methods exist for confirming a genomic locus can be targeted by homologous 
recombination.  Constructs based on pHH-1 (Reed et al., 2000) have routinely 
been used to confirm locus targeting (Patzewitz et al., 2012), and also genetic 
manipulation of target genes (Gunther et al., 2007, Storm et al., 2011). Unlike 
pCC-4-based constructs, pHH-1 is designed to contain a single homologous region 
to promote integration of the entire plasmid by via a single cross over event. Use 
of a homologous area corresponding to a region within the ORF of a gene of 
interest can be used to effectively knock out a gene by insertion of the entire 
plasmid sequence into the ORF, disrupting the gene through frame shift, 
insertion of premature stop codons or other means (Crabb, 2002, Gunther et al., 
2007, Storm et al., 2011). However, single cross over integration can also be 
used to show targeting of a gene locus without deleteriously disrupting the ORF 
of the gene of interest (Patzewitz et al., 2012). Use of a homologous region 
encoding a sequence identical to the gene ORF results in the maintenance of a 
full gene ORF following integration of the plasmid. The gene of interest is 
maintained but has a 3’ UTR derived from the plasmid, as its own 3’ UTR is 
forced downstream behind the integrated plasmid. Knockout attempts were not 
performed with a pHH-1-based construct for two reasons. Firstly, due to the fact 
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that without negative selection to remove episomally maintained plasmids, it 
can often take a longer period of cycling off and on selective pressure to 
generate cultures with integrated plasmid. Secondly, the small size of the Pfatg8 
ORF would also provide an obstacle for generating a construct with a homologous 
region sufficiently long to support efficient homologous recombination. Typically 
around 800 bp of sequence homologous to the gene ORF would be used, to 
ensure efficient targeting (Patzewitz et al., 2012). The fact that the Pfatg8 ORF 
is only 375 bp in length likely means that portions of either the 5’ UTR or 3’ UTR 
regions would also be needed to facilitate recombination. Potential approaches 
that could be used are represented graphically in Figure 4.11. In either instance, 
an efficient disruption of the Pfatg8 ORF could not be assured. If a sequence 
covering a portion of the 5’ UTR and a portion of the Pfatg8 ORF were used (A), 
depending on how much 5’ UTR was needed to facilitate recombination, a 
functional Pfatg8 ORF might remain following integration. If a sequence covering 
a portion of the Pfatg8 ORF and a portion of the 3’ UTR were used (B), careful 
primer design or site directed mutagenesis could be used to produce a Pfatg8 
ORF without a stop codon. However, due to the likelihood of the 3’ UTR 
encoding a stop codon in frame with the Pfatg8 ORF, it is possible that an 
‘artificially elongated’ PfATG8 might be expressed. Due to these issues, 
attempts to knockout the Pfatg8 ORF were focussed on the use of the pCC-4 
construct. 
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Figure 4.11: Schematic representation of potential gene disruption strategies using 
constructs based on pHH-1. 
(A) A construct containing a homologous region covering portions of the 5’ UTR and Pfatg8 
ORF could integrate by single cross over. However, this might leave a functional Pfatg8 ORF 
(-?-). 
(B) A construct containing a homologous region covering portions of the Pfatg8 ORF and 3’ 
UTR could integrate by single cross over. However, even if the Pfatg8 ORF stop codon was 
excluded from the plasmid sequence, expression of PfATG8 plus additional residues encoded 
by the 3’ UTR might occur (-?-). 
 
However, the small size of the Pfatg8 ORF does not prevent the use of pHH-1-
based constructs to be used to confirm locus targeting. Modifications of methods 
A or B, detailed above, could be used to provide evidence that the Pfatg8 gene 
locus is susceptible to modification by homologous recombination, even though 
the regions used would be different to those used in Pfatg8-pCC-4. Integration 
following a single cross over event could be analysed by PCR analysis and 
Southern blotting, similarly to the methodologies performed here. 
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The possibility remains that PfATG8 is essential for the viability of blood stage 
parasites. Indeed, it has been suggested that knockout of the atg8 gene 
homologue found in P. berghei has a lethal phenotype (Duszenko et al., 2011) 
but no experimental data has so far been published. Where genetic knockout of 
a target gene is precluded by its essentiality, knockdown of transcript and 
protein levels can be used to mimic genetic knockout. RNA interference (RNAi) 
technology is commonly exploited to study the effects of down regulation of 
essential genes in parasites and other organisms (Manzano-Roman et al., 2012). 
Unfortunately, Plasmodium spp. have been found to lack the necessary enzymes 
required to produce an RNAi induced down regulation of gene expression (Baum 
et al., 2009). Goldberg and co-workers have developed a protein destabilisation 
mechanism for use in P. falciparum, based on ligand-regulatable FKBP tagging 
(Armstrong and Goldberg, 2007). This mechanism uses episomal expression of an 
FKBP-tagged fusion protein in order to alleviate reliance on the endogenous gene 
allowing knockout by the aforementioned methods. The FKBP domain fused to 
the protein product of the gene of interest will direct it for degradation unless it 
is stabilised by interaction with a rapamycin analogue ligand called Shld1. 
Expression of the fusion protein in the presence of Shld1 allows for the genetic 
knockout of the endogenous gene but then also facilitates tunable regulation of 
protein stability through controlled removal of Shld1. Resultant phenotypes can 
then be assessed (provided the result of protein down regulation isn’t lethal). 
The observation that degradation of the fusion protein is not complete, even in 
the absence of Shld1, allows for the phenotypic analysis of parasites in which a 
genetic knockout of the gene of interest would be lethal (Patzewitz, 2009). The 
relatedness of the knockdown phenotype to the actual effect of genetic ablation 
will be influenced by the level of knockdown and the ability of the parasite to 
compensate for reduced protein levels. 
This methodology can also be used to mimic genetic knockout of a gene of 
interest by the regulatable over expression of an inactive form of its protein 
product (Patzewitz, 2009, Santos et al., 2011). Expression of an FKBP-tagged 
inactive form of a protein in the presence of Shld1 can lead to the inhibition of 
the endogenous protein through, for example, competition for binding partners 
or stalling of conjugation pathways. The culture of parasites without Shld1 
following transfection with the construct used to drive expression of the inactive 
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fusion protein allows establishment of transfected lines without the deleterious 
phenotype associated with expression of the inactive fusion protein as it would 
be quickly degraded. This approach could possibly be used in the exploration of 
the effect of PfATG8 knockdown. Expression of an FKBP-tagged PfATG8∆G could 
possibly result in a phenotype mimicking the effect of genetic knockout through 
competition of PfATG8 for binding partners involved in its conjugation pathway. 
However it would need to be experimentally determined whether the over 
expression of a mutant form of PfATG8 caused a competitive inhibition of 
endogenous PfATG8. From the analysis of transgenic parasites expressing 
mCherry-PfATG8∆G, it would appear that this is not sufficient to cause a 
detectable phenotype indicating inhibition of endogenous PfATG8 function. 
Attempts to knockout Pfatg8 in the presence of episomally expressed mCherry-
PfATG8 appeared to be hampered by recombination between the EP-mC-A8 and 
Pfatg8-pCC-4 constructs. A secondary issue observed when using the EP-mC-A8 
construct as a platform to alleviate reliance on endogenous PfATG8, was that it 
appeared to integrate into the parasite genome into an unknown locus or loci. 
The Gateway system was used to generate constructs for mCherry-PfATG8 
expression due to the simplicity of the cloning steps required and because of 
experimental evidence for its effectiveness (Gunther et al., 2007, van Dooren et 
al., 2005). However additional methods exist for generating transgenic lines in 
which fluorescent fusion proteins are expressed. For example a method for 
genetic integration utilising the Mycobacteriophage Bxb1 integrase has recently 
been described (Adjalley et al., 2010, Nkrumah et al., 2006). The serine 
integrase of Bxb1 is able to catalyse directional recombination between the viral 
attP site and its target attB site without the need for bacterial host factors, 
divalent cations or DNA supercoiling (Ghosh et al., 2003). The availability of 3D7 
and Dd2 parasite lines possessing an attB site integrated into the non-essential 
cg6 locus, facilitates co-transfection of a construct driving expression of Bxb1 
integrase (pINT) along with a construct harbouring an attP site and the gene 
element(s) of interest.  
Use of the Bxb1 integrase system might prove a better method of providing an 
exogenous copy of Pfatg8 to facilitate knockout attempts. An mCherry-PfATG8 
expression cassette could be directionally cloned into the modified pBLUESCRIPT 
vector, pLN, used in combination with pINT (Adjalley et al., 2010). Expression of 
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the Bxb1 integrase from pINT would result in the integration of the mCherry-
PfATG8 construct into the cg6 locus. This controlled and targeted integration 
can be easily assessed, unlike the apparently random integration observed when 
using EP-mC-A8. This technique could therefore be used to not only generate a 
parasite line stably expressing mCherry-PfATG8 from a genomic, rather than an 
episomal locus but could also be used to help determine whether the 
endogenous copy of Pfatg8 can be knocked out using Pfatg8-pCC-4. 
Other methods for genetic knockout employing a modification of, or straying 
away from the reliance on homologous recombination are also now being 
employed in P. falciparum. Zinc-finger nuclease (ZFN) technology is increasingly 
being used for high efficiency and high specificity genetic modifications (Carroll, 
2011). This technology relies on the coupling of a zinc-finger DNA binding 
domain, specifically engineered to bind a DNA sequence of interest, with a DNA 
cleavage domain. Following recognition of target DNA sequences by the zinc 
finger domain, double strand breaks are created, which are repaired by the 
organisms endogenous DNA repair mechanisms. Typically, non-specific cleavage 
domains of restriction endonucleases such as FokI are used, which require 
dimerisation before performing DNA cleavage (Kim et al., 1996). Therefore zinc-
finger nucleases are designed to work in pairs, greatly increasing their specificity 
by ensuring cleavage only occurs when two heterologous subunits form the 
cleavage complex. Careful design of ZFNs ensures that cleavage complexes 
cannot be formed by two homologous subunits (Miller et al., 2007). The double 
stranded break created by a cleavage complex can be repaired in one of two 
ways. The organism’s endogenous DNA repair machinery might, in the absence of 
a homologous template to guide repair, rely on non-homologous end joining 
(Carroll, 2011). This process commonly results in mutation to the original 
sequence by introducing deletions or insertions resulting in frame shifts and in 
some cases effectual genetic ablation. This process of repair can therefore result 
in a gene knockout but this is not assured. However, by the exogenous provision 
of a sequence with regions homologous to the site of double stranded break, 
homologous recombination can be employed to repair the break. Design of the 
homologous sequence acting as a template for repair to contain a non-
homologous region enables the insertion of a non-homologous sequence into the 
specific locus determined by zinc-finger design. This can be exploited to insert 
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regions containing premature stop codons or other elements that modify a gene 
of interest. While use of this process has yet to be published in P. falciparum, 
work is underway to establish a robust and highly specific mechanism for genetic 
ablation of target genes in P. falciparum (Personal communication with Prof. 
David Fidock). Their work suggests that a ZFN system can be employed to 
produce homogenous knockout populations of parasites within 2 weeks of 
transfection. This could certainly change the way that knockout experiments are 
performed in P. falciparum and it certainly has the possibility to be used to 
determine whether or not Pfatg8 is essential to intraerythrocytic P. falciparum 
parasites. 
The transfection method used here involves electroporation of erythrocytes 
infected with ring stage parasites with a low voltage and high capacitance 
electric pulse (Crabb et al., 2004). This method has been modified and improved 
since its first use and has been used extensively (Fidock and Wellems, 1997, Wu 
et al., 1995). While it has proved reliable and efficient, an additional method 
relying on the spontaneous uptake of exogenous DNA by intraerythrocytic 
parasites has since been developed (Deitsch et al., 2001). Preloading of 
erythrocytes with DNA for transfection has recently been shown to be 5-180 
times more efficient than a method similar to that used here (Hasenkamp et al., 
2012). While transfection efficiency did not appear to be a limitation to 
generation of fusion protein expressing parasites, roughly 90 % success rate was 
observed, potentially a more efficient method could help improve upon the 40 % 
success rate observed for transfection with pCC-4-based constructs.  
While significant advances have been made in our understanding of parasite 
biology since the first transient transfection reported in 1995 (Wu et al., 1995), 
overcoming the obstacles to genetic manipulation of P. falciparum has proven 
difficult. However, a range of techniques can now be performed in Plasmodium 
and related parasites (Goldberg et al., 2011). Steps towards automation of P. 
falciparum transfection and analysis are now being made (Caro et al., 2012) and 
may well be coupled with high-throughput forward genetic approaches (Balu et 
al., 2005, Fonager et al., 2011). It seems possible that recent developments in 
our ability to genetically manipulate P. falciparum and other related parasites 
will mean that a new period of enlightenment in this, the post genomic era of 
research, is on the horizon.  
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5   Localisation and function of PfATG8 
5.1  Introduction 
Due to the association of ATG8 with autophagosomes from early in their 
formation through to degradation of cargo in the lytic compartment, introducing 
a tagged atg8 copy into model organisms has proven to be an invaluable tool in 
the study of autophagosomes and autophagy (Klionsky, 2011). In Chapter 3, 
antisera raised against recombinantly expressed His-PfATG8 were used to 
examine the expression of PfATG8 in wild type parasites. Transgenic parasite 
lines expressing mCherry-PfATG8 or mCherry-PfATG8ΔG were also generated 
which aided the analysis of the lipidation state of PfATG8. In order to build on 
these findings, the aim of work presented in this chapter was to examine the 
localisation of the endogenous PfATG8 protein and to use the transgenic lines as 
a tool to study PfATG8 localisation further. It was anticipated that 
PfATG8/mCherry-PfATG8 would localise to puncatate structures representing 
autophagosomes, similarly to what has been seen with ATG8 homologues in other 
organisms. 
5.2  Results 
5.2.1  Analysis of PfATG8 localisation in P. falciparum blood stage 
parasites 
In order to determine the subcellular localisation of PfATG8 in the 
intraerythrocytic stages of P. falciparum, immunofluorescence assays (IFA) were 
performed using an Axioskop 2 mot plus microscope. PfATG8 was detected with 
antisera raised against His-PfATG8 purification B. Both 3D7 and D10 parasites 
were analysed although for the sake of brevity, only images collected of D10 
parasites are shown (Figure 5.1). The localisation of PfATG8 was seen to be 
similar in both D10 and 3D7 P. falciparum lines, concentrating to defined areas 
within the parasite. PfATG8 appeared to localise to punctate structures along 
with larger, elongated structures, most prominent in the later stages of 
intraerythrocytic development. The localisation of PfATG8 to such structures 
supported the belief that similarly to mCherry-PfATG8, endogenous PfATG8 is 
also post-translationally modified and that this impacts on its localisation. 
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Figure 5.1: Analysis of PfATG8 localisation. 
Wild type D10 P. falciparum were prepared for IFA with rabbit anti-PfATG8 antisera from 
His-PfATG8 purification B (1:1,000) and goat anti-rabbit Alexa Fluor 488-conjugated 
polyclonal antibodies (1:1,500). Representative images of trophozoites are shown. Scale bar 
= 2 µm. 
 
5.2.2 Analysis of mCherry-PfATG8ΔG and mCherry-PfATG8 
localisation 
The analysis of mCherry-PfATG8 by western blotting had shown that the protein 
was post-translationally modified into a form reminiscent of lipidated protein. 
On the other hand, the truncated form of the fusion protein, mCherry-
PfATG8ΔG, was detected as only a single form, corresponding with the 
unmodified full length protein. Extraction of parasite protein with lysis buffer 
containing 1 % Triton X-100 detergent had disrupted parasite membranes to the 
extent that both the unmodified and lipid-modified forms of mCherry-PfATG8 
were observed in the ‘soluble’ fraction. To determine the location of fusion 
proteins in live parasites, parasites transfected with EP-mC-A8, EP-mC-A8∆G, 86-
mC-A8, EP-eY-A8, EP-eY-A8∆G and 86-eY-A8 and 86-eY-A8∆G were analysed by 
live cell fluorescence light microscopy. A clear difference in the localisation of 
full length fusion proteins (mCherry-PfATG8 and eYFP-PfATG8) and truncated 
fusion proteins (mCherry-PfATG8∆G and eYFP-PfATG8∆G) was observed. For 
clarity, images collected from parasites transfected with EP-mC-A8 or EP-mC-
A8ΔG are presented here. 
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Figure 5.2: localisation of mCherry-PfATG8∆G. 
Parasites transfected with EP-mC-A8∆G were analysed by live cell fluorescence light 
microscopy (A-D) and IFA with mouse anti-mCherry monoclonal (1:1,000) and goat anti-
mouse Alexa Fluor 488-conjugated polyclonal antibodies (1:1,500) (E and F). Representative 
images of life cycle stages trophozoite (A, B, E and F), early schizont (C) and late schizont (D) 
are shown. Scale bar = 2 µm. 
 
Parasites expressing mCherry-PfATG8∆G and eYFP-PfATG8∆G were analysed at 
different stages of intraerythrocytic development (mCherry-PfATG8∆G shown in 
Figure 5.2). At all stages, in parasites in which a detectable amount of the fusion 
protein was expressed, mCherry-PfATG8∆G and eYFP-PfATG8∆G were found to 
be dispersed throughout the cytosol. As it appeared that the signal from 
mCherry fusion proteins was more easily detected than the signal from eYFP 
fusion proteins with less bleed through of signal from Hoechst 33258, further 
analysis was concentrated on parasites expressing mCherry-PfATG8∆G. Parasites 
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expressing mCherry-PfATG8∆G were prepared for IFA with anti-mCherry and 
anti-mouse Alexa Fluor 488-conjugated secondary antibodies. Antibody staining 
detected in the fluoresceine-isothiocyanate (FITC) channel was observed in the 
parasite cytosol and overlapped with the signal from mCherry fluorescence 
detected in the mChery channel. These findings supported and built upon the 
analysis of mCherry-PfATG8∆G by western blotting by showing that without 
conversion of this protein into a lipidated form, a cytosolic localisation was 
characteristic. 
In stark contrast to the localisation of the truncated fusion proteins, mCherry-
PfATG8 and eYFP-PfATG8 were rarely observed to display a cytosolic dispersion. 
In the majority of parasites in which a detectable amount of the fusion protein 
was observed, both mCherry-PfATG8 and eYFP-PfATG8 were seen to localise to 
distinct subcellular structures with a characteristic pattern observed for each 
life cycle stage (mCherry-PfATG8 shown in Figure 5.3). Again, mCherry-PfATG8 
was more easily detected than eYFP-PfATG8 with less bleed through of signal 
from Hoechst 33258. Further analysis was concentrated on parasites expressing 
mCherry-PfATG8.  
Congruous with the expression profile of mCherry-PfATG8 as analysed by western 
blotting, in ring stage parasites, little mCherry-PfATG8 was detected. In 
parasites where a visible amount of the fusion protein was expressed, it 
appeared to be predominantly cytosolic but in some cells was also concentrated 
at a single focus. Not only did this support the observation that  mCherry-PfATG8 
was weakly expressed in ring stage parasites but also that only a low proportion 
of mCherry-PfATG8 was lipidated (1:1 ratio of non-lipidated to lipidated), again 
indicating that modification was responsible for localisation of the full length 
protein to subcellular structures. In trophozoite stage parasites, less cytosolic 
mCherry-PfATG8 was seen. Instead, it appeared that mCherry-PfATG8 labelled a 
tubular structure that varied in length and curvature between different cells of 
different ages. A longer structure was typically labelled in multi-nucleated 
trophozoites. In early schizont stages, mCherry-PfATG8 labelled longer, often 
more branched tubular structures. In late schizonts, mCherry-PfATG8 labelled 
elaborately branched tubular structures. This again supported the observations 
by western blot analysis that during the transition from ring to schizont stages, 
more mCherry-PfATG8 is converted to the lipidated form. In stages resembling 
Localisation and function of PfATG8  137 
segmenter, where nuclear division appears complete, mCherry-PfATG8 was seen 
to label multiple small structures that appeared to be distributed into each 
forming daughter merozoite. The labelling of structures in these late stage 
parasites supported the observation of a high proportion of lipidated mCherry-
PfATG8 in protein analysed by western blotting (1:2.7 ratio of non-lipidated to 
lipidated). Parasites expressing mCherry-PfATG8 were also prepared for IFA as 
detailed above. It was observed that anti-mCherry antibodies specifically 
detected the same structures labelled by mCherry-PfATG8.  
Crucially, the appearance of the mCherry-PfATG8-labelled structures resembled 
those seen in IFA analysis of wild type parasites probed with rabbit anti-PfATG8 
antisera and Alexa Fluor 488-conjugated secondary antibodies. This provided 
important evidence that the localisation of mChery-PfATG8 was representative 
of that of the endogenous protein. It was therefore deemed that mCherry-
PfATG8 expressing parasites could be used as a substitute for wild type cells 
allowing much greater flexability in the analysis of PfATG8 localisation and 
function. 
The increasing labelling of tubular structures by mCherry-PfATG8 during 
intraerythrocytic development, in combination with the increasing ratio of 
lipidated mCherry-PfATG8, as seen by western blot analysis, suggested that this 
localisation correlates with lipidation and therefore represents an association of 
mCherry-PfATG8 to a membrane-bound structure. Indeed, the fact that this 
structural localisation is entirely absent in parasites expressing the truncated 
mCherry-PfATG8∆G, shows that the C-terminal glycine is essential for this 
localisation. 
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Figure 5.3: Localisation of mCherry-PfATG8. 
Parasites transfected with EP-mC-A8 were analysed by live cell fluorescence light microscopy 
(A-E) and IFA with mouse anti-mCherry monoclonal (1:1,000) and goat anti-mouse Alexa 
Fluor 488-conjugated polyclonal antibodies (1:1,500) (F). Representative images of life cycle 
stages ring (A), trophozoite (B and F), early schizont (C), late schizont (D) and segmenter (E) 
are shown. A trophozoite parasite prepared for IFA with rabbit anti-PfATG8 antisera 
(1:1,000) and goat anti-rabbit Alexa Fluor 488-conjugated polyclonal antibodies (1:1,500) is 
shown for comparison (G). Scale bar = 2 µm. 
 
Capturing images of merozoites proved difficult. They reinvade erythrocytes 
within seconds of rupture (Boyle et al., 2010) and due to the mechanical 
pressure inflicted during live cell microscopy, it is difficult to ascertain whether 
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extracellular parasites are ‘true’ merozoites or the result of segmenter that that 
been ruptured prematurely. While others have shown that successful imaging of 
merozoites is possible (Angrisano et al., 2012, Baum et al., 2006), and various 
techniques have been successfully used to isolate and concentrate merozoites 
(Boyle et al., 2010), these techniques were not performed as part of this study. 
Of note is the observation that only a proportion of parasites were seen to 
express a visible amount of any of the fusion proteins and this proportion was 
seen to vary from ~ 45 % to as low as 15 % across all experiments performed. It 
was noted also, that when a cell line was in culture for an extended period of 
time, in excess of 4 weeks, the proportion of parasites expressing mCherry-
PfATG8 reduced. For subsequent microscopy-based experiments, parasites in 
culture for no longer than 4 weeks following recovery from liquid nitrogen were 
used.  
Along with the characteristic labelling of subcellular structures by mCherry-
PfATG8, a small proportion of parasites with fluorescent signal in the digestive 
vacuole were also observed. The mCherry signal from this organelle was 
generally very low in relation to any signal from labelled structures. mCherry-
PfATG8 degradation products were not observed in analysis by western blotting. 
The proportion of parasites exhibiting a vacuolar pattern also appeared to 
increase when parasites expressing mCherry-PfATG8 were at a low parasitaemia 
or imaged on sparsely loaded slides. These findings strongly suggested that the 
weak signal corresponding with the digestive vacuole in a small proportion of 
parasites represented an artefact, resultant from an over correction of auto-
contrast. However, due to the possibility that mCherry fluorescence in the 
digestive vacuole was due to targeting of mCherry-PfATG8, these parasites were 
included in subsequent analysis. 
In light of the array of localisation patterns of mCherry-PfATG8∆G and mCherry-
PfATG8 in parasites expressing these fusion proteins, and the varying proportion 
of parasites that show no visible levels of either protein, a robust scoring system 
was utilised in order to categorise each cell imaged (Figure 5.4).  
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Figure 5.4: Classification of life cycle stage and scoring categories of mCherry-PfATG8 and 
mCherry-PfATG8∆G expression. 
(left) Intraerythrocytic parasites were classified as per their morphology under DIC 
illumination and the number and spatial distribution of nuclei. 
(right) The distribution of fusion proteins in each parasite imaged was assigned to a scoring 
category in order to quantify any differences between parasite lines or following any 
treatment performed on parasite lines. 
 
5.2.3 Effect of autophagy regulation on tagged-protein expression 
and localisation  
The labelling of tubular structures by mCherry-PfATG8 was unexpected as it did 
not conform to the usual punctate labelling of autophagosomes by ATG8 in the 
cells of other organisms (Xie et al., 2008). It was therefore necessary to 
determine whether these structures represented autophagosome-like structures 
or were in fact, structures unrelated to an autophagic process.  
Labelling of tubular structures by GFP-LmATG8 has recently been reported in 
Leishmania major (Williams et al., 2012). However, this fluorescence pattern is 
predicted to be a result of fusion between GFP-LmATG8–labelled punctate 
autophagosomes and the multi-vesicular tubular (MVT)-lysosome, similar to the 
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labelling of autophagolysosomes in mammalian cells (Dennemarker et al., 2010). 
No punctate autophagosomes labelled by mCherry-PfATG8 were detected in 
parasites under normal growth conditions, suggesting that the labelling of these 
tubular structures was not the result of fusion between labelled punctate 
autophagosomes and a pre-existing lytic structure.  
In the cells of many other organisms, even in the absence of conditions to trigger 
an autophagic response, a basal level of autophagy, characterised by punctate 
autophagosomes, is observed (Omatsu-Kanbe et al., 2011). Basal autophagy is 
thought to be necessary for cell homeostasis by, among other roles, the removal 
of aberrantly folded proteins from the cytosol even under nutrient-rich 
conditions (Mizushima and Klionsky, 2007). Autophagy has also been strongly 
linked to cell aging (Vellai et al., 2009), underlining its importance in cellular 
homeostasis and survival. By triggering autophagy through chemical or 
environmental manipulation, an increase in autophagosome formation and 
turnover can be analysed by ATG8 lipidation and localisation (Mizushima and 
Yoshimori, 2007). The apparent absence of mCherry-PfATG8-labelled punctate 
autophagosomes in parasites under normal culture conditions may indicate that 
a low (undetectable) level of basal autophagy is undertaken in these parasites. 
An array of compounds and environmental conditions are known to modulate the 
process of autophagy and the resultant localisation of ATG8 in other organisms. 
To help determine whether the structures labelled by mCherry-PfATG8 
represented autophagic compartments, or to see if the localisation of mCherry-
PfATG8 could be altered by triggering autophagy, experiments were performed 
in which manipulation of autophagy regulation was attempted. 
5.2.3.1 Compound effectors of autophagy 
In order to influence the regulation of a possible autophagic process in P. 
falciparum intraerythrocytic stages, the effect of the compounds wortmannin, 
rapamycin and bafilomycin A1 on parasite lines expressing mCherry-PfATG8 was 
analysed. These compound effectors of autophagy act on various stages of 
autophagosome formation and degradation and have apposing effects on ATG8 
lipidation and localisation in other organisms, summarised in (Figure 5.5). For 
each drug treatment performed, changes in mCherry-PfATG8 expression and 
localisation analysed by live cell light microscopy would be used as a diagnostic 
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for any visible effect. Following treatment with wortmannin, the expression and 
lipidation of mCherry-PfATG8 was also analysed by western blotting of protein 
extracted from parasites following treatment. While the proportion of parasites 
exhibiting a visible expression of mCherry-PfATG8 was predicted to provide 
insight into mCherry-PfATG8 expression level, analysis by western blot was 
intended to supplement this analysis. As it has been shown in yeast that ScATG8 
expression increases upon induction of autophagy this was intended to provide 
an indication that treatments intended to trigger autophagy were valid (Kirisako 
et al., 1999). 
 
Figure 5.5: Compound modulators of autophagy. 
Rapamycin inhibits TOR kinase, which in turn promotes the initiation of autophagy. 
Wortmannin inhibits PI3K, which in turn reduces the allocation of membrane to 
autophagosome generation. Bafilomycin A1 inhibits V-type H+ATPase, which in turn prevents 
both the fusion of autophagosomes with the lytic compartment and also lytic degradation of 
autophagolysosome contents. 
 
Wortmannin is used as a potent, specific and irreversible inhibitor of 
phosphatidylinositol 3-kinase (PI3K) and has been used to study autophagy in a 
number of organisms (Ponpuak et al., 2009). Through its inhibition of class III 
PI3K, which phosphorylates phosphatidylinositol, it prevents generation of 
phosphatidylinositol 3-phosphate (PI3P) on pre-autophagosome membranes. 
This, in turn, prevents the recruitment of ATGs to these autophagosome 
nucleation sites, resulting in an overall reduction in autophagosome formation 
and therefore turnover of intended cargo (Blommaart et al., 1997). Wortmannin 
is however, known to have a number of off-target effects through interaction 
with protein kinases such as myosin light chain kinase (MLCK) (Nakanishi et al., 
1992) and mitogen-activated protein kinase (MAPK) (Ferby et al., 1996) 
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dependent on treatment conditions, as well as a counter effect on autophagy 
regulation through inhibition of class I PI3K (Wu et al., 2010).  
A class III PI3K has been characterised in P. falciparum (Vaid et al., 2010). 
Wortmannin has been used as a PI3K inhibitor in P. falciparum intraerythrocytic 
stages but evidence of its potency varies (Tawk et al., 2010, Vaid et al., 2010). 
Tawk and co-workers reported that wortmannin is unstable in culture medium 
(Yuan et al., 2007). They showed that a single dose of 25 µM is not sufficient to 
cause a growth defect over 48 h. However, they did show that treatment of 
parasites enriched for late stages via Plasmion treatment (Lelievre et al., 2005) 
with 100 nM wortmannin for 1.5 h was sufficient to cause a 58 % reduction in 
PI3P levels. Vaid and co-workers reported that as little as 3 µM wortmannin 
causes a 50 % growth inhibition over 144 h (6 days) with cultures being fed with 
wortmannin-dosed medium daily. They also showed that under shorter 
incubations the specific effects of wortmannin on PI3K can be seen. Incubation 
of late stage parasites with 10 µM wortmannin for ~ 5 h resulted in a 4 fold 
accumulation of haemoglobin in parasites. They showed along with other data 
that this results from an inhibition of endocytosis. Together these data suggest 
that wortmannin inhibits endocytosis in late stage parasites via the 
downregulation of PI3P synthesis by PI3K. 
In light of the absence of a clear IC50 value for wortmannin, to determine an 
appropriate treatment for the parasite lines used in this study an IC50 
experiment was performed with the D10 parental line of mCherry-PfATG8 and 
mCherry-PfATG8∆G expressing parasites (Figure 5.6). An IC50 of 73.0 ± 14.6 µM 
(S.E.M.) over 72 h was considerably higher than that reported by Vaid and co-
workers and that for other organisms (2-4 nM in mammalian cells (Powis et al., 
1994)). In consideration of the reported poor stability of this compound in 
culture medium, an IC50 experiment was also performed where drug-dosed 
medium was replaced each day. The resultant IC50 of 46.3 ± 22.4 µM (S.E.M.) was 
not statistically different to the first IC50 (unpaired t-test, P = 0.378), indicating 
that the stability of wortmannin in culture medium was not responsible for its 
lack of potency.  
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Figure 5.6: Determination of the IC50 value of wortmannin over 72 h. 
(left) D10 parasites were treated with a serial dilution of wortmannin either once at the 
beginning of a 72 h experiment (normal), or daily (refresh). Parasite growth was measured 
after 48 h by analysing [3H]-labelled hypoxanthine incorporation. Treatments were 
performed 3 times with 2 sets of technical replicates each time. A representative parasite 
viability curve is shown for an individual experiment. The IC50 for normal wortmannin 
treatment was 73.0 ± 14.6 µM (S.E.M.). The IC50 for wortmannin refreshed daily was 46.3 ± 
22.4 µM (S.E.M.). 
(right) The IC50 of wortmannin over 72 h was compared between a single dose (normal) and 
repeated dose (refresh). No significant difference was determined by unpaired t test (P = 
0.3738). 
 
A second PI3K inhibitor was also used by both Vaid and Tawk. LY294002 is 
structurally different from wortmannin, acting reversibly and less potently but it 
has been reported to be more stable in culture medium than wortmannin (Tawk 
et al., 2010). An IC50 experiment with a single dose of LY294002 was performed 
over 72 h with the D10 parental line of mCherry-PfATG8 expressing parasites. An 
IC50 of 42 ± 6.9 µM (S.E.M.) was approximately double than that reported by 
Tawk and Vaid. Due to the multitude of off target effects reported for this 
compound  (Gharbi et al., 2007), treatment of parasites with wortmannin was 
pursued as this appears to be the more commonly used compound. 
Treatment with 10 µM wortmannin for 6 h was used to analyse the effect of PI3K 
inhibition on the expression, lipidation and localisation of mCherry-PfATG8.  
Asynchronous parasites expressing mCherry-PfATG8 were incubated under 
normal conditions i.e. at 37 °C under reduced oxygen, with culture medium 
dosed with 10 µM wortmannin or an equivalent volume of DMSO as a control on 3 
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separate occasions. Analysis of mCherry-PfATG8 by western blotting revealed no 
difference in either the ratio of non-lipidated to lipidated mCherry-PfATG8 
(1:2.9 Control, 1:2.8 Wortmannin) or the overall expression of both forms 
between treated and control samples (Figure 5.7). The localisation of mCherry-
PfATG8 was also assessed by preparing treated and untreated cells for live cell 
fluorescence light microscopy. There was no difference in either the proportion 
of parasites expressing a visible amount of mCherry-PfATG8 (~ 20 %) or the 
distribution of parasites into each scoring category. From these data it was 
concluded that under these conditions wortmannin has no effect on mCherry-
PfATG8 expression, localisation and lipidation. 
 
Figure 5.7: Effect of wortmannin on mCherryPfATG8 expression, localisation and lipidation. 
Asynchronous parasites transfected with EP-mC-A8 were treated with 10 µM wortmannin or 
DMSO (Control) for 6 h under normal culture conditions. (A) Wortmannin and Control 
parasites were analysed by live cell fluorescent light microscopy. Treatments were 
performed three times with 375 (Wortmannin) and 323 (Control) cells being counted. 
Numbers indicate percentage of cells counted and scored into each category ± S.D. (B) 20 µg 
protein extracted from Wortmannin and Control parasites was separated by 7.5% SDS-PAGE 
and mCherry-PfATG8 was detected by western blotting with mouse anti-mCherry monoclonal 
(1:1,000) and rat anti-mouse HRP-conjugated polyclonal antibodies (1:10,000). The western 
blot was stripped and reprobed with rabbit anti-BCDH antisera (1:1,000) as a loading control. 
The relative intensities of upper and lower anti-mCherry reactive bands in each lane were 
calculated densitometrically using ImageJ, normalised to loading controls and are presented 
graphically. Numbers indicate the ratio of non-lipidated mCherry-PfATG8 (upper band) to 
lipidated mCherry-PfATG8 (lower band). 
 
The use of wortmannin had been predicted to down regulate a potential 
autophagic process in intraerythrocytic parasites. If the labelling of structures 
with mCherry-PfATG8 in these parasites was the result of an autophagic process 
then it might have been presumed that such labelling would be decreased in the 
presence of wortmannin. In the absence of any effect of wortmannin on the 
expression, lipidation or localisation of mCherry-PfATG8, it was concluded that 
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the labelling of structures by mCherry-PfATG8 was not dependent on PI3K 
activity. Next, in order to determine if the localisation of mCherry-PfATG8 could 
be affected by triggering autophagy, parasites were treated with the compounds 
rapamycin and bafilomycin A1. 
Rapamycin inhibits the Target of Rapamycin (TOR), a serine/threonine protein 
kinase. TOR (mTOR in humans and other mammals) forms complexes with a 
number of regulatory and effector proteins and acts as a point of convergence of 
a number of signalling pathways (Weichhart, 2012). In relevance to autophagy, 
mTOR has been shown to restrict the initiation of autophagy via, in part, its 
interaction with the ATG1 complex. Rapamycin, via interaction with FKBP12 
inhibits mTOR and hence promotes initiation of autophagy, characterised by an 
increase in autophagosome formation (Chang et al., 2009). While a gene 
predicted to encode a homologue of TOR has yet to be identified in P. 
falciparum, rapamycin has been found to have an IC50 of 2.6 µM over 48 h (Bell 
et al., 1994). 
Treatment with 4.5 µM rapamycin for 6 h was used to analyse the effect of 
rapamycin treatment on mCherry-PfATG8 localisation. Asynchronous parasites 
expressing mCherry-PfATG8 were incubated under normal conditions with 
culture medium dosed with 4.5 µM or an equivalent volume of DMSO as a 
control. The localisation of mCherry-PfATG8 was then assessed in treated or 
untreated parasites by live cell fluorescence light microscopy (Figure 5.8). There 
was no difference between treated or untreated parasites in either the 
proportion of parasites expressing a visible amount of mCherry-PfATG8 (~ 38 %) 
or the distribution of parasites into each scoring category. While analysis by 
microscopy was only performed once, a large number of parasites were imaged, 
resulting in a substantial data set. From this data it was concluded that under 
these conditions rapamycin has no effect on mCherry-PfATG8 localisation. 
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Figure 5.8: Effect of rapamycin on mCherry-PfATG8 expression and localisation. 
Asynchronous parasites transfected with EP-mC-A8 were treated with 4.5 µM rapamycin or 
DMSO (Control) for 6 h under normal culture conditions and analysed by live cell 
fluorescence light microscopy. Treatments were performed once with 300 (Rapamycin) and 
300 (Control) cells being counted. Numbers indicate percentage of cells counted and scored 
into each category. 
 
Bafilomycin A1 is a reversible inhibitor of vacuolar (V)-type H+ATPase. Unlike 
wortmannin and rapamycin, bafilomycin A1 acts to regulate, not the initiation 
stages of autophagy but the later stages of autophagosome flux. Its inhibitory 
effect on autophagosome turnover is attributed to both reducing the proteolytic 
environment within endolysosomal compartments that rely on  V-type H+ATPase 
for acidification (particularly in short term treatments) and causing a block in 
the fusion of autophagosomes with these endolysosomal compartments (Klionsky 
et al., 2008, Yamamoto et al., 1998). Typically, an accumulation of ATG8-
positive autophagosomes is observed in cells treated with bafilomycin A1. A V-
type H+ATPase pump has been identified in P. falciparum (Marchesini et al., 
2005) and bafilomycin A1 has been shown to have antimalarial properties, with 
an IC50 of 19.8 nM over 48 h (van Schalkwyk et al., 2010). 
Treatment with 100 nM bafilomycin A1 for 0.5 h was used to analyse the effect 
of V-type H+ATPase inhibition on mCherry-PfATG8 localisation. Parasites 
expressing mCherry-PfATG8 were synchronised to ring stages by a single 
incubation in 5 % sorbitol. Approximately 16 h later, when cultures contained 
primarily trophozoite stages, parasites were incubated under normal conditions 
with culture medium dosed with 100 nM bafilomycin A1 or an equivalent volume 
of DMSO and the localisation of mCherry-PfATG8 was assessed by fluorescence 
light microscopy (Figure 5.9). There was no difference in either the proportion 
of parasites expressing a visible amount of mCherry-PfATG8 (~ 30 %) or the 
distribution of parasites into each scoring category. Again, while this analysis 
was only performed once, a strong data set was generated from which it was 
concluded that under these conditions bafilomycin A1 had no effect on mCherry-
PfATG8 localisation. 
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Figure 5.9: Effect of bafilomycin A1 on mCherry-PfATG8 expression and localisation. 
Late stage parasites transfected with EP-mC-A8 were treated with 100 nM bafilomycin A1 or 
DMSO (Control) for 0.5 h under normal culture conditions and analysed by live cell 
fluorescent light microscopy. Treatments were performed once with 410 (Bafilomycin A1) 
and 497 (Control) cells being counted. Numbers indicate percentage of cells counted and 
scored into each category. 
 
Taken together, these experiments suggest that compounds known to regulate 
the process of autophagy and therefore the localisation of ATG8 in other 
organisms have no effect on mCherry-PfATG8 expression, lipidation or 
localisation in intraerythrocytic stages of P. falciparum.  
Treatment with wortmannin had not caused a decrease in the labelling of sub-
cellular structures by mCherry-PfATG8, suggesting that this process is not 
dependent on the activity of PI3K. Treatment with rapamycin or bafilomycin A1 
had not caused an effect in the labelling of structures and had not resulted in 
the detection of canonical punctate autophagosomes by promoting their 
formation or preventing their degradation. These experiments had shown that 
the regulation of the process responsible for the labelling of subcellular 
structures by mCherry-PfATG8 appeared to be distinct from the expected 
autophagic regulation mechanisms. The primary indication of autophagy remains 
a response to nutrient starvation. While compound modulators of autophagy 
regulators have been used to manipulate ATG8 lipidation and localisation in 
other organisms, it is possible that divergency in the regulation mechanisms in P. 
falciparum, preclude the use of the same compounds used in other organisms. In 
order to determine whether mCherry-PfATG8 expression, lipidation and 
localisation are affected by nutrient starvation, experiments were performed 
which starved parasites of either amino acids, or both amino acids and glucose, 
bypassing the need to elucidate the downstream signalling and regulation 
pathways of these effects. 
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5.2.3.2 Environmental triggers of autophagy 
As the primary environmental trigger for autophagy has long been regarded as 
amino acid starvation, experiments to explore the regulation of autophagy are 
often based on either limiting availability of amino acids or inhibiting their 
acquisition (Munafo and Colombo, 2001). To analyse the influence of amino acid 
starvation on mCherry-PfATG8 expression and localisation, parasites expressing 
mCherry-PfATG8 were subjected to an amino acid-limitation procedure. 
Parasites expressing mCherry-PfATG8 were synchronised to ring stages by a 
single incubation in 5 % sorbitol and returned to normal culture conditions. 
Around 16 h later, when cultures contained primarily trophozoite stages, 
parasites were transferred to amino acid-limited medium and cultured at 37 °C 
for 6 h. This culture medium is devoid of all amino acids with the exception of 
isoleucine, cysteine, methionine, glutamine and glutamic acid. Parasites were 
then dosed with 28 µM E64 or an equivalent volume of ethanol for a further 2 h. 
By limiting the availability of exogenous amino acids, this experiment was 
intended to force parasites to rely solely on amino acid acquisition from 
haemoglobin degradation and then block the degradation of haemoglobin by 
inhibiting cysteine peptidases with E64 (Liu et al., 2006, Vaid et al., 2010). 
mCherry-PfATG8 expression and lipidation state was analysed by western 
blotting (Figure 5.10). Little difference in either the ratio of non-lipidated to 
lipidated forms of mCherry-PfATG8 (1:3.3 Control, 1:2.6 E64) or the overall 
expression of both forms was seen between protein extracted from E64 treated 
or control parasites. The localisation of mCherry-PfATG8 was analysed by 
fluorescence light microscopy following E64 or control treatment (Figure 5.10). 
In an attempt to improve the efficiency of microscopic analysis, magnetic 
enrichment was performed to increase parasitaemia before imaging. No 
difference in either the proportion of parasites expressing a visible amount of 
mCherry-PfATG8 (~ 45 %) or the distribution of parasites into each scoring 
category was observed between E64 treated or control parasites. These data 
suggested that limiting the availability and acquisition of amino acids had no 
effect on mCherry-PfATG8 expression, lipidation and localisation. 
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Figure 5.10: Effect of amino acid limitation and E64 treatment on mCherry-PfATG8 
expression, localisation and lipidation. 
Late stage parasites transfected with 86-mC-A8 were incubated in limited medium for 6 h 
under normal culture conditions before addition of 28 µM E64 or DMSO (Control) for a further 
2 h incubation. (A) E64 and Control parasites were enriched by magnetic isolation and 
analysed by live cell fluorescent light microscopy. Treatments were performed once with 
554 (E64) and 522 (Control) cells being counted. Numbers indicate percentage of cells 
counted and scored into each category. (B) 20 µg protein isolated from E64 and Control 
parasites was separated by 7.5 % SDS-PAGE and mCherry-PfATG8 was detected by western 
blotting with mouse anti-mCherry monoclonal (1:1,000) and rat anti-mouse HRP-conjugated 
polyclonal antibodies (1:10,000). The western blot was stripped and reprobed with rabbit 
anti-BCDH antisera (1:1,000) as a loading control. The relative intensities of upper and lower 
anti-mCherry reactive bands in each lane were calculated densitometrically using ImageJ, 
normalised to loading controls and are presented graphically. Numbers indicate the ratio of 
non-lipidated mCherry-PfATG8 (upper band) to lipidated mCherry-PfATG8 (lower band). 
 
In order to test whether inhibition of aspartyl peptidases had an effect on 
mCherry-PfATG8 localisation in parasites adjusted to growth in amino acid-
limited medium, the same experiment was repeated but with a 2 h incubation in 
75 µM pepstatin A or DMSO as a control, rather than E64. Following magnetic 
enrichment, the localisation of mCherry-PfATG8 was analysed by live cell 
fluorescent light microscopy (Figure 5.11). Again, no difference in either the 
proportion of parasites expressing a visible amount of mCherry-PfATG8 (~ 20 %) 
or the distribution of parasites into each scoring category was observed between 
treated or control parasites. It should be noted that E64 and ethanol control 
treated parasites were those transfected with 86-mC-A8 rather than EP-mC-A8. 
This could account for the higher proportion of parasites exhibiting a visible 
level of mCherry-PfATG8 expression than that typical of parasites transfected 
with EP-mC-A8, as demonstrated by the relative expression profiles of each line 
shown in Figure 3.14. From these experiments it was concluded that amino acid 
starvation has no effect on mCherry-PfATG8 expression, lipidation or 
localisation. 
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Figure 5.11: Effect of amino acid limitation and pepstatin A treatment on mCherry-PfATG8 
expression, localisation and lipidation. 
Late stage parasites transfected with EP-mC-A8 were incubated in limited medium for 6 h 
under normal culture conditions before addition of 75 µM Pepstatin A or DMSO (Control) for a 
further 2 h incubation. Pepstatin A and Control parasites were enriched by magnetic 
isolation and analysed by live cell fluorescent light microscopy. Treatments were performed 
once with 396 (Pepstatin A), 679 (Pepstatin A control) cells being counted. Numbers indicate 
percentage of cells counted and scored into each category. 
 
In order to analyse the effect of glucose starvation on mCherry-PfATG8 
expression and localisation, parasites expressing mCherry-PfATG8 were 
synchronised to ring stages by a single incubation in 5 % sorbitol. Approximately 
16 h later, while the culture contained primarily trophozoite stages, parasites 
were incubated at 37 °C under reduced oxygen, not in culture medium but in 
Earle’s Balanced Salt Solution (EBSS) either supplemented with 11 mM glucose as 
a control (EBSS+G) or without glucose for 0.5 h. Parasite protein extracted from 
glucose starved and control parasites was analysed by western blotting (Figure 
5.12). The ratio of non-lipidated to lipidated forms of mCherry-PfATG8 appeared 
to be unaffected by the removal of an extracellular source of glucose (1:2.1 
Control, 1:2.3 EBSS) as was the overall expression level. Analysis of mCherry-
PfATG8 localisation by fluorescence light microscopy following magnetic 
enrichment revealed no difference in either the proportion of parasites 
expressing a visible amount of mCherry-PfATG8 (~ 35 %) or the distribution of 
parasites into each scoring category. These data showed that removal of all 
amino acids and glucose from culture medium for 30 min did not cause an effect 
on mCherry-PfATG8 expression, lipidation or localisation. 
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Figure 5.12: Effect of glucose starvation on mCherry-PfATG8 expression, localisation and 
lipidation. 
Late stage parasites transfected with EP-mC-A8 were incubated in EBSS or EBSS 
supplemented with 11 µM glucose (Control) for 0.5 h under normal culture conditions. (A) 
EBSS and Control parasites were enriched by magnetic isolation and analysed by live cell 
fluorescent light microscopy. Treatments were performed three times with 1578 (EBSS), 
1258 (Control) cells being counted. Numbers indicate percentage of cells counted and scored 
into each category ± S.D. (B) 20 µg protein isolated from EBSS and Control parasites was 
separated by 7.5 % SDS-PAGE and mCherry-PfATG8 was detected by western blotting with 
mouse anti-mCherry monoclonal (1:1,000) and rat anti-mouse HRP-conjugated polyclonal 
antibodies (1:10,000). The western blot was stripped and reprobed with rabbit anti-BCDH 
antisera (1:1,000) as a loading control. The relative intensities of upper and lower anti-
mCherry reactive bands in each lane were calculated densitometrically using ImageJ, 
normalised to loading controls and are presented graphically. Numbers indicate the ratio of 
non-lipidated mCherry-PfATG8 (upper band) to lipidated mCherry-PfATG8 (lower band). 
 
Parasites expressing mCherry-PfATG8∆G were subjected to the same treatment 
and analysed by fluorescence light microscopy. Removal of glucose and all amino 
acids did not alter the proportion of parasites expressing a visible amount of 
mCherry-PfATG8∆G (~ 15 %) or the distribution of parasites into each scoring 
category, with a cytosolic dispersion remaining the characteristic pattern (Figure 
5.13). This showed that starvation of glucose did not induce a translocalisation 
of cytosolic mCherry-PfATG8ΔG to subcellular structures and supported the 
notion that in the absence of its C-terminal glycine residue, mCherry-PfATG8∆G 
can not participate in the same process as full length mCherry-PfATG8. 
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Figure 5.13: Effect of glucose starvation on mCherry-PfATG8∆G expression and localisation. 
Late stage parasites transfected with EP-mC-A8∆G were incubated in EBSS or EBSS 
supplemented with 11 µM glucose (Control) for 0.5 h under normal culture conditions. EBSS 
and Control parasites were enriched by magnetic isolation and analysed by live cell 
fluorescent light microscopy. Treatments were performed three times with 1662 (EBSS) and 
4009 (Control) cells being counted. Numbers indicate percentage of cells counted and scored 
into each category ± S.D. 
 
Together, these sets of experiments were designed to induce and manipulate 
the regulation of autophagy, in order to determine whether mCherry-PfATG8 
was involved in an autophagic process. Data collected suggested that mCherry-
PfATG8 was not involved in such a process. Under no conditions were canonical 
ATG8-positive punctate autophagosomes observed. This suggested that the 
subcellular structures labelled by mCherry-PfATG8 may well have been a novel 
autophagic structure. However, under no treatment conditions was the labelling 
of this structure by mCherry-PfATG8 seen to alter. This suggested that the 
labelling of this structure did not represent an autophagic process. As the 
labelling of this subcellular structure by mCherry-PfATG8 did not appear to 
represent the hallmarks of autophagy, it remained to be determined what the 
structure represented and why it was labelled by mCherry-PfATG8.  
5.2.4 Characterisation of mCherry-PfATG8-labelled structures 
The combination of an unusual localisation of mCherry-PfATG8 and the fact that 
commonly used compound and environmental modulators of autophagy appeared 
to have no effect on the expression or localisation of mCherry-PfATG8, 
suggested that this protein was not involved in an autophagic process. However, 
mCherry-PfATG8 was seen to label a subcellular structure, which exhibited a 
changing appearance in different stages of intraerythrocytic development. 
Labelling of this structure was entirely dependent on the C-terminal glycine of 
PfATG8, suggesting that this labelling correlates with its specific lipidation. In 
order to further characterise and place these structures in context of subcellular 
organisation, colocalisation studies were performed with co-expressed organelle 
markers, vital stains and antibodies in immunofluorescence assays. 
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5.2.4.1 Analysis of mCherry-PfATG8-labelled structures in relation to acidic 
compartments 
Autophagosomes must become acidified before their contents can be degraded 
and recycled (Nakamura et al., 1997). Acidification of autophagosomes occurs 
primarily via fusion with late endosomes, forming amphisomes or fusion with the 
lytic compartment, forming autophagolysosomes (Shintani and Klionsky, 2004). 
The precise chronology of these fusion steps is difficult to pin-point due to the 
tight integration of the endosomal and lysosomal systems and therefore these 
steps are often referred to as endolysosomal fusion (Hundeshagen et al., 2011). 
Following these fusion events hydrolytic enzymes within the lytic compartment 
can degrade autophagosome contents. The contents of autophagosomes can also 
be degraded following acquisition of proton pumps and hydrolytic enzymes 
directly from the trans-Golgi network (Rajawat et al., 2010).  
Plasmodium spp. possess a large digestive vacuole, the site of haemoglobin 
degradation, but appear to lack canonical lysosomes. Therefore the likely 
endolysosomal target of autophagosomes, should a canonical autophagy process 
exist, would be the digestive vacuole. It also can not be discounted that 
autophagosomes could be acidified and degrade their contents without fusion 
with a lytic compartment by gaining digestive enzymes from the trans-Golgi 
network. Digestion of haemoglobin has been observed in haemoglobin-containing 
vesicles prior to, or in the absence of fusion with the digestive vacuole (Abu 
Bakar et al., 2010). This may indicate precedent for the maturation of vesicles 
into lytic compartments in the absence of interaction with the main lytic 
compartment, the digestive vacuole. LysoTracker and LysoSensor probes were 
used to assess the potential acidification of mCherry-PfATG8-labelled structures. 
LysoTracker Red has been shown to accumulate into autophagosomes shortly 
after their formation in mammalian cells (Kim and Lemasters, 2011). 
Asynchronous D10 parasites were incubated with LysoTracker Red DND-99 under 
normal culture conditions before analysis by fluorescence light microscopy 
(Figure 5.14). LysoTracker, a fluorophore linked to an acidotropic weak base, 
concentrated to the digestive vacuole in trophozoites and schizonts of wild type 
parasites. This probe is reported to accumulate in compartments at ~ pH 5.2, 
which correlates well with pH reported for the digestive vacuole (pH 5.2 – 5.4) 
(Hayward et al., 2006). With the absence of any staining beyond the digestive 
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vacuole, it appeared unlikely that mCherry-PfATG8-labelled structures were 
acidified to this extent.  
 
Figure 5.14: Identification of acidic compartments with LysoTracker DND-99. 
Asynchronous D10 parasites were incubated with 50 nM LysoTracker DND-99 for 45 min 
under normal culture conditions. Parasites were analysed by live cell fluorescence light 
microscopy. Representative images of late trophozoites (B) and early schizonts (A and C) are 
shown. Scale bar = 2 µm. 
 
An attempt was made to ascribe a rough pH value to mCherry-PfATG8-labelled 
structures by using LysoSensor probes. Unlike LysoTracker which maintains its 
fluorescence independently from pH, LysoSensor probes accumulate in acidic 
compartments but have differing spectral properties dependent on pH (Life 
Technologies). LysoSensor Green DND-189 is most fluorescent when in an acidic 
environment because its fluorescence is quenched until protonation occurs at 
low pH, whereas LysoSensor Green DND-153 is brightly fluorescent at neutral pH 
and is reported to concentrate to the membranes of weakly acidic compartments 
(Life Technologies). Asynchronous parasites expressing mCherry-PfATG8 were 
incubated with LysoSensor Green DND-189 and analysed by fluorescence light 
microscopy. No strong fluorescence was observed in any subcellular structure 
(including the digestive vacuole), with a weak diffuse signal characteristic of all 
life cycle stages imaged (Figure 5.15 (A-C)). This cytosolic staining did not 
overlap with the structures labelled by mCherry-PfATG8. This suggests that the 
probe was either unable to accumulate in acidic compartments, or that once in 
the digestive vacuole it was quickly degraded. Asynchronous parasites expressing 
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mCherry-PfATG8 were incubated with LysoSensor Green DND-153 and analysed 
by fluorescence light microscopy. A strong fluorescence was seen concentrated 
to subcellular structures in parasites of all stages imaged (Figure 5.15 (D-G)). In 
late stage parasites in particular, the fluorescence pattern resembled a complex 
and vast membranous network where apparently very large vacuoles or tubular 
membrane structures were labelled. This suggested that LysoSensor Green DND-
153 concentrates to membranes throughout the parasite and fluoresces strongly 
while in an environment of near-neutral pH. In some parasites mCherry-PfATG8-
labelled structures overlapped with structures where LysoSensor Green DND-153 
had concentrated. This suggested that mCherry-PfATG8-labelled structures are 
membrane bound organelles with a near neutral pH. 
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Figure 5.15: Identification of acidic compartments with LysoSensor DND-189 and LysoSensor 
DND-153. 
(Upper panels) Asynchronous parasites transfected with EP-mC-A8 were incubated with 10 
nM LysoSensor DND-189 at 37 °C for 5 min before analysis by live cell fluorescence light 
microscopy. Representative images of trophozoites (B) and schizonts (A and C) are shown. 
(Lower panels) Asynchronous parasites transfected with EP-mC-A8 were incubated with 10 
nM LysoSensor DND-153 at 37 °C for 5 min before analysis by live cell fluorescence light 
microscopy. Representative images of trophozoites (D and E) and schizonts (F and G) are 
shown. 
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Incubation of parasites expressing mCherry-PfATG8 with each of these probes 
revealed that mCherry-PfATG8-labelled structures are unlikely to be acidified. 
This supported previous findings that suggested that mCherry-PfATG8-labeled 
structures were not involved in a canonical autophagic process.  
5.2.4.2 Analysis of mCherry-PfATG8-labelled structures in relation to the 
mitochondrion and apicoplast 
Plasmodium spp. possess a mitochondrion and apicoplast as single copy 
organelles, which elongate and segment during schizogony to ensure that each 
daughter merozoite inherits a functional organelle (van Dooren et al., 2005). It 
has previously been shown by GFP-tagging mitochondrial and apicoplast resident 
proteins that the expansion and segmentation of these organelles involves 
striking morphological development with characteristic stages through the 
intraerythrocytic development of the parasite (McMillan, 2006, McMillan et al., 
2005). The appearance of mCherry-PfATG8-labelled structures resembled the 
appearance of both the mitochondrion and apicoplast as they develop. Further 
microscopic analyses were performed to investigate the possible relationship 
between mCherry-PfATG8-labelled structures and the mitochondrion and 
apicoplast. 
A range of commercially available mitochondrial-specific probes can be used to 
identify the mitochondrion in live and fixed cells (Cottet-Rousselle et al., 2011). 
MitoTracker Green-FM was used to visualise the mitochondrion in live parasites 
expressing mCherry-PfATG8. This cell permeable probe accumulates within an 
active mitochondrion and fluoresces upon conjugation to thiols (Life 
Technologies). Asynchronous parasites expressing mCherry-PfATG8 were 
incubated with MitoTracker Green-FM under normal culture conditions prior to 
analysis by fluorescence light microscopy. mCherry-PfATG8-labelled structures 
did not colocalise with the active mitochondrion reported by MitoTracker in any 
of the life cycle stages imaged (Figure 5.16 (A-C)).  
In the cells of organisms that perform mitophagy, either the whole organelle or 
damaged portions are selectively incorporated into autophagosomes as cargo 
destined for degradation (Kim et al., 2007). The precise factors that promote 
mitophagy have yet to be confirmed but recent work in mammalian cells has 
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shown that the formation of permeability transition pores which result in the 
depolarization of mitochondria likely play a role (Kim et al., 2007). By 
identifying where these pores form, selective turnover of these portions of 
mitochondrial membrane by mitophagy may facilitate organelle homeostasis in 
organisms where removal of the entire organelle is not possible. The 
visualisation of mitochondria with MitoTracker probes is dependent on an active 
membrane potential. Due to the possibility of the collapse of membrane 
potential in areas of the mitochondrion that may be labelled by mCherry-
PfATG8, possibly indicating mitophagy, a second method was used in order to 
assess possible colocalisation of mCherry-PfATG8 with mitochondrial proteins. If 
mCherry-PfATG8 was observed to colocalise with mitochondrial proteins it might 
indicate a role in turnover of damaged or unnecessary mitochondrial material 
that would be missed by probing with MitoTracker. In order to facilitate 
colocalisation with PfATG8, immunofluorescence assays were performed using a 
mitochondrial GFP-reporter line. A line already generated by a previous member 
of the lab had been shown to have a strong GFP signal in the lumen of the 
mitochondrion (McMillan, 2006). In brief, this line was generated by transfection 
of D10 parasites with a construct based on pHH2, in which the genomic sequence 
encoding amino acids 1-33 of PFL1550w was cloned in frame with a C-terminal 
GFP-tag (mE3-GFP-pHH2). Parasites transfected with mE3-GFP-pHH2 and 
selected with WR99210 exhibit strong fluorescence in the lumen of the 
mitochondrion in all intraerythrocytic life cycle stages. Approximately 80 – 90 % 
of parasites analysed by live cell fluorescence light microscopy as part of this 
study expressed visible levels of mE3-GFP.  
Endogenous PfATG8 was detected in asynchronous parasites expressing mE3-GFP 
by IFA with rabbit antisera raised against His-PfATG8 purification B and mouse 
Alexa Fluor 594-conjugated anti-rabbit polyclonal antibodies (Figure 5.16 (D)). 
As expected, mE3-GFP appeared to label the mitochondrion similarly to during 
live cell fluorescent light microscopy; however the labelling was often less 
homogeneous, suggesting loss of structural integrity during the IFA procedure. As 
had been seen in IFA analysis of wild type parasites, antisera raised against His-
PfATG8 detected structures similar to those labelled by mCherry-PfATG8 in live 
cell microscopy, which often also displayed a slightly fragmented appearance. 
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No overlap was observed between the structures reported by detection of 
endogenous PfATG8 and structures labelled with mE3-GFP.  
The lack of colocalisation between PfATG8-positive structures and either the 
intact mitochondrion or a mitochondrial resident protein, suggested that it was 
unlikely that PfATG8 plays a role in mitochondrial homeostasis in 
intraerythrocytic stages as no overlap between PfATG8 and the mitochondrion 
was observed.  
 
Figure 5.16: Localisation of mCherry-PfATG8 in relation to the mitochondrion. 
(A - C) Asynchronous parasites transfected with EP-mC-A8 were incubated with 25 nM 
MitoTracker Green-FM for 20 min under normal culture conditions before analysis by live cell 
fluorescence light microscopy. Representative images of a trophozoite (A), early schizont (B) 
and late schizont (C) are shown. (D) Asynchronous parasites transfected with mE3-GFP-pHH2 
were prepared for IFA with rabbit anti-PfATG8 antisera (1:1,000) and goat anti-rabbit Alexa 
Fluor 594-conjugated polyclonal antibodies (1:1,500). A representative image of a 
trophozoite is shown. Scale bar = 2 µm. 
 
In the absence of commercially available apicoplast-specific probes the possible 
relationship between the apicoplast and PfATG8 relied on the use of an 
apicoplast reporter line, again generated by Dr. P. McMillan (McMillan, 2006). In 
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brief, the genomic sequence encoding amino acids 1-134 of PF08_0066 was 
cloned into pHH2 in frame with a C-terminal GFP-tag (aE3-GFP-pHH2). Wild type 
D10 parasites transfected with aE3-GFP-pHH2 and selected with WR99210 exhibit 
strong GFP fluorescence in the lumen of the apicoplast in all intraerythrocytic 
life cycle stages. Approximately 80 – 90 % of parasites analysed by live cell 
fluorescence light microscopy as part of this study expressed visible levels of 
aE3-GFP. Asynchronous parasites expressing aE3-GFP were prepared for IFA with 
rabbit antisera raised against His-PfATG8 purification B and Alexa Fluor 594-
conjugated mouse anti-rabbit monoclonal antibodies (Figure 5.17 (A)). As 
expected the apicoplast was labelled by aE3-GFP similarly to when examined by 
live cell fluorescence light microscopy. However, as with the IFA of cells 
expressing mE3-GFP, it appeared that the apicoplast’s structure had been 
disrupted during the IFA procedure. Most likely the fixation and permeabilisation 
steps in the preparation of slides were responsible for causing collapse of the 
organelle’s integrity leading to a fragmented appearance. Despite this, it could 
be seen that there were areas of overlap between the GFP-labelled apicoplast 
and the structure detected by antisera raised against His-PfTAG8. 
To explore the relationship between the apicoplast and PfATG8 further, a co-
expressing parasite line was generated. This required the generation of a new 
EP-mC-A8 expression vector based on the destination vector pHBlR-3/4, which 
would allow selection with blasticidin-S-HCl (BLA) in parasites already requiring 
WR99210 for maintenance of the aE3-GFP-pHH2 construct. For simplicity, this 
construct is also referred to as EP-mC-A8 (see Table 2.1). 
D10 wild type parasites were transfected with the new EP-mC-A8 construct and 
parasites resistant to BLA were detected 6-8 weeks later. Analysis of mCherry-
PfATG8 localisation by fluorescence light microscopy revealed the same 
characteristic fluorescence patterns as those previously described. This 
confirmed that expression of mCherry-PfATG8 was comparable when driven from 
either the pHBlR-3/4 or pCHDR-3/4-based constructs. D10 parasites previously 
transfected with aE3-GFP-pHH2 were then transfected with EP-mC-A8 and 
parasites resistant to both BLA and WR99210 were detected in Giemsa-stained 
thin smears after 6-8 weeks. Analysis of the aE3-GFP line transfected with EP-
mC-A8 by live cell fluorescence light microscopy following magnetic enrichment 
showed that in a small (~ 5 %) proportion of parasites, both mCherry-PfATG8 and 
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aE3-GFP were expressed (Figure 5.17 (B-D)). Co-expression of mCherry-PfATG8 
had not affected the expression or localisation of aE3-GFP to the apicoplast. 
Conversely, in the proportion of parasites expressing mCherry-PfATG8, similar 
structures were observed to those in parasites expressing mCherry-PfATG8 only. 
This showed that the expression of two fusion proteins had not affected the 
distribution of either in comparison to when they were individually expressed. 
 
Figure 5.17: Localisation of mCherry-PfATG8 in relation to the apicoplast. 
(A) Endogenous PfATG8 was detected in parasites transfected with aE3-GFP-pHH2 by IFA 
with rabbit anti-PfATG8 antisera (1:1,000) and anti-rabbit Alexa Fluor 594-conjugated 
polyclonal antibodies (1:1,500). A representative image of a trophozoite is shown.  
(B-D) Late stage parasites transfected with both EP-mC-A8 and aE3-GFP-pHH2 were enriched 
by magnetic isolation and analysed by fluorescence light microscopy using a Delta Vision Core 
microscope.  Representative images of life cycle stages trophozoite (B), schizont (C) and 
segmenter (D) are shown. Scale bar = 2 µm. 
 
Images were collected of parasites at different stages of intraerythrocytic 
development. It was found that mCherry-PfATG8 was closely associated with the 
apicoplast throughout the life cycle, with a partial overlap between the 
structures labelled by mCherry-PfATG8 and the apicoplast lumen, reported by 
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aE3-GFP. However, a complete co-localisation between the two reporters was 
not observed. This finding was not surprising considering the aE3-GFP protein 
resides in the apicoplast lumen, while mCherry-PfATG8 does not possess a 
bipartite signal required for entry into the apicoplast lumen and, according to 
evidence collected in this study, is predicted to be membrane associated due to 
its lipid modification. 
The relationship between mCherry-PfATG8 and aE3-GFP was analysed by 
determining the Pearson’s coefficient representing co-localisation between the 
two signals of mCherry and GFP i.e. the overlap of red and green signal in the 
same pixel, over whole parasites using SoftWoRx software (Applied Precision). 
The average Pearson’s coefficient was found to be 0.69 ± 0.07 (S.D. n = 25). This  
represents a high degree of correlation with 48 % of variance being linked (Adler 
and Parmryd, 2010). This can be interpreted as that when a pixel contains signal 
from aE3-GFP it will also contain signal from mCherry-PfATG8 in 48 % of cases 
(http://www.svi.nl/PearsonsInterpretation [last accessed 15/06/2012]). This 
showed that there was a considerable association between mCherry-PfTAG8 and 
aE3-GFP but confirmed that the two reporters did not fully co-localise. 
This crucial finding added to the characterisation of PfATG8 and the 
determination of the identitiy of PfATG8-positive structures. Data collected to 
this point suggested that PfATG8 (and mCherry-PfATG8) is lipidated and 
associated with a membrane-bound organelle, which appears to be the 
apicoplast. This labelling of the apicoplast is entirely dependent on the C-
terminal glycine residue of PfATG8 but is not regulated by the processes known 
to influence control of the autophagic pathway in other organisms. This left the 
question, why does PfATG8 label the apicoplast? In Toxoplasma gondii, which 
possesses an apicoplast, it has recently been shown that an ATG8 homologue 
plays a role in mitochondrion homeostasis (Besteiro et al., 2011) but no link 
between TgATG8 and the apicoplast was alluded to. In order to understand why 
PfATG8 labels the apicoplast attempts to explore the relationship between 
PfATG8 and the apicoplast were made. 
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5.2.5 Chemical disruption of the apicoplast 
It has recently been shown that production of isoprenoid precursors is the only 
essential function of the apicoplast in the intraerythrocytic stages of P. 
falciparum (Yeh and DeRisi, 2011). Yeh and DeRisi showed that antibiotic 
treatment leads to a delayed death phenotype due to perturbation of apicoplast 
development and subsequent lack of inheritance by daughter merozoites. 
However, by supplying the parasites with exogenous isopentenyl pyrophosphate 
(IPP), indefinite continuation of parasite cultures is possible. They show that an 
apicoplast-targeted acyl carrier protein-GFP fusion protein resides in vesicles 
scattered throughout the cytosol in parasites that have lost their apicoplast, 
suggesting that without the presence of an apicoplast, apicoplast-targeted 
vesicles accumulate. Given the close association of mCherry-PfATG8 and the 
apicoplast reporter aE3-GFP, a similar experiment was performed to analyse the 
localisation of mCherry-PfATG8 in antibiotic treated, IPP rescued parasites. 
Parasites expressing both mCherry-PfATG8 and aE3-GFP were synchronised to 
ring stages by a single incubation in 5 % sorbitol. Approximately 16 h later, when 
cultures mainly contained trophozoite stages, parasites were incubated in 
culture medium dosed with 50 µM chloramphenicol or an equivalent volume of 
ethanol as a control. Twenty four hours later the parasites were again fed with 
chloramphenicol-dosed culture medium. Forty eight and 72 h after the first dose 
of chloramphenicol, parasites were fed with culture medium dosed with 
chloramphenicol and supplemented with 200 µM IPP. After a total of 96 h from 
the initial dose of chloramphenicol, parasites were magnetically enriched and 
analysed by live cell fluorescence light microscopy (Figure 5.18). 
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Figure 5.18: Effect of apicoplast loss on mCherry-PfATG8 and aE3-GFP localisation. 
Late stage parasites transfected with both EP-mC-A8 and aE3-GFP-pHH2 were treated with 
50 µM chloramphenicol or ethanol (Control) for 96 h and 200 µM IPP for the final 48 h prior 
to enrichment by magnetic isolation and analysis by live cell fluorescence light microscopy. 
(A) Representative image of a control trophozoite, (B,C) representative images of 
chloramphenicol treated trophozoites. (D) Representative image of a control schizont, (E,F) 
representative images of chloramphenicol treated schizonts. Scale bar = 2 µm. 
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Similarly to data presented by Yeh and DeRisi, the apicoplast-targeted aE3-GFP 
protein resided in vesicles scattered throughout the cytosol and no structure 
resembling an apicoplast was present, confirming that the apicoplast had been 
lost due to chloramphenicol treatment. The diameter of aE3-GFP labelled 
vesicles was analysed using SoftWoRx software (Applied Precision). The average 
diameter of 26 vesicles was 399 ± 99 nm (S.D.). However, these vesicles were 
often irregular shapes, potentially representing fusion products of multiple 
vesicles. 
In chloramphenicol treated and IPP rescued parasites, mCherry-PfATG8 also 
presented a vesicular distribution and the labelling of tubular structures 
observed in untreated or control parasites was not observed. The localisation of 
mCherry-PfATG8 was scored as previously described and while the low 
proportion of cells displaying vacuolar or cytosolic patterns remained the same 
following treatment, the proportion of cells displaying a structure(s) pattern had 
reduced and been replaced by cells displaying a vesicular pattern (Figure 5.19).  
  
Figure 5.19: Effect of apicoplast loss on mCherry-PfATG8 expression and localisation. 
Late stage parasites transfected with aE3-GFP-pHH2 and EP-mC-A8 were treated with 50 µM 
chloramphenicol or ethanol (Control) for 96 h and 200 µM IPP for the final 48 h prior to 
enrichment by magnetic isolation and analysis by live cell fluorescence light microscopy. 
Treatments were performed four or three times with 2107 (Chloramphenicol) and 1446 
(Control) cells being counted, respectively. Numbers indicate percentage of cells counted 
scored into each category ± S.D. 
 
Similarly to the association observed between mCherry-PfATG8 and aE3-GFP in 
untreated cells, there appeared to be a partial overlap between mCherry-
PfATG8 and aE3-GFP-labelled vesicles following chloramphenicol treatment 
(Figure 5.20). mCherry-PfATG8-labelled vesicles also appeared to be of various 
sizes and shapes. 
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Figure 5.20: Effect of apicoplast loss on mCherry-PfATG8 and aE3-GFP localisation. 
(Upper panels) Two examples of ethanol control parasites are shown. Insets A, B and C show 
an overlap but not complete colocalisation between mCherry-PfATG8 (red) and aE3-GFP 
(green)-labelled structures. (Lower panels) Two examples of chloramphenicol treated 
parasites are shown. Insets D, E and F show an overlap but not complete colocalisation 
between mCherry-PfATG8 (red) and aE3-GFP (green)-labelled vesicles. 
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The correlation between mCherry-PfATG8 and aE3-GFP across whole parasites 
was analysed by determination of the Pearson’s coefficient. The average 
Pearson’s coefficient was found to be 0.69 ± 0.07 (S.D. n = 28). As in untreated 
parasites, this represents a high degree of correlation (Figure 5.21) An indicates 
that the degree of colocalisation between the two proteins does not differ 
following apicoplast disruption.  
This experiment had shown that in addition to labelling the intact apicoplast, 
mCherry-PfATG8 also labelled vesicles containing apicoplast-targeted protein 
when the intact apicoplast was absent as a result of chloramphenicol treatment. 
This suggested that the association of mCherry-PfATG8 to the apicoplast 
membrane was independent of apicoplast function. 
 
Figure 5.21: Analysis of the relationship between mCherry-PfATG8 and aE3-GFP with or 
without chemical disruption of the apicoplast. 
Deconvolved Z stacks (18 x 0.2 µm) of images obtained from previous experiments were 
analysed for correlation between mCherry-PfATG8 and aE3-GFP using SoftWoRx software 
(Applied Precision). Each data point indicates a whole parasite analysed, solid points 
indicating ethanol (Control) treated parasites and hollow points indicating chloramphenicol 
and IPP treated parasites. The average correlation and standard deviation are indicated by 
bars and whiskers.  
 
Due to the very low proportion of parasites that expressed visible amounts of 
both mCherry-PfATG8 and aE3-GFP, chloramphenicol treatment and IPP rescue 
was also performed on parasites expressing only mCherry-PfATG8. Visible 
amounts of mCherry-PfATG8 are typically seen in ~ 20 % of parasites transfected 
with EP-mC-A8 only, while only ~ 5 % of co-transfected parasites expressed 
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visible amounts of both mCherry-PfATG8 and aE3-GFP. Parasites expressing 
mCherry-PfATG8 were treated and analysed as above. As in parasites expressing 
both mCherry-PfATG8 and aE3-GFP, the labelling of tubular structures seen in 
untreated parasites was mostly lost upon chloramphenicol treatment and was 
replaced by labelling of vesicles throughout the cytosol (Figure 5.22). This large 
shift in mCherry-PfATG8 localisation was more apparent in these lines and 
together with data collected from co-expressing lines, represented the first 
incidence in which the localisation of mCherry-PfATG8 has been altered through 
manipulation of parasites. 
  
Figure 5.22: Effect of apicoplast loss on mCherry-PfATG8 expression and localisation. 
Late stage parasites transfected with EP-mC-A8 were treated with 50 µM chloramphenicol or 
ethanol (Control) for 96 h and 200 µM IPP for the final 48 h prior to enrichment by magnetic 
isolation and analysis by live cell fluorescence light microscopy. Treatments were performed 
twice with 961 (Chloramphenicol and IPP), 791 (Control) cells being counted. Numbers 
indicate percentage of cells counted scored into each category ± S.D. 
 
In order to determine whether the vesicular pattern of mCherry-PfATG8 
observed following chloramphenicol treatment was dependent on its lipidation, 
the same experiment was also performed on parasites expressing mCherry-
PfATG8∆G. The cytosolic distribution of mCherry-PfATG8∆G in untreated 
parasites was also seen in chloramphenicol treated parasites (Figure 5.23). This 
showed that the labelling of vesicles by mCherry-PfATG8 in chloramphenicol 
treated parasite is entirely dependent on its C-terminal glycine residue, strongly 
suggesting that this localisation is due to a lipid conjugation and represents a 
specific association of mCherry-PfATG8 with vesicular membranes rather than 
the non-selective packaging of the fusion protein into these vesicles. 
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Figure 5.23: Effect of apicoplast loss on mCherry-PfATG8∆G expression and localisation. 
Late stage parasites transfected with EP-mC-A8∆G were treated with 50 µM chloramphenicol 
or ethanol (Control) for 96 h and 200 µM IPP for the final 48 h prior to enrichment by 
magnetic isolation and analysis by live cell fluorescence light microscopy. Treatments were 
performed twice with 792 (Chloramphenicol and IPP) and 842 (Control) cells being counted. 
Numbers indicate percentage of cells counted scored into each category ± S.D.  
 
5.2.6 Characterisation of apicoplast-targeted vesicles 
Chemical disruption of the apicoplast leads to the accumulation of apicoplast-
targeted vesicles containing proteins such as ACP-GFP (Yeh and DeRisi, 2011) and 
now reported here, aE3-GFP. The observation that mCherry-PfATG8 appears to 
label these vesicles indicated that they display a characteristic of 
autophagosomes. In order to determine whether aE3-GFP-positive apicoplast-
targeted vesicles displayed additional characteristics of autophagosomes in other 
organisms, IFA analyses were performed using antibodies against PfRab7. Rab7, a 
member of the large family of Rab GTPases (Chua et al., 2011) is recruited to 
mature autophagosomes and facilitates fusion with endolysosomal vesicles prior 
to autophagolysosome formation (Gutierrez et al., 2004). Parasites expressing 
aE3-GFP were subjected to chloramphenicol treatment and IPP rescue as above 
and were prepared for IFA using antibodies against PfRab7 to detect the 
endogenous protein (Figure 5.24). In untreated control parasites, the intact 
apicoplast is reported by aE3-GFP. In these parasites, PfRab7 localised to 
punctuate structures representing endolysosomal vesicles (Personal 
communication with Dr. Gordon Langsley). The degree of correlation as 
demonstrated by the Pearson’s coefficient between aE3-GFP and PfRab7 was low 
in all parasites analysed (0.23 ± 0.07 (S.D. n = 3)), indicating that PfRab7 did not 
label the intact apicoplast. In treated parasites in which the intact apicoplast 
was absent, the correlation between aE3-GFP-positive vesicles and PfRab7-
labelled endolysosomes was also low, 0.29 ± 0.04 (S.D. n = 3), indicating that 
apicoplast-targeted vesicles are not labelled by PfRab7. This finding suggests 
that apicoplast-targeted vesicles do not show additional characteristics of 
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autophagsomes, other than being labelled by mCherry-PfATG8, providing further 
evidence that they participate in an anabolic rather than catabolic process.  
 
Figure 5.24: Analysis of colocalisation between apicoplast-targeted vesicles and PfRab7 
Late stage parasites transfected with aE3-GFP-pHH2 were treated with 50 µM 
chloramphenicol or ethanol (Control) for 96 h and 200 µM IPP for the final 48 h prior to 
analysis by IFA with rat anti-PfRab7 peptide antibodies (1:300) and anti-rat Alexa Fluor 594-
conjugated polyclonal antibodies (1:3,000). Representative images of schizont stage 
parasites are shown. Scale bar = 2 µm. 
 
The same treatment was also performed on D10 wild type P. falciparum in order 
to assess the localisation of endogenous PfATG8 and PfRab7 in the same cells. An 
IFA using peptide antibodies against PfATG8 (not those detailed in Chapter 3) 
and PfRab7 revealed that as expected, in untreated parasites PfATG8 and 
PfRab7 labelled distinct structures – PfATG8 labelled a structure resembling the 
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intact apicoplast while PfRab7 labelled multiple puncta (as above) believed to 
represent endolysosomal vesicles (Figure 5.25). In treated parasites, in which 
the characteristic PfATG8-labelling of the intact apicoplast was replaced by the 
labelling of multiple vesicles (as observed in lines expressing mCherry-PfATG8), 
the degree of colocalisation between PfATG8 and PfRab7 was not notably 
increased in comparison to untreated parasites (untreated: r = 0.39 ± 0.07 (S.D. 
n = 2), treated: r = 0.33 ± 0.05 (S.D. n = 2)). This showed that the redistribution 
of mCherry-PfATG8 from the intact apicoplast in untreated parasites to 
apicoplast-targeted vesicles in treated parasites was representative of the same 
redistribution of the endogenous PfATG8 protein. It also supported previous 
findings that PfATG8-labelled apicoplast-targeted vesicles are not also labelled 
by PfRab7, indicating that they do not show additional characteristics of 
canonical autophagosomes. 
 
Figure 5.25: Analysis of colocalisation between PfATG8 and PfRab7 
Late stage D10 P.falciparum were treated with 50 µM chloramphenicol or ethanol (Control) 
for 96 h and 200 µM IPP for the final 48 h prior to analysis by IFA with rat anti-PfRab7 
peptide antibodies (1:300), guinea pig anti-PfATG8 peptide antibodies (1:3,000), anti-rat 
Alexa Fluor 594-conjugated polyclonal antibodies (1:3,000) and anti-guinea pig Alexa Fluor 
488-conjugated polyclonal antibodies (1:6,000). Representative images of schizont stage 
parasites are shown. Scale bar = 2 µm. 
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5.3  Discussion 
5.3.1 Characterisation of mCherry-PfATG8 
This chapter has detailed the use of tools to study the localisation of both 
endogenous PfATG8 and mCherry-PfATG8(/PfATG8ΔG) in wild type or transgenic 
parasites, respectively. The use of the Gateway cloning platform provided an 
excellent tool with which to generate a number of constructs for transfection, 
with minimal cloning steps. Transfection of P. falciparum 3D7 and D10 strains 
yielded parasite lines resistant to WR99210 or BLA in over 90 % of occasions. 
mCherry or eYFP-tagged fusion proteins were seen to be expressed in all the 
lines generated, although it appeared that the maintenance of expression of the 
fusion proteins was limited to ~ 4 weeks after thawing a stabilate, after which 
point the proportion of parasites seen to express a delectable level of the fusion 
protein decreased. These effects may stem from the recombination events 
between the EP-mC-A8 construct and the parasite genome as disscussed in 
Chapter 4. Nevertheless, these transgenic lines proved to be an invaluable tool 
in the characterisation of PfATG8.   
This study solely focussed on the use of N-terminal fluorescent tagging of PfATG8 
in order to use the fusion protein as a marker for autophagic structures. The use 
of a C-terminal tag is certainly one that should be explored in P. falciparum. 
Due to the protein being expressed in a conjugation-competent (PfATG8-I) form, 
the initial role of PfATG4 in the cleavage of residues 3’ of the essential glycine is 
bypassed (Tanida et al., 2004). However, the necessity of processing to 
deconjugate PfATG8-II, recycling it back to the conjugation-competent form has 
yet to be explored. Expression of an N-terminal and C-terminally-tagged PfATG8 
in intraerythrocytic stage parasites could highlight potential C-terminal 
processing. Cleavage of the C-terminal tag could indicate the ability of PfATG4 
or an ATG4-like peptidase to process the C-terminus of PfATG8, potentially 
indicating that delipidation of PfATG8 is also performed. Certainly, the 
conservation of residues in PfATG8 shown to be responsible for recognition by 
ATG4 in other organisms (Amar et al., 2006) and the identification of a putative 
PfATG4 homologue in the genome of P. falciparum 3D7 strain, suggests that this 
type of processing might occur. An absence of C-terminal processing of PfATG8 
in P. falciparum could indicate a variation in the typical role of PfATG8. As an 
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autophagosome forms it engulfs ATG8 conjugated to PE in its inner leaflet. This 
ATG8 is trapped and destined for degradation along with autophagosome cargo 
by lysosomal peptidases. ATG8 conjugated to PE on the outer surface of an 
autophagosome has been suggested to require removal before endolysosomal 
fusion can occur (Kabeya et al., 2004). If C-terminal processing of PfATG8 was 
absent, this may suggest that lipidation of PfATG8 was permanent. Expression of 
recombinant PfATG4 and incubation with protein extracted from parasites 
expressing mCherry-PfATG8 could provide additional evidence for de-lipidation 
of PfATG8, as a reduction in lipidated mCherry-PfATG8, similar to that seen 
following phospholipase D incubation, would indicate a PfATG8 processing 
activity for PfATG4 (Williams et al., 2009).  
Based on comparison between localisation of the two proteins, it seemed that 
mCherry-PfATG8 was a suitable tool with which to explore the function of 
endogenous PfATG8, as has been reported for the use of similar fusion proteins 
in other organisms (Pankiv et al., 2007, Perry et al., 2009). The observation of a 
more fragemented appearance of PfATG8-labelled structures in IFA analysis 
using PfATG8-specific antisera (or latterly peptide antibodies) was attributed to 
partial disruption of subcellular integrity, as demonstrated by the often 
fragmented appearance of the apicoplast and mitochondrion following fixation 
and permeabilisation in IFA preparation. For flexability and ease of use, 
mCherry-PfATG8 expressing parasites were used in the analysis of PfATG8 
localisation but, when applicable and possible, analysis of endogenous PfATG8 
localisation was also performed.  
After establishing that mCherry-PfATG8 exhibited a localisation similar to that of 
the endogenous PfATG8 protein, the next step was to use this tool to elucidate 
the potential function of PfATG8 in intraerythrocytic parasites. Detailed analysis 
of the localisation of mCherry-PfATG8 revealed that this protein did not appear 
to label canonical autophagosome-like puncta under normal growth conditions. 
Instead, the protein localised to distinctive subcellular structures that appeared 
to elongate and divide during the intraerythrocytic development of the parasite. 
Time-lapse microscopy of single parasites over the course of their 
intraerythrocytic development was not attempted as part of this study (Gruring 
et al., 2011). It would certainly have been interesting to track the temporal 
development of the mCherry-PfATG8-labelled structures. From the extensive 
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analysis performed, it could be concluded that in parasites expressing mCherry-
PfATG8, the labelling of this structure appeared not to be transient as labelling 
of the structure at all intraerythrocytic stages was observed.  
The presence of mCherry-PfATG8-labelled structures and the absence of any 
canonical autophagosome-like puncta begged the question as to whether the 
structures observed represented a novel type of autophagosome-like structure in 
P. falciparum. Autophagy is known to be used in the response to environmental 
and intracellular stress, as a mechanism to deal with nutrient starvation and 
during the process of cellular differentiation (Duszenko et al., 2011). Even under 
conditions of unhindered growth, a dependency on a basal level of autophagy 
has been shown (Pattison et al., 2011). Inside a host erythrocyte, the developing 
parasite is relatively well protected from stress and can generate the energy and 
nutrients it needs for growth from glycolysis and acquirement pathways, 
respectively (Baumeister et al., 2010). However, as the parasite proceeds 
through multiple asexual cycles of development, it must undergo vast and 
successive morphological changes. Remodelling of the cell’s architecture, 
metabolism and biochemistry requires huge turnover of proteins. Indeed, during 
the asexual cycle, each parasite must not only develop from ring, to trophozoite 
to schizont forms, expanding as it does so but crucially it must generate multiple 
invasive merozoites. This requires the generation of a number of invasive 
organelles de novo. Once a merozoite has invaded a new erythrocyte, it must 
then return itself to a form in which it can develop within the erythrocyte, using 
haemoglobin as its primary nutrient source. This led to the hypothesis that 
autophagy might play less of a role in stress response, instead contributing more 
to differentiation. It would seem logical that as the parasite converts between 
life cycle stages, it would do so with the minimum of waste by activating 
autophagy to facilitate the reuse of amino acids and other cellular components 
that were needed during a precise stage in development but are no longer 
required during the next. The identification of a large, constitutive structure 
labelled by mCherry-PfATG8 suggested that the potential requirement for an 
autophagic process during cellular differentiation had resulted in a variation on 
the typical autophagic process in P. falciparum. The experiments that followed 
were intended to determine whether mCherry-PfATG8, or the structure which it 
labelled, showed any characteristics of an involvement in an autophagic process. 
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5.3.2 Effect of autophagy regulators on mCherry-PfATG8 
Through the use of compounds known to inhibit or activate autophagy in other 
organisms, attempts were made to influence the expression, lipidation or 
localisation of mCherry-PfATG8. Firstly, wortmannin was used in order to 
determine what effect the inhibition of PfPI3K might have on mCherry-PfATG8. 
It was predicted that, if the labelling of subcellular structures by mCherry-
PfATG8 was PI3K-dependant, as is the labelling of autophagosomes by ATG8 
homologues in other organisms (Fujita et al., 2008), then a decrease in mCherry-
PfATG8 labelling may have been expected. The treatments performed did not 
have any effect on either the expression of mCherry-PfATG8, or its lipidation 
and localisation to subcellular structures. This suggested that the labelling of 
subcellular structures by mCherry-PfATG8 is not dependent on PfPI3K activity. 
This suggests that one of the upstream events known to promote ATG8 lipidation 
in other organisms does not play a role in the lipidation and localisation of 
PfATG8. Parasites expressing mCherry-PfATG8 were also treated with rapamycin 
and bafilomycin A1. These two compounds have the effect of increasing the 
number of autophagosomes in other organisms (Chang et al., 2009, Spencer et 
al., 2009). Rapamycin inhibits mTOR, which itself is an inhibitor of autophagy 
initiation (Raught et al., 2001). Therefore rapamycin causes an increase in 
autophagosome formation, mimicking the triggering of autophagy by 
environmental or intracellular stresses. Bafilomycin A1 causes an increase in 
autophagosomes, not by influencing the initiation of autophagy but by 
preventing the turnover of autophagosomes that have already formed. 
Treatments were performed with these compounds in order to determine 
whether mCherry-PfATG8 could be seen to label canonical punctate 
autophagosomes, when induced to do so, or to determine what the effect on the 
mCherry-PfATG8 labelling of subcellular structures might be. Again, no effect on 
either mCherry-PfATG8 expression or its lipidation and localisation was seen. 
This suggested that either canonical punctate autophagosomes can not be 
induced by these treatments or that they are not labelled by mCherry-PfATG8. It 
also showed that the labelling of subcellular structures was not altered by either 
of these compounds. Together these results suggested that the subcellular 
structures labelled by mCherry-PfATG8 appear to be distinct from canonical 
autophagic process.  
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These three treatments are commonly used in the study of autophagy in other 
organisms (Chang et al., 2009, Klionsky et al., 2008, Ponpuak et al., 2009). 
However, any effect of these compounds on PfATG8 in P. falciparum would rely 
not only on the involvement of PfATG8 in an autophagic process but also the 
presence and conservation of their targets in an autophagic process. This study 
involved some of the first work to determine whether PfPI3K, TOR or V-type 
H+ATPase play any role in an autophagic process in Plasmodium spp. Data 
collected suggest that these three regulators do not contribute to an autophagic 
process characterised by effects on mCherry-PfATG8 expression, lipidation and 
localisation. However, these treatments may need to be optimised further to 
exclude the possibility that they are involved in an autophagic process.  
From what is known about PfPI3K, TOR and V-type H+ATPase in P. falciparum, it 
might be predicted that their potential involvement in an autophagic process 
may not be as straight forward as it appears to be in a number of other 
organisms. PfPI3K has been shown to be excreted into the host erythrocyte, as 
well as being indicated in the endocytosis of host cell haemoglobin and its 
transport to the digestive vacuole (Vaid et al., 2010). The product of PfPI3K, 
PI3P, has been reported in the membranes of the digestive vacuole, apicoplast 
and seemingly non-endocytic, single membraned vesicles (Tawk et al., 2010). 
Together, these findings indicate roles for PfPI3K in multiple membrane-
facilitated transport processes. In light of this, inhibition of PfPI3K using 
wortmannin is likely to have a number of effects in addition to inhibiting a 
potential autophagic process. Experiments to test additional PI3K inhibitors, 
such as LY294002 or 3-methyladenine could provide further insight into the 
involvement of PI3K in the regulation of mCherry-PfATG8 lipidation. While 
rapamycin has been shown to have anti-malarial properties, it’s supposed target 
has yet to be identified (Monaghan and Bell, 2005). The P. falciparum genome 
does not encode a protein homologous to TOR. The gene identified as having the 
highest P-value in the bioinformatic screen performed in this study was  
PFE0765w, which has since been characterised as PfPI3K (Vaid et al., 2010). 
Either a TOR kinase of sufficient divergence to escape identification through 
bioinformatic screening is expressed in P. falciparum blood stages, or rapamycin 
causes death through either an alternative or non-specific mechanism. The IC50 
value of rapamycin has been shown to be in the low µM range (unpublished data 
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from this lab and (Bell et al., 1994)). The treatment performed in this study was 
intended to be a dose equivalent to 5 x IC50 but for a brief time period, in an 
attempt to limit off target effects. It could prove valuable to analyse the effects 
of additional concentrations of rapamycin on mCherry-PfATG8 expression, 
lipidation and localisation. The intended target of bafilomycin A1, a V-type 
H+ATPase, has been identified and characterised in P. falciparum blood stages 
(Marchesini et al., 2005). It has been shown to be localised to the membrane of 
the digestive vacuole suggesting a role in the acidification of this lytic 
compartment but has also been seen to localise to the plasma membranes of the 
parasite and the host erythrocyte along with membranous structures within the 
host erythrocyte, suggesting more universal roles in electrochemical balance 
(Beyenbach and Wieczorek, 2006). Allen and Kirk showed that a 30 min 
treatment of both isolated FAF6 and D10 parasites and infected erythrocytes 
with 100 nM bafilomycin A1 was sufficient to cause a partial depolarisation of 
parasite membrane potential (Allen and Kirk, 2004). This was therefore 
considered an appropriate experimental procedure to probe for any effect of V-
type H+ATPase inhibition on the expression and localisation of mCherry-PfATG8. 
If autophagosomes were generated in intraerythrocytic stage P. falciparum 
parasites, it would seem likely that their target would be the only lytic 
compartment described in these stages, the digestive vacuole (Dluzewski et al., 
2008). Prevention of the acidification of the digestive vacuole could therefore 
result in an accumulation of autophagosomes. However, in light of the multiple 
locations and therefore likely roles of the V-type H+ATPase in addition to the 
acidification of the digestive vacuole, the effect of bafilomycin A1 is unlikely to 
be restricted to the digestive vacuole.  
5.3.3 Effect of environmental triggers of autophagy on mCherry-
PfATG8 
In addition to the intended compound-based manipulation of autophagy 
regulation, adjusting environmental conditions was also used as a mechanism 
predicted to trigger autophagy. Amino acid starvation is generally regarded as 
the gold standard for autophagy induction (Ni et al., 2011). While triggering 
autophagy through manipulation of the nutrient sensing pathways with 
rapamycin is commonly used in the study of autophagy, it is known that amino 
acid starvation results in a more pronounced autophagic upregulation, at least in 
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mammalian cells, suggesting that other signalling pathways are also triggered 
(personal communication with Dr. Patrice Codongo). Therefore, it was predicted 
that while the use of rapamycin had shown to have no effect on mCherry-PfATG8 
expression, lipidation or localisation, which may have been the result of 
divergency in the pathways responsible for nutrient sensing, amino acid 
starvation upstream of any cellular response could provide a trigger to a 
potential autophagic process. 
Unlike in yeast and mammalian cells, where removal of the exogenous supply of 
amino acids has a starvation effect, due to the fact that intraerythrocytic P. 
falciparum parasites acquire most of the nutrients they need through 
haemoglobin digestion, a different approach is needed in order to starve them of 
amino acids (Liu et al., 2006). Experiments performed here, with incubation in 
amino acid-limited medium and pepstatin A or E64 treatment were intended to 
make parasites more reliant on haemoglobin digestion, by limiting the exogenous 
supply of amino acids, before blocking this process by inhibition of proteolysis.  
It was initially reported that supplementation of culture medium with cysteine, 
glutamate, glutamine, isoleucine, methionine, proline, and tyrosine was 
necessary for continuous culture of P. falciparum (Divo et al., 1985). Goldberg 
and co-workers later reported that parasites cultured in medium supplemented 
with only methionine, cysteine, isoleucine, glutamine and glutamate grew 
normally but were more sensitive to an aspartic peptidase inhibitor than the 
same parasites grown in complete medium (Francis et al., 1994). This indicated 
that growth in limited medium placed parasites in a state where they relied 
more heavily on haemoglobin degradation than when supplied with an exogenous 
source of 20 amino acids in complete medium. Later work from Goldberg and co-
workers showed that the doubling time of 3D7 parasites when grown in limited 
medium for 56 h was approximately 50 % longer than when grown in complete 
medium (Liu et al., 2005). This was shown to be a result of a decrease in 
multiplicity rate rather than an increase in developmental time suggesting a lack 
of material from which to generate daughter merozoites. They also reported IC50 
values of 7.5 ± 0.5 μM and 1.1 ± 0.02 μM for pepstatin A and E64, respectively, 
for 3D7 parasites grown in complete medium for 72 h. Goldberg and co-workers 
then expanded experiments using limited medium further (Liu et al., 2006). 
They showed that it was in fact only isoleucine for which P. falciparum was 
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auxotropic. They showed that supplementation of medium with 147.5 µM 
isoleucine as the only amino acid allowed parasites to grow within 86 % of those 
grown in complete medium over 51 h and that these parasites were viable in 
culture for over 2 months provided isoleucine was present in the culture 
medium. They also reported IC50 values of 60 µM and 4.4 µM for pepstatin A and 
E64, respectively, for 3D7 parasites grown in complete medium for 62 h. The 
large difference in the IC50 reported for pepstatin A when compared to that 
previously reported was attributed to contamination of the older stock of 
pepstatin A. They also showed that these IC50 values were lower in parasites that 
were grown in isoleucine-supplemented medium, dropping to 31 µM and 2.8 µM, 
respectively. Sharma and co-workers then showed that treatment of 3D7 
parasites grown in complete medium with 30 µM pepstatin A resulted in a ~ 5 % 
growth defect (Vaid et al., 2010). However, when the same parasites were 
grown in isoleucine-supplemented medium for 96 h prior to treatment with 
pepstatin A the growth defect observed over 6 days was as great as ~ 80 %. 
Taken together, these data show that limiting the availability of exogenous 
amino acids makes parasites more reliant on haemoglobin degradation in order 
to acquire necessary nutrients. This therefore increases the susceptibility of 
these parasites to inhibition of haemoglobin degradation. Certainly, the 
expansion and maintenance of a large repertoire of haemoglobin-degrading 
peptidases in P. falciparum along with evidence collected from genetic 
knockouts of key peptidases (Liu et al., 2006) indicates that haemoglobin 
breakdown is important for parasite growth. These data strongly suggest that 
haemoglobin degradation plays a role in nutrient acquisition, possibly along with 
other hypotheses based on the requirement to generate space for development 
and the maintenance of osmotic stability (Dalal and Klemba, 2007). 
Experiments using pepstatin A and E64 treatment on parasites expressing 
mCherry-PfATG8 were designed with these data in mind. They appeared to show 
that amino acid starvation has no effect on mCherry-PfATG8 expression, 
lipidation or localisation. This may not be too surprising as parasites residing 
within host erythrocytes would be unlikely to be exposed to an environment of 
limited amino acid availability for extended periods of time. While it has been 
shown that isoleucine levels in the circulation of malnourished individuals in 
malaria endemic areas can drop as low as 10 µM (Baertl et al., 1974) (complete 
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culture medium contains 381 µM), the impact of this on parasite growth remains 
largely unexplored. It is therefore questionable whether an artificially created 
amino acid starvation environment in culture of P. falciparum, would represent 
what the parasite might experience in vivo. The necessity of a potential role of 
autophagy and PfATG8 in amino acid starvation-induced turnover of cellular 
material is therefore uncertain. It is possible that the parasite has lost the 
ability to up-regulate autophagy in response to amino acid starvation in blood 
stage parasites. It is known that Plasmodium parasites have a limited ability to 
regulate transcription in response to amino acid availability. They lack a 
canonical TOR homologue (Brennand et al., 2011) and lack the transcription 
factors and amino acid synthesis pathways that act downstream of eIF2α kinase 
signalling. While an orthologue of yeast GCN2, an eIF2α kinase responsible for 
amino acid sensing has been identified and been found to be expressed in blood 
stage parasites (Fennell et al., 2009), it has been shown not to be essential. 
While strong data sets were generated, experiment design proved difficult and a 
number of factors may have influenced the potency of the treatments 
performed. Firstly, a 6 h incubation of parasites in limited medium may not have 
been long enough to place a substantial need for haemoglobin degradation as 
the sole source of most amino acids. Cultures were transferred to limited 
medium when parasites were predominantly trophozoites, as these stages are 
known to be the most metabolically active (Francis et al., 1997) but longer 
periods of growth in limited or isoleucine-supplemented medium should be 
performed in future before addition of pepstatin A or E64. Secondly, due to the 
discrepancies in reported IC50 values for pepstatin A and the fact that the 
parental line of mCherry-PfATG8 expressing parasites is D10 rather than 3D7, it 
would certainly be wise to perform IC50 experiments in D10 with the same drug 
stocks used for treatments of mCherry-PfATG8 expressing parasites. These 
experiments were designed to give parasites a short exposure to ~ 10 x IC50 
concentrations of pepstatin A and E64. However, without determining the IC50 
value in D10 parasites it is unknown how a treatment with 75 µM  pepstatin A or 
28 µM E64 might relate to their IC50 values. A longer (overnight) incubation was 
performed with 75 µM pepstatin A on parasites expressing mCherry-PfATG8 and 
appeared to have resulted in a complete block of growth, suggesting that this 
concentration of pepstatin A was at least enough to have a profound effect on 
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parasite growth over this period. Once a robust experiment design was 
determined there would be a need for repeated executions bearing in mind the 
degree of variation observed in other experiments. More standardised assays for 
amino acid starvation of P. falciparum intraerythrocytic stages are beginning to 
be established (Istvan et al., 2011). Further experimentation making use of 
these recent developments in our understanding of parasite nutritional needs 
could provide valuable information of the effect of amino acid starvation on the 
expression and localisation of mCherry-PfATG8.  
Experiments intended to starve parasites of glucose were of a simpler design 
than those probing amino acid starvation. Removal of complete culture medium 
and incubation in EBSS instantly removes the exogenous source of glucose and 
amino acids and parasites quickly die, identified by a rounded and shrunken 
appearance under microscopy and a visible lack of digestive vacuole activity in 
late stage parasites. Therefore, experiments were designed to image parasites 
after just 30 min starvation to ensure that the majority of parasites were still 
alive at the time of image collection. Again, there was no change in mCherry-
PfATG8 expression, localisation or lipidation, leading to the conclusion that 
glucose starvation does not influence these processes. Energy sensing in the 
parasite is poorly understood. P. falciparum possesses upstream components of 
energy sensing - two adenylate kinases and a GTP:AMP phosphotransferase 
(Rahlfs et al., 2009) and downstream components – an SNF1-type kinase (Bracchi 
et al., 1996) and a putative AMPK (Talevich et al., 2011). Quite how these 
components integrate into an energy sensing mechanism is not clear. It is 
possible that the adaptation to its specialised niche has disrupted the connection 
between energy sensing and an autophagic response in P. falciparum.  
A hindering factor to all treatment experiments performed was the variability in 
the proportion of parasites expressing visible amounts of mCherry-PfATG8. This 
likely stems from the variable copy number and transcriptional regulation of 
episomally maintained plasmids combined with the integration of the plasmid as 
seen in Chapter 4 (Kong et al., 2009). As this is a common problem, additional 
methods for transgene expression have been developed and might be worthwhile 
to explore for PfATG8 fusion protein expression.  
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A novel centromeric sequence-based construct has recently been generated that 
facilitates expression of a transgene from a singly maintained episomal plasmid 
(Iwanaga et al., 2012). Inclusion of A/T rich centromeric sequences in the 
construct PfCEN, promotes efficient segregation, stable maintenance, and low 
copy number via interaction with the kinetochore, the protein:DNA complex 
formed during chromosome segregation (Maiato et al., 2004). While a low copy 
number may limit efforts to over-express a transgene by using a heterologous 
promoter, this could be used in an attempt to mimic expression of an 
endogenous protein from its genomic locus. If this construct was used to stably 
express mCherry-PfATG8 under control of the endogenous Pfatg8 promoter 
region, it would be predicted that expression levels could closely mimic that of 
the endogenous protein.  
As discussed in Chapter 4.3.2, targeted insertion of plasmid elements driving 
expression of fusion proteins into a specific locus using attP and attB sites and 
expression of Bxb1 integrase, can lead to the maintenance of expression of the 
fusion protein, whilst reducing the episomal plasmid copy number (Adjalley et 
al., 2010). The G/C rich nature of the attB sites means that integration is 
unlikely to occur elsewhere in the genome (Nkrumah et al., 2006). This system 
has been used to generate parasite lines with improved proportions of individual 
parasites expressing a fluorescently tagged protein of interest, in relation to 
parasite populations maintaining episomal expression constructs (Adjalley et al., 
2010). A more homogeneous parasite population could allow for greater 
reproducibility between experiments as the variation deriving from plasmid copy 
number and transgene phenotype variability are eliminated. These systems could 
be used to supplement and build upon the analysis of PfATG8 through expression 
of mCherry-PfATG8 presented here. 
From these, and the preceding experiments, designed to explore commonly used 
methods to manipulate autophagy in other organisms that might trigger a 
response in parasites characterised by a change in mCherry-PfATG8 expression, 
lipidation or localisation, it was concluded that mCherry-PfATG8 appears not to 
be involved in an autophagic process. It appeared instead that mCherry-PfATG8 
is lipidated and associates to a subcellular structure constitutively, regardless of 
how autophagy control mechanisms are influenced. It remained to be 
determined what the structure labelled by mCherry-PfATG8 was. If this structure 
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was not involved in an autophagic process, why did mCherry-PfATG8 associate 
with it? In order to characterise the mCherry-PfATG8-labelled structure, a series 
of microscopy-based experiments were designed and performed. 
5.3.4 Characterisation of mCherry-PfATG8-labelled structures 
Thorough microscopic analysis was performed in order to determine the 
localisation of mCherry-PfATG8 and PfATG8 within the parasite’s subcellular 
architecture. Through the use of LysoTracker and LysoSensor dyes in wild type P. 
falciparum, or parasites expressing mCherry-PfATG8 it was found that mCherry-
PfATG8-labelled structures were unlikely to be acidified. Of interest was the 
complexity of the architecture of intraerythrocytic parasites, as shown by the 
staining observed using LysoSensor 153. While there did appear to be some 
degree of overlap between the structures stained using LysoSensor 153 and 
mCherry-PfATG8-labelled structures, unfortunately the use of a manually 
operated epifluorescent microscope rather than an automated deconvolving 
microscope capable of collecting Z-stacks, meant that quantification of the 
degree of correlation was not possible in the analysis of these treatments.  
Canonical autophagosomes become acidified in order for their contents to be 
degraded by proteolytic enzymes. This usually occurs as a result of fusion with 
the lytic compartment (Kawai et al., 2007). Identifying a potential acidification 
of mCherry-PfATG8-labelled structures may have indicated a role in an 
autophagy-like process, however, the use of LysoSensor probes proved too 
limited to properly characterise potential acidification. Modifying the incubation 
conditions of LysoSensor in an attempt to reduce background staining were 
unsuccessful and highlighted a potential limitation of this probe in specifically 
labelling subcellular compartments within intraerythrocytic parasites. There is 
also some controversy surrounding analysis of intracellular pH in live parasites by 
fluorescence light microscopy due to the changes in the parasite that occur as a 
result to light exposure (Wissing et al., 2002).  
The appearance of the mCherry-PfATG8-labelled structures had initially been 
remarked to be reminiscent of the mitochondrion and apicoplast (van Dooren et 
al., 2005). In the absence of any evidence to support the notion that these 
structures represented a novel autophagic structure, it seemed likely that 
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mCherry-PfATG8 may in fact be associated with either of these organelles. 
Indeed, in T. gondii, TgATG8 has been shown to play a role in mitochondrial 
homeostasis (Besteiro et al., 2011) and in yeast it has been shown that 
mitochondria participate in autophagy by providing lipids for autophagosome 
formation via ATG9 shuttling (Reggiori et al., 2005). Of note was the observation 
that The transcriptional profiles exhibited by PfATG8 and PfATG4 bear 
similarities to that of many apicoplast or mitochondrion-targeted proteins 
(Bozdech et al., 2003) and such features have been used to identify apicoplast-
targeted nuclear-encoded proteins in T. gondii (Sheiner et al., 2011). 
Analysis of mCherry-PfATG8 and PfATG8-labelled structures in relation to the 
mitochondrion clearly showed that there was no colocalisation between these 
two structures. This was in starck contrast to TgATG8 in T. gondii. T. gondii is 
often used as a model organism for Plasmodium spp.. This work identifies clear 
differences between T. gondii and P. falciparum in the role of their respective 
ATG8 homologues. The fact that PfATG8 and TgATG8 share 83.1 % similarity in 
their amino acid sequences but appear to be involved in very different processes 
in the two organisms demonstrates that while T. gondii can act as a usefull tool 
in the study of Apicomplexans as a whole, care must be taken in translating 
findings in T. gondii to Plasmodium spp.. 
The absence of colocalisation with the mitochondrion left the apicoplast as the 
likely candidate for the structure labelled by mCherry-PfATG8. Through IFA using 
antisera raised against His-PfATG8 and co-expression of mCherry-PfATG8 in an 
aE3-GFP apicoplast reporter parasite line, it was shown that there was a close 
association between the mCherry-PfATG8-labelled structure and the apicoplast. 
From images collected it appeared that mCherry-PfATG8 may label the outer 
membrane (or membranes) of the apicoplast while aE3-GFP resides in the lumen. 
Analysis of mCherry-PfATG8 or PfATG8 localisation by immunoelectron 
microscopy would be needed to provide further evidence of this. 
A set of experiments were then performed that involved the chemical removal 
of the apicoplast via chloramphenicol treatment. The apicoplast does not 
develop in treated parasites and when daughter merozoites form, they do not 
inherit an apicoplast (Yeh and DeRisi, 2011). The lethality of this outcome is 
countered by the supplementation with an exogenous source of IPP. These 
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experiments showed that not only does mCherry-PfATG8 label the intact 
apicoplast but that it also associates to vesicles containing apicoplast-targeted 
protein. These vesicles have been suggested to be formed following budding 
from the ER but in the absence of an intact apicoplast, they do not have a target 
membrane with which to fuse in order to deliver their contents (Personal 
communication with Dr. Ellen Yeh). The fact that mCherry-PfATG8 associates 
with these vesicles suggests that it may play a role in the trafficking of 
apicoplast material from the ER to the apicoplast. The material being trafficked 
could be protein and or lipids. 
The use of a Delta Vision Core deconvolving microscope facilitated quantification 
of correlation between mCherry-PfATG8 and aE3-GFP. The Pearson’s Coefficient 
was calculated from Z stacks of whole parasites or individual vesicles using 
SoftWoRx. This algorithm calculates the degree of overlap between signals from 
two channels in each pixel in 3 dimensions and returns a coefficient between 
1.0, indicating total colocalisation and -1.0, indicating an inverse relationship 
(Adler and Parmryd, 2010).  
Analysis of the correlation between mCherry-PfATG8 and aE3-GFP showed that 
there was a strong correlation with a coefficient of 0.69 ± 0.07 (S.D. n = 25). This 
was significantly different from the coefficient representing the background i.e. 
comparing the correlation between mCherry-PfATG8 and Hoechst 33258 (r = 0.21 
± 0.06 (S.D. n = 28)) (unpaired t-test, P = < 0.0001), and showed that there was 
a large degree of overlap between mCherry-PfATG8 and aE3-GFP, but that there 
was not a complete colocalisation. This supported the subjective observations 
performed by eye. Quantification of the correlation between mCherry-PfATG8 
and GFP-aE3 also allowed for comparison between untreated parasites and 
parasites in which the apicoplast had been chemically ablated via 
chloramphenicol treatment. The coefficient of correlation between mCherry-
PfATG8 and aE3-GFP in entire parasites after chloramphenicol treatment was 
0.69 ± 0.07 (S.D. n = 28), indicating that the degree of correlation was 
unaffected by disruption of the apicoplast. The degree of correlation between 
mCherry-PfATG8 and aE3-GFP in chloramphenicol treated and IPP rescued cells 
was also analysed per individual vesicle. Twenty six vesicles were analysed and 
an average Pearson’s coefficient of 0.65 ± 0.06 (S.D. n = 26) was recorded. While 
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this was found to be marginally significantly different to that derived from 
analysis of whole parasites (unpaired t test, P = 0.0290) it was concluded that 
analysis of the entire parasites was a more reliable method for comparing values 
against untreated parasites.  
Unfortunately, as SoftWoRx software does not generate values representing 
correlation between the two channels separately, the ratio of singly-labelled 
vesicles to vesicles apparently positive for aE3-GFP and also labelled with 
mCherry-PfATG8 could not be ascertained. Subjective analysis by eye suggests 
that while the majority of vesicles were positive for both mCherry-PfATG8 and 
aE3-GFP, populations of vesicles only positive for mCherry-PfATG8 or aE3-GFP 
were also present. This could suggest that the labelling of aE3-GFP-positive 
vesicles by mCherry-PfATG8 is transient and, as not all mCherry-PfATG8-positive 
vesicles are also positive for aE3-GFP, these vesicles contain different cargo 
destined for the absent apicoplast. The use of dedicated analytical software 
such as Volocity 3D Image Analysis (Perkin Elmer) could enable more detailed 
analysis of the relationship between mCherry-PfATG8 and aE3-GFP in untreated 
and chloramphenicol treated parasites (Barlow et al., 2010).  
5.3.5 Interpreting the relationship between mCherry-PfATG8 and 
the apicoplast 
Association of PfATG8 to the apicoplast throughout the development of the 
organelle suggests that it may have a role in the processes responsible for its 
expansion, segmentation and inheritance into daughter merozoites. Quite how 
PfATG8 contributes to these processes is worthy of further exploration as the 
apicoplast and the functions it performs are valid drug targets (Fichera and 
Roos, 1997, Wiesner et al., 2008). Further elucidation of the role of PfATG8 in 
apicoplast homeostasis may expose further approaches to target Plasmodium 
parasites in the symptomatic intraerythrocytic stages of their life cycle. In 
consideration of the attempts to genetically ablate Pfatg8 presented in Chapter 
4, it now appears that PfATG8 could potentially play an essential role apicoplast 
homeostasis. If this were the case then It might be expected that knockout of 
Pfatg8 in wild type parasites might only be achieved if IPP was supplied to 
parasites exogenously as this has been shown to facilitate chemical ablation of 
the apicoplast (Yeh and DeRisi, 2011).  
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It has been reported that ATG8 homologues can be ‘incorrectly’ associated with 
the lipids of non-autophagosomal membranes, and only via the activity of ATG4 
is lipidation-competent ATG8-I released into the cytosol ready for 
autophagosome biogenesis (Nakatogawa et al., 2012a). This could possibly 
explain the labelling of the apicoplast by mCherry-PfATG8 but the specificity of 
apicoplast labelling and the fact that mCherry-PfATG8 does not appear to be 
released from the apicoplast following any treatment intended to induce 
autophagy, suggest that this is not the case. ‘Chlorophagy’ in plant leaves in 
response to carbon starvation has been reported in A. thaliana (Izumi et al., 
2010). In this case, the Rubisco-rich stroma of chloroplasts is selectively 
targeted for degradation in the food vacuole by a subset of autophagosomes 
called Rubisco-containing bodies. Again, this more canonical form of autophagic 
degradation does not appear to explain the localisation of PfATG8 to the 
apicoplast membrane(s). No autophagosome formation was seen under basal or 
induced conditions suggesting that the apicoplast is not selectively turned over 
by a ‘chlorophagy’-like process. 
The labelling of what appear to be apicoplast-targeted vesicles by mCherry-
PfATG8 following loss of the apicoplast strongly suggests that the association 
between PfATG8 and the apicoplast is of physiological relevance. Yeh and DeRisi 
made use of an acyl carrier protein-GFP fusion protein as a marker for the 
apicoplast (Yeh and DeRisi, 2011). By showing a similar localisation of a second 
apicoplast reporter, aE3-GFP, following apicoplast loss, the hypothesis of 
apicoplast-targeted proteins being delivered to the organelle by vesicular 
transport has been further supported in this study. Co-labelling of these vesicles 
could indicate a variety of roles for PfATG8. Regarding a more classical view of 
the role of ATG8, labelling of apicoplast-targeted vesicles by mCherry-PfATG8 
could represent an autophagy-like process. If parasites without an apicoplast 
still translate nuclear-encoded apicoplast-targeted proteins and package them 
for vesicular trafficking to their absent apicoplast target, accumulation of these 
redundant vesicles may trigger their targeting for degradation by an autophagy-
like process that requires PfATG8 labelling. However, the lack of lysosomal 
targets for these autophagosome-like vesicles and the absence of either mCherry 
or GFP in the digestive vacuole of chloramphenicol treated cells, suggest that 
these vesicles are not targeted for lytic degradation. Colocalisation between 
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ATG8-positive autophagosomes and markers for late endosomes and lysosomes 
has been used to suggest maturation and subsequent acidification of 
autophagosomes in mammalian cells (Corcelle et al., 2006, Jager et al., 2004). 
As demonstrated by the absence of apicoplast-targeted vesicle labelling by 
PfRab7, it appears that these vesicles do not mature in an autophagosome-like 
manner. Additional IFA experiments with antibodies against late endosomal 
markers responsible for vesicle acidification such as the B subunit of V-type 
H+ATPase could be used to support this notion further (Karcz et al., 1994). 
Presented here, however, is strong evidence that apicoplast-targeted vesicles do 
not mature in a manner similar to autophagosomes or small haemoglobin-
containing vesicles involved in haemoglobin degradation (Abu Bakar et al., 
2010).   
An autophagy-like process would be unlikely to exist in order to deal with such 
redundant vesicles as they are unlikely to occur under normal parasite 
development – loss of the apicoplast would ultimately lead to death of the 
parasite (Fichera and Roos, 1997) so the opportunity to develop and inherit a 
mechanism to deal with it is unlikely to have arisen. Also, considering the fact 
that PfATG8 labels the intact organelle during normal development, it is unlikely 
that it would be playing a role in a process of degradation. As the parasite 
undergoes schizogony, the apicoplast is postulated to be expanded and 
eventually segmented and incorporated into daughter merozoites via an 
interaction with centrosomes (Striepen et al., 2000, Waller and McFadden, 
2005). During this process the apicoplast must expand enormously and only at 
the very end of schizogony does it segment, requiring an uncharacterised 
membrane degradation process that facilitates the ‘pinching’ of all four 
apicoplast membranes (van Dooren et al., 2005). The temporal and spatial 
control of this segmentation must be exquisitely tightly regulated. Each 
daughter merozoite inherits a single apicoplast while no remaining apicoplast 
material is left behind in the residual body following egress. Considering the 
fairly homogeneous association of mCherry-PfATG8 with the entire apicoplast in 
all intraerythrocytic stages of parasite development, it would seem unlikely that 
this protein was involved in a degradative process responsible for segmentation 
at specific points of the apicoplast during the final stages of schizogony.  
Localisation and function of PfATG8  190 
Evidence presented here supports a hypothesis that PfATG8 plays a role in 
apicoplast homeostasis in an autophagy-independent manner. Labelling of aE3-
GFP-positive apicoplast-targeted vesicles by mCherry-PfATG8 suggests that this 
protein is involved in the delivery of lipids and nuclear-encoded apicoplast-
targeted proteins to the apicoplast. An involvement of PfATG8 in this process 
was unexpected and appears to represent a Plasmodium-specific role for 
PfATG8, not shared by the ATG8 homologue in the closely related parasite T. 
gondii (Besteiro et al., 2011). The delivery of apicoplast-targeted proteins to the 
apicoplast lumen is not fully understood (Lim et al., 2009). While much is known 
about the Toc and Tic transporters of chloroplasts and hence transport across 
the two inner most apicoplast membranes, of cyanobacterial (first) and plant 
origin (second) (Parsons et al., 2007), less is known about the transit of luminal 
proteins across the two outer most membranes, of secondary endo-symbiont 
(third) and parasite (fourth) origin (Tonkin et al., 2008).  The limiting membrane 
of the apicoplast is considered, due to either its transient or continuous 
connection to the membrane of the ER, to be translocated by apicoplast-
targeted proteins co-translationally (Waller and McFadden, 2005). The initial 
signal peptide of the bipartite leader of apicoplast-targeted proteins promotes 
co-translational translocation across the ER membrane from the cytosol to the 
ER lumen. The signal peptide is then cleaved leaving the transit peptide. The 
next stage of the process is poorly understood (Waller and McFadden, 2005). 
Multiple methods have been proposed for transfer of ER luminal proteins to the 
space between the limiting and periplastid membranes of the apicoplast. It has 
been shown that apicoplast-targeted proteins enter the secretory pathway, as 
removal of the transit peptide from the bipartite leader fused to GFP results in 
secretion of GFP into the parasitophorous vacuole (Waller et al., 2000). Whether 
the apicoplast represents a terminal location for a subpopulation of proteins in 
the secretory pathway, which would require recognition and separation of 
apicoplast-targeted proteins from other secreted proteins in the ER, or whether 
all secreted proteins enter the space between the fourth and third membranes 
of the apicoplast and non-apicoplast-targeted proteins then continue on to the 
Golgi, has yet to be elucidated (Tonkin et al., 2008). The presence of mCherry-
PfATG8-labelled aE3-GFP-positive vesicles in chloramphenicol treated parasites 
would support the hypothesis that sorting of apicoplast-targeted proteins occurs 
in the ER before reaching the apicoplast. Yeh and DeRisi and now this study have 
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shown that parasites that have lost their apicoplast are viable provided that an 
exogenous source of IPP was provided (Yeh and DeRisi, 2011). If the secretory 
pathway relied on first passing through the apicoplast one might presume that 
loss of the apicoplast would have profound effects on the ability of parasites to 
target proteins to the host erythrocyte and to its own digestive vacuole. The 
viability of antibiotic treated parasites in the presence of IPP suggests this not to 
be the case. It therefore seems most likely that aE3-GFP-positive, mCherry-
PfATG8-labelled vesicles represent apicoplast-targeted vesicles that are distinct 
from non-apicoplast-targeted secretory vesicles. The apparent absence of these 
vesicles under normal growth is likely due to their highly transient nature, 
budding from the ER and fusing with the limiting membrane of the apicoplast in 
a short space of time (Karnataki et al., 2007). The fact that the apicoplast can 
not be synthesised de novo shows that a protein or proteins encoded by the 
small apicoplast genome must be essential to apicoplast function (Biswas et al., 
2011). It seems possible that in light of the accumulation of apicoplast-targeted 
vesicles in parasites that have lost their apicoplast, that an apicoplast-encoded 
factor facilitates the fusion of these vesicles with the inherited organelle. 
Indeed, treatment of P. falciparum with anti-bacterial compounds in order to 
block apicoplast-encoded gene translation has been noted to disrupt import of 
nuclear-encoded proteins (Goodman et al., 2007). Delivery of nuclear-encoded 
proteins to the chloroplasts of plants may share some similarities to the process 
suggested here. For many years it was suggested that the chloroplast is not part 
of the endomembrane system, and that transport of proteins into the chloroplast 
relies solely on Tic and Toc transporters (Jarvis, 2008). However, recent work 
has lead to the belief that proteins targeted to the membrane(s)/lumen of the 
chloroplast may also be delivered by small ER/Golgi-derived vesicles (Li and 
Chiu, 2010). Whether ATG8 plays a role in delivery of chloroplast-targeted 
material in plants has yet to be determined. 
ATG8 homologues are known to interact with a number of other proteins to 
provide specificity to cargo selection during autophagosome generation 
(Johansen and Lamark, 2011) and to provide an anchor for which the completed 
autophagosome can rely on interaction with the microtubule network (Pankiv et 
al., 2010) and other proteins to dictate the fate of cargoes (Popovic et al., 
2012). It is certainly possible that the labelling of apicoplast-targeted vesicles by 
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mCherry-PfATG8 represents a role for PfATG8 in providing an anchor for 
interaction of these vesicles with the microtubule network or the apicoplast 
itself. Microtubules have been shown to play important roles in intracellular 
transport, organelle dynamism, chromosomal segregation and determination of 
cell shape (Fennell et al., 2008). P. falciparum encodes 2 isoforms of alpha-
tubulin, and a single form of beta-tubulin, all three of which are expressed in 
intraerythrocytic stages, with the two alpha-tubulin forms up-regulated during 
the schizont stage (Bell, 1998). P. falciparum also encodes a single copy of 
gamma-tubulin, which is primarily associated with nuclear division and 
microtubule assembly (Maessen et al., 1993). Mammalian ATG8 homologues have 
been shown to interact with microtubules when in both non-lipidated and 
lipidated forms (Geeraert et al., 2010). This is thought to facilitate the transport 
of autophagosomes from the cell periphery towards the core of mammalian cells 
to promote endolysosomal fusion. The separation of completed autophagosomes 
and lysosomes to stable microtubules and incomplete, forming autophagosomes 
to dynamic microtubules is thought to provide a physical separation of 
incomplete autophagosomes from lysosomes to prevent the initiation of fusion 
before autophagosome cargo has been fully sequestered (Geeraert et al., 2010). 
The potential role for PfATG8 in interaction with microtubules is one that should 
be explored. Microtubules have been shown to be valid drug targets (Fennell et 
al., 2008, Kappes and Rohrbach, 2007), understanding the role they play in 
apicoplast homeostasis could facilitate the exploration of further avenues of 
therapeutic target discovery.  
In addition to interaction with the microtubule network, ATG8 homologues are 
known to act as an anchor point for a number of protein:protein interactions. As 
available evidence suggests that apicoplast-targeted vesicles are single 
membraned and that PfATG8 does not reside within the ER lumen, it would seem 
that PfATG8 plays no role in the selective incorporation of apicoplast-targeted 
proteins into vesicles that bud from the ER. However, it is possible that PfATG8 
conjugated to PE on the outer leaflet of vesicle membranes provides a platform 
for interaction with other proteins. A large number of proteins have now been 
shown to specifically interact with ATG8 homologues (Behrends and Fulda, 2012, 
Johansen and Lamark, 2011, Popovic et al., 2012). LIR (LC3-interacting motif) 
containing proteins interact directly with ATG8 and usually with other proteins 
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forming a bridge between ATG8 and the rest of the proteome. Bioinformatic 
searches for LIR motifs in the proteome of P. falciparum did not identify strong 
candidates for homologues of the LIR containing proteins found in other 
organisms detailed in Figure 5.26. However, as more and more interactions are 
identified the divergence of LIR motifs is expanding rapidly. In fact it has 
recently been reported that ATG1 actually possesses an LIR, and that in addition 
to its role in the initiation of autophagy, it specifically interacts with ATG8 and 
is incorporated into autophagosomes (Nakatogawa et al., 2012b). It is possible 
that P. falciparum possesses divergent LIR motif containing proteins that 
interact with PfATG8.  
The question as to the physiological relevance of the Plasmodium specific loop 
present in PfATG8 also remains. The observation that the 9 residue extension 
between the third beta sheet and alpha helix is conserved in all Plasmodium 
spp. suggests that these residues might contribute an additional binding capacity 
for these proteins. Bioinformatic identification of proteins that may interact 
with PfATG8 will therefore need to take this motif into account. A number of 
immunoprecipatation choices are available to identify protein interacting 
partners. Affinity pull down experiments with extracts from parasites expressing 
either mCherry-PfATG8 or GST-PfATG8 using RFP-Trap (Chromotek) or GST 
Protein Interaction Pull–Down (Thermo Scientific) kits, respectively, followed by 
mass spectrometry could be used initially to identify PfATG8 interacting 
partners. Similar experiments were performed to identify the interaction of 
ATG8 with the cargo recruitment factor p62 (Pankiv et al., 2007), the Rab7 
effector FYCO1 (Pankiv et al., 2010) and an array of Rab GTPase-activating 
proteins (Popovic et al., 2012). Knowledge of proteins with which PfATG8 might 
interact would contribute enormously to the elucidation of the role(s) of PfATG8 
in intraerythrocytic parasites. 
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Figure 5.26: Alignment of LC3 Interaction Regions (LIR) of known interaction partners of the 
yeast and human homologues of ATG8. 
The so called WxxL motif (sometimes referred to as an Atg8-family Interaction Motif (AIM)) 
was first described as forming an interaction with the hydrophobic pocket of ATG8 / LC3 
(Noda et al., 2008). As the number of ATG8 / LC3 interacting proteins has grown, so too has 
the diversity of the WxxL motif (Behrends and Fulda, 2012, Lamark et al., 2009, Noda et al., 
2010, Yamaguchi et al., 2010). 
 
The membrane of the apicoplast has been shown to be highly enriched with PE 
(Personal communication with Prof. Geoffrey McFadden). Another possible 
function for PfATG8 in apicoplast biogenesis could be to ensure provision of PE 
for the membranes of the apicoplast. PE is generated in the ER membrane by 
CDP-ethanolamine:diacylglycerol ethanolaminephosphotransferase from cytidine 
diphosphoethanolamine and diacylglycerol (Bisanz et al., 2006) and can also be 
generated in the mitochondria of mammals from the conversion of 
phosphatidylserine (PS) by PS decarboxylase (Vance, 2008) . Conjugation of PE 
by PfATG8 might sequester PE into the membrane of apicoplast-targeted vesicles 
budding from the ER. Delivery of these PE-enriched vesicles to the apicoplast 
would therefore provide PE for the expansion of the apicoplast during 
schizogony. Neither mCherry-PfATG8 nor PfATG8 have been shown to label the 
ER but in the absence of colocalisation analysis with markers for the ER it can’t 
be discounted that PfATG8 associates with the membrane of this organelle as 
well as the apicoplast. However, considering all the images that have been 
collected showing what appears to be a specific labelling of only the apicoplast 
or apicoplast-targeted vesicles, it seems more likely that PfATG8 only associates 
with apicoplast-targeted vesicles after or very shortly before they bud from the 
ER. This supports the hypothesis of PfATG8 playing a role in apicoplast 
biogenesis dependent on protein:protein interactions, rather than in the supply 
of PE. However, through protein:protein interactions, PfATG8 may contribute to 
the control of the dynamics of the apicoplast limiting membrane. Association of 
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PfATG8 to the limiting membrane of the apicoplast may serve as an anchor point 
for proteins that can alter the properties of this membrane. In other organisms 
ATG8 itself and through interaction with the ATG12:5:16 complex has been 
suggested to mediate the curvature of the expanding autophagosomal membrane 
during the early stages of autophagy (Axe et al., 2008). It is also possible that 
PfATG8 may recruit proteins which play roles in membrane curvature, fluidity 
and rigidity, such as DESAT-1, a lipid desaturase which is suggested to regulate 
membrane fluidity at the site of autophagosome generation in Drosophila sp. 
(Kohler et al., 2009). 
5.3.6 Proposing a model for PfATG8 function 
Based on evidence gathered from biochemical and microscopic analysis of 
mCherry-PfATG8 and PfATG8, a model highlighting the potential roles for 
PfATG8 in the intraerythrocytic stages of P. falciparum can be drawn (Figure 
5.27). Apicoplast-targeted proteins and proteins destined for the secretory 
pathway which possess a signal peptide are co-translationally transported into 
the ER lumen. Once within the ER, their signal peptides are cleaved by the signal 
peptidase complex (Chang et al., 2008, Tuteja et al., 2008). At this point, 
apicoplast-targeted proteins that possess a transit peptide are recognised and 
differentially sorted from proteins destined for the secretory pathway. 
Apicoplast-targeted proteins are recruited to the lumen of single membraned 
vesicles that bud from the ER. These vesicles may form at sites where the ER 
membrane is enriched for PE and PI3P. PfATG8 may also be recruited to forming 
vesicles shortly before their release, or if not, shortly after. PfATG8 conjugated 
to PE on the outer leaflet of apicoplast-targeted vesicles may facilitate their 
trafficking to the apicoplast through either direct interaction with the 
microtubule network, or through interaction with proteins that do. PfATG8 may 
also play a role in the fusion of vesicles with the apicoplast, either through 
interaction with PfATG8 already conjugated to PE on the apicoplast via its ability 
to promote membrane fusion (Nakatogawa et al., 2007) or through further 
interaction with other proteins, possibly including an apicoplast-encoded 
protein. Once fusion has occurred, PfATG8 remains conjugated to PE on the 
outer leaflet of the apicoplast’s limiting membrane. This might promote fusion 
of further apicoplast-targeted vesicles or provide a platform for interaction of 
the apicoplast limiting membrane with other proteins. Proteins targeted to the 
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apicoplast lumen then cross the remaining three membranes via ERAD-like, TOC 
and TIC transport (see 1.1.3.3). Once inside the apicoplast lumen, the transit 
peptide is cleaved by a resident peptidase. 
 
Figure 5.27: Model of PfATG8 function in apicoplast biogenesis. 
1. Proteins possessing a signal peptide are co-translationally transported to the ER 
lumen 
2. The signal peptide is cleaved by ER resident peptidases 
3. Proteins possessing an transit peptide are recognised and differentially packaged into 
apicoplast-targeted vesicles 
4. PfATG8 is recruited to PE in the outer leaflet of forming or newly formed vesicles 
5. Apicoplast-targeted vesicles are transported toward the apicoplast, possibly 
promoted by PfATG8 interaction with microtubules 
6. Fusion of the vesicles with the limiting (fourth) membrane of the apicoplast releases 
the contents into the space between this and the periplastid (third) membrane, 
possibly facilitated by direct or indirect PfATG8 interaction with an apicoplast 
encoded protein (A) (insert) and other nuclear-encoded proteins such as SNAREs (V, 
T) and Rab GTPases (R) 
7. Proteins possessing a transit peptide traverse the third membrane via an ERAD-like 
complex or a TOC apparatus 
8. Traversal of the second membrane is via a TOC apparatus 
9. Traversal of the final (first) membrane is via a TIC apparatus. Once inside the 
apicoplast lumen, the transit peptide is cleaved to produce a mature protein 
10. ER luminal proteins lacking a transit peptide are packaged into non-apicoplast-
targeted vesicles that are not labelled by PfATG8 
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6   Summary and conclusions 
This work has been one of the first to explore the potential for an autophagic 
process in the intraerythrocytic stages of P. falciparum. It has added to evidence 
that autophagy-related proteins, particularly ATG8, may have roles distinct from 
their involvement in a canonical autophagic process and has opened up an 
exciting new avenue of research in P. falciparum.  
Initial identification of potential homologues to a number of ATG and proteins 
complementary to autophagy suggested that the genome of P. falciparum may 
well encode at least a minimal set of core autophagic genes. This analysis was 
supported by a later publication (Brennand et al., 2011) which identified a 
number of the same genes as potential homologues to those in other organisms.  
This study went on to focus on one gene in particular, PF10_0193, predicted to 
encode a homologue to ATG8. Characterisation of the protein product of this 
gene revealed that PfATG8 was expressed during intraerythrocytic stages, 
predominantly during the later stages of parasite development. It was also seen 
to complement ScATG8, suggesting that not only was it capable of fulfilling the 
role of ScATG8 but also that it was able to interact with the ScATG8 conjugation 
machinery present in S. cerevisiae. PfATG8 was seen to localise to subcellular 
structures in intraerythrocytic stage wild type parasites by IFA. These structures 
appeared to differ from the classical punctate appearance of autophagosomes 
observed in other organisms, being elongated and irregularly shaped.  
Expression of an mCherry-tagged PfATG8 fusion protein in P. falciparum 
intraerythrocytic stages was utilised to facilitate further characterisation of 
PfATG8. mCherry-PfATG8 had a similar localisation to endogenous PfATG8, while 
a truncated version, mCherry-PfATG8∆G was found to be dispersed in the 
parasite cytosol. It was observed that mCherry-PfATG8 was processed into a 
modified form and this processing was dependent on the presence of its C-
terminal glycine residue. The modification could also be partially reversed by 
phospholipase D treatment, shown by a decrease in the more mobile form of 
mCherry-PfATG8. These data led to the interpretation that PfATG8 is modified 
by conjugation to a lipid, most likely phosphatidylethanolamine. Modification of 
mCherry-PfATG8 was required for its localisation to subcellular structures, which 
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through colocalisation studies was determined to be the apicoplast. It is 
therefore suggested that endogenous PfATG8 is also modified via its C-terminal 
glycine, and that this results in its association with the apicoplast. The 
processing and localisation of mCherry-PfATG8 was seen to be unaffected by 
methods commonly used to manipulate autophagy in other organisms. This 
suggested that the mechanisms controlling PfATG8 processing and localisation 
may be distinct to those usually responsible for the regulation of autophagy in 
other organisms. Attempts to genetically ablate Pfatg8 were inconclusive and 
the exciting possibility of Pfatg8 being an essential gene remains. 
Together the findings of this study point to a role for PfATG8 in apicoplast 
homeostasis, possibly in membrane-mediated trafficking of apicoplast-targeted 
components. This could represent a novel role for PfATG8 but it does not 
preclude the possibility of PfATG8 being involved in a canonical autophagy 
process at other stages of parasite development or under different growth 
conditions. A role for PfATG8 in apicoplast homeostasis might also be conserved 
in other Apicomplexan parasites possessing an apicoplast but has not yet been 
identified in T. gondii. In this closely related organism an association of TgATG8 
with the apicoplast has not been reported, indicating a key difference between 
teh ATG8 homologues in these two organisms. Further exploration of the 
involvement of PfATG8 in this process might give rise to the identification of 
novel therapeutic targets based around the apicoplast, which has already been 
proven to be essential and a valid drug target (Wiesner et al., 2008). By 
targeting PfATG8, it may be found that parasites can be killed due to defects in 
the apicoplast. While the amino acid sequence similarity between PfATG8 and 
human ATG8 homologues is fairly high, there remains the intriguing presence of 
the Plasmodium-specific loop formed by the 9 amino acid sequence absent in 
other ATG8 homologues. If PfATG8 was found to be essential, there is potential 
scope for design of inhibitors specific for PfATG8 that would not inhibit the 
human ATG8 homologues. Also, as the role of PfATG8 is likely, to some degree, 
rely on the contribution of proteins involved in its conjugation pathway e.g. 
ATG3, inhibition of PfATG8 conjugation may prove to be a valid therapeutic 
strategy. 
While this thesis was being compiled, an article was published entitled 
‘Autophagy-Related Atg8 Localizes to the Apicoplast of the Human Malaria 
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Parasite Plasmodium falciparum’ (Kitamura et al., 2012). Experiments reported 
in this article were similar to those performed as a part of this study and 
reported here. Crucially, the authors of the published article detail similar 
experimental outcomes and draw conclusions in line with those presented here.  
The results of a bioinformatic screen identified the same genes encoding 
potential homologues for Vps34, ATG18, ATG12, ATG7, ATG5, ATG3, ATG4, ATG7 
and ATG8 as those identified in this study.  
Similar characterisation of the potential PfATG8 homologue elucidated that the 
protein appears to be more abundant later in intraerythrocytic development 
with a peak in the schizont stages. They discovered that the protein appeared to 
be present predominantly as a modified form, by comparison to PfATG8 
expressed in mammalian cells which appears not to be modified. They also 
showed that treatment of intraerythrocytic P. falciparum with chloroquine (CQ) 
did not affect the abundance of PfATG8 which led to the conclusion that PfATG8 
is not involved in an autophagic process. 
Localisation studies then reported that PfATG8 appeared to be associated with 
the apicoplast, and by immunoelectron microscopy, they showed that PfATG8 
localised to the membranes of the apicoplast rather than its lumen. Finally they 
reported that neither CQ nor wortmannin treatment of intraerythrocytic P. 
falciparum affected the localisation of PfATG8 leading to the conclusion that the 
association of PfATG8 to the apicoplast membrane(s) is independent of PI3K 
function and therefore appears to represent a role distinct from autophagy. 
While similar conclusions were expressed in this article, the methodologies used 
to gain results were, in some cases, very different to those used in this study. 
This article relied on the use of antibodies raised against PfATG8, which enabled 
immunoelectron microscopy aiming to detect PfATG8 to be performed. This 
confirmed that PfATG8 localises to the membrane(s) of the apicoplast and not to 
its lumen, a conclusion also drawn from the thorough analysis of mCherry-
PfATG8 localisation in this study. The difficulties encountered in generating 
robust antisera specific for PfATG8 in this study precluded the possibility of 
performing immunoelectron microscopy. It is therefore reassuring to see data 
attained by independent research that supports the conclusions drawn in this 
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study. While the use of immunoelectron microscopy is often regarded as the gold 
standard of protein localisation methodologies, a number of key findings 
presented as part of this study can also add to that of the published article. 
Complementation of ScATG8 was crucial to determining that PF10_0193 encodes 
a functional homologue of ScATG8. The generation of P. falciparum lines 
expressing mCherry-PfATG8 and mCherry-PfATG8∆G enabled experiments that 
showed that the C-terminal glycine residue of PfATG8 is essential for its 
modification and that the modified form is sensitive to phospholipase D 
treatment. Chloramphenicol treatment to disrupt the apicoplast in P. falciparum 
intraerythrocytic stages also led to the key finding that mCherry-PfATG8 and by 
inference PfATG8 associates with structures postulated to be apicoplast-targeted 
vesicles. These vesicles did not show additional features of canonical 
autophagsomes, such as labelling by PfRab7, indicating a likely anabolic rather 
than catabolic role. This led to the conclusion that PfATG8 might be involved in 
the processes that provide the apicoplast with proteins and or lipids from the 
ER. This parasite-specific role for PfATG8, which may or may not be in addition 
to its participation in canonical autophagy, was also the main conclusion of 
Kitamura et al. The work presented here therefore appears to be complimentary 
to and also builds upon that now published.  
This work has begun the characterisation of PfATG8 in P. falciparum erythrocytic 
stages. As is often the case, exploring the role of this protein has created more 
questions than answers. The original hypothesis of this study was that P. 
falciparum was likely to make use of the conserved eukaryotic process of 
autophagy to face the differentiation and adaptation challenges encountered 
during its complex life cycle. It appears that while the autophagy-related 
protein ATG8, central to autophagy in other organisms, is conserved, along with 
its ability to become lipidated and associate with membranes, its involvement in 
an autophagic process in P. falciparum erythrocytic stages has not been 
maintained. The association of this protein to the membranes of the apicoplast 
or apicoplast-targeted vesicles appears to be independent of the regulatory 
mechanisms known to modulate autophagy in other organisms. This leaves the 
questions:-  
Is PfATG8 involved in autophagy in other life cycle stages or under different 
growth conditions?  
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 Attempts to inhibit or induce and autophagic response in P. falciparum 
erythrocytic stages did not have an effect on PfATG8 expression, 
lipidation or localisation. However, further experimentation is required to 
exclude the possibility of PfATG8 contributing to an autophagic response 
under certain stimuli. 
What factors control the lipidation of PfATG8 and therefore its association to 
membranes?  
 PfATG8 is translated in a lipidation-competent form. When the temporal 
regulation of expression was altered by expression of a fusion tagged 
mCherry-PfATG8 copy, lipidation of this protein was dependent on cell 
cycle stage. This suggests that the lipidation of PfATG8 is not entirely 
dependent on the temporal control of expression. 
With what proteins does PfATG8 interact? 
 ATG8 homologues in other organisms are known to interact with many 
other proteins, in particular adapter proteins which link ATG8 with the 
rest of the proteome. Identification of PfATG8 binding partners could 
shed light on the function of this protein, particularly in relation to 
apicoplast homeostasis. 
Can PfATG8 be the focus of a therapeutic strategy? 
 Expanding our basic understanding of parasite biology is crucial for the 
identification of much needed novel drug targets. It appears from this 
study that the role of PfATG8 and certain features of the protein itself 
vary from the ATG8 homologues present in humans. This leads to the 
exciting proposition that PfATG8, or the process(es) in which it 
participates, might prove to be valid drug targets. 
This is by no means an exhaustive list of remaining questions but these issues 
could potentially be resolved by future experimentation exploring the PfATG8 
protein in P. falciparum and its homologues in other species of Plasmodium 
parasite. 
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